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Abstract 
Breast tissue engineering is an interdisciplinary field which combines expertise from 
engineering, cell biology, material science and plastic surgery primarily aiming to 
reconstruct breasts following a post-tumour mastectomy. Since breast implants also 
have a cosmetic function, there are a variety of factors that need to be considered in 
order to achieve an ideal surgical and cosmetic outcome. An off-the-shelf 3D printed 
macroporous scaffold therefore may be unnatural-looking and problematic for a large 
number of patients with unusual body shapes. This thesis is therefore focused on 
fabricating scaffolds that can be tailored and customised for each individual patient. 
As part of this PhD project, an integrated strategy was developed whereby image is 
first taken of the breast region of a mastectomy patient using medical imaging 
techniques such as 3D laser scanning, CT or MRI scans. Software packages were 
then developed to process the captured images into a patient-specific 3D computer-
aided design (CAD) model which is then sent to a bioprinter to be fabricated in the 
form of a scaffold suitable for tissue engineering. Concurrently, on the tissue culture 
side, 2 tissue engineering strategies – precursor cell induction vs body-as-a-
bioreactor approach were explored. In the precursor cell induction strategy, patient-
specific scaffolds were seeded with human umbilical cord perivascular cells and 
cultured under static conditions for 4 weeks and subsequently 2 weeks in a biaxial 
rotating bioreactor. These tissue-engineered constructs were then seeded with Human 
Umbilical Vein Endothelial Cells and implanted subcutaneously into athymic nude 
rats for 24 weeks. Angiogenesis and adipose tissue formation were observed 
throughout all constructs at all timepoints. The percentage of adipose tissue 
compared to overall tissue area increased from 37.17% to 62.30% between week 5 
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and week 15 (p<0.01), and increased to 81.2% at week 24 (p<0.01). In case of the 
body-as-a-bioreactor approach, we devised a concept of delayed fat injection 
combined with an empty biodegradable scaffold. 3 study groups were included in 
this study: 
1) Empty scaffold. 
2) Scaffold containing 4 cm3 lipoaspirated adipose tissue. 
3) Empty scaffold + 2 week prevascularisation period. After 2 weeks of 
prevascularisation, 4 cm
3
 of lipoaspirated adipose tissue was injected into 
scaffolds.  
The implants were placed in immunocompetent minipigs  and the animals were 
sacrificed after 24 weeks. Histological evaluation showed that multiple areas of well 
vascularised adipose tissue were found in all groups. The negative control empty 
scaffold group had the lowest relative area of adipose tissue (8.31% ± 8.94) which 
was significantly lower than both lipoaspirate-only (39.67% ± 2.04) and 
prevascularisation + lipoaspirate group (47.32% ± 4.12) and also compared to native 
breast tissue (44.97% ± 14.12) (p<0.05, p<0.01 and p<0.01 respectively). 
During the course of this PhD project, a clinically viable route to design and fabricate 
biodegradable patient-specific scaffolds directly from 3D imaging data sets has been 
demonstrated. To our knowledge we are the first group showing a sustained 
regeneration of high volume adipose tissue over a long period of time using patient-
specific biodegradable scaffolds.  
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Prologue 
 
I remember vividly how the start of this project came to be. In October of 2011, I 
was working as a research assistant in the labs of Dr. Mia Woodruff at the Institute of 
Health and Biomedical Innovation (IHBI). At the time I never thought IHBI would 
continue to remain my “2nd home” for the next 3 years. Late one night, one of the 
other RAs, Edward Ren, and I were examining some microscope images when 
Edward told me that he was applying for a PhD position. I’d never considered 
staying on for a PhD. I’d always wanted to go out to the real world, run a business, 
become an entrepreneur etc. But over the next 2 hours, Ed told me how I could never 
manage researchers without ever being into the shoes of a scientist. At the end of the 
discussion and after mulling the notion a bit more, I had pretty much set my mind 
onto doing a PhD.  
Thus I began searching for researchers whose interests were similar to mine. There 
are many high calibre researchers at QUT which made my decision very difficult. I 
also emailed a Professor at the Karolinska Institute and another at the Australian 
Institute of Bioengineering and Nanotechnology to see if they had any positions 
available. Fortunately, I recalled that one of the Professors at IHBI, whom I’d 
previously helped build a business plan for the first-ever melt electrospinning 
machine, is involved in additive manufacturing and tissue reconstruction research. I 
immediately went to the website of Professor Dietmar Hutmacher and looked up his 
research interests and, having found an instant match, shot him an email at around 
midnight. Dietmar emailed me back at around 1.30am asking me to come in for an 
interview the following morning. So here I was, 7 days before the scholarship round 
deadline, meeting my future boss about a PhD project. At the interview, we mostly 
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talked about the German football league, the Bundesliga, and towards the end we 
started discussing about a potential project. He showed me a few proposals he had. 
One of them was about designing a perfusion-flow bioreactor, another was about 
melt electrospinning and a 3
rd
 one about periosteum tissue engineering. While all 
these projects were really fascinating, they did not match my interests. It was in this 
moment, when all hope was slowly fading, that Dietmar said “We have one more 
project. It’s really new and not much work has been done on it”. He passed a 3-page 
proposal into my hands. I looked at the cover. It was titled ... “Breast Tissue 
Engineering”.....          
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Chapter 1: Introduction 
1.1 Introduction 
The fundamental concept underlying tissue engineering (TE) is the use of a 
combination of cells, biomaterials and physico-chemical factors to improve or 
replace a biological organ. Langer and Vacanti [2] describe tissue engineering as “an 
interdisciplinary field that applies the principles of engineering and life sciences 
towards the development of biological substitutes that restore, maintain or improve 
tissue function” and as such it reflects the congruence of seemingly disparate 
domains: clinical medicine, engineering and biology. The scaffold is expected to 
perform various functions, including the support of cell colonization, migration, 
growth and differentiation. Furthermore, the design physicochemical properties, 
morphology and degradation kinetics of Tissue Engineered Constructs (TEC) must 
also be considered [3, 4].  Owing to such complex design, complex regulatory 
pathways and an intellectual challenge of enormous magnitude, the progress of the 
TE field with respects to its headline goal – to create living replacement parts for the 
human body – has been slow[5]. However, the work of the past twenty years by 
leading scientists and research laboratories in the area have served to clarify our 
understanding of the underlying factors important to achieve the full extent of TE’s 
therapeutic vision. Particular shortcomings of the current TE paradigm involving 
large volume prefabricated scaffolds include the inability to: i) mimic the cellular 
organization of natural tissues; ii) upscale fabrication methods to the economically 
viable scale necessary for clinical application; and iii) address the issue of 
vascularization of the TEC.  
 18 Chapter 1: Introduction 
1.2 Breast tissue engineering 
Since the turn of the 21
st
 century, impetus has been gradually growing towards TE-
based regeneration of adipose tissue for breast reconstruction post-mastectomy. 
Breast cancer is the most frequent cancer among women with an estimation of 1.67 
million of new cases diagnosed worldwide in 2012 resulting in 522,000 deaths.[6] 
Owing to the large number of clinical occurrences, breast reconstruction following 
lumpectomy (partial removal of breast tissue) or radical mastectomy (total removal 
of the breast) has become the sixth most common reconstructive procedure 
performed in America [7]. Lumpectomy defects of less than 25% of the total breast 
volume can typically be corrected by rearranging the local breast tissue. Larger 
lumpectomies and mastectomies require more comprehensive reconstruction 
modalities [8]. Studies show that many women who have had a mastectomy tend to 
suffer from a syndrome “marked by anxiety, insomnia, depressive attitudes, 
occasional ideas of suicide, and feelings of shame and worthlessness”[9]. 
Reconstruction of the breast mound following a mastectomy has proven to alleviate 
the sense of mutilation and suffering that women experience post-surgery. As a 
result, breast reconstruction is offered as a valuable option to any woman undergoing 
surgery for breast cancer. 
Currently, a majority of breast reconstructions are performed with the use of non-
degradable prosthetic implants or by transplantation of autologous free or pedicled 
tissue flaps consisting of skin, muscle and connected vasculature [8]. It is known that 
reconstruction using silicone-based implants leads to formation of a rigid fibrous 
tissue surrounding the implant on an average 5-10 years post surgery - giving a 
spherical and unnatural appearance to the breast [8, 10]. Reconstruction using 
autologous tissue is also associated with tissue resorption and necrosis [11, 12]. 
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Since the publication of the highly cited research paper by Patrick [13] who used 
preadipocyte-seeded polyglycolic acid (PLGA) scaffolds for regenerating small 
volumes of adipose tissue, although many research groups around the world [14-22] 
have made  progress towards the regeneration of  small volumes of adipose tissue, 
significant breakthroughs towards regenerating clinically relevant volumes of fat 
remain elusive. An avid reader will notice that these research groups are ultimately 
targeting perhaps the most critical challenge facing large volume adipose tissue 
regeneration – vascularisation. Within the human body, a majority of the cells lie 
within a distance of 100-200 µm from the nearest capillary, with this spacing 
providing an adequate environment for nutrient diffusion, oxygen supply and waste 
removal [23]. Consistent with this discovery, researchers aiming to regenerate tissue 
using biodegradable scaffolds discovered that this limitation only allowed cells 
within a distance of 200 µm from the nearest nutrient source to  survive and 
participate in the regeneration process [24, 25]. As most such scaffolds rely on the 
principle of diffusion for transporting nutrients and oxygen to the cells, a diffusion 
gradient is formed within the construct where the cells at the periphery of the 
constructs have greater accessibility to nutrients and are therefore most viable. The 
viability and cell number decreases with the thickness of the construct owing to 
differences in nutrient concentration [26]. It has been speculated that this is the cause 
for the unpredictability in the engineering of adipose tissue with a thickness greater 
than a few hundred microns in the laboratory [26].  
Furthermore, the body and breast shape and size of each woman are different [27-
29]. Since breast implants also have a cosmetic function, there are a variety of factors 
that need to be considered in order to achieve an ideal surgical and cosmetic 
outcome. An off-the-shelf 3D printed macroporous scaffold therefore may be 
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unnatural-looking and problematic for a large number of patients with unusual body 
shapes. Our research is therefore focused on generating scaffolds that can be tailored 
and customised for each individual patient. 
In order to overcome these key barriers and engineering challenges, we envisage an 
integrated strategy where images are first taken of the breast region of a mastectomy 
patient using medical imaging techniques such as 3D laser scanning, CT or MRI 
scans. The images captured can then be processed into a patient-specific 3D 
computer-aided design (CAD) model which is then sent to a bioprinter to be 
fabricated in the form of a scaffold appropriate for tissue engineering. Concurrently, 
on the tissue culture side, fat tissue is harvested from the patient. Pre-adipocytes or 
adipose-derived mesenchymal stem cells (AMSCs) and endothelial cells are then 
separated from it and co-cultured onto the fabricated scaffold. Finally, after sufficient 
vascularisation and adipose cell growth is achieved in vitro, the TEC is implanted 
back into the patient to regenerate the breast shape.  
1.3 Main purposes of the PhD project 
The purpose of this research project was three-fold: 
1) Investigate whether surface morphology of silicone implants on a 
microscopic level has a major influence on the cellular behaviour and 
foreign body response.  
2) Develop a methodology to design highly customised patient-specific 
biodegradable scaffolds using a combination of medical imaging and 
additive manufacturing technologies.  
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a. Developing a streamlined methodology to convert a medical 
imaging data set into a CAD format suitable for additive 
manufacturing.  
b. Developing computer algorithms allowing researchers to design 
internal architecture of scaffolds directly from CAD files.  
c. Development of automated algorithms allowing researchers to 
rapidly generate finite element models of a set of scaffold and pore 
architectures directly from computer-numerical-control (CNC) 
machining codes. 
3) Assess the adipose tissue regeneration capabilities of patient-specific 
biodegradable scaffolds in vivo. 
1.4 Possible outcomes and significance 
As a direct outcome of this PhD project, we are the first group demonstrating a 
clinically viable route to achieve sustained regeneration of high volume adipose 
tissue over a long period of time. From a translational research point of view, this 
research will enable the development of world’s first regenerative medicine-based 
therapy for breast reconstruction. Requiring only one surgical procedure, this 
technology demonstrates an adequate cost effectiveness ratio and is therefore 
expected to be driven forward to broad clinical use within a short span of time.  
Key outcomes of this project include the development of innovative new strategies 
for additive tissue manufacturing for soft tissue interfaces and advancement of the 
translation of novel Tissue Engineering/Regenerative Medicine (TE/RM) 
technologies into clinical application. More specifically, direct outcomes of this PhD 
project would: 
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1) Deliver a modular, user friendly software allowing researchers to design 
complex pore architectures within solid CAD models with a level of 
sophistication and control over extrusion parameters not available with 
current computer-aided-manufacturing (CAM) software. 
2) Streamline the process of designing and fabricating patient-specific scaffolds 
by incorporating in silico FEA-based pre-testing methods into the design 
process – allowing a significant shift from the currently popular heuristic 
methods of scaffold design. 
3) Provide a reproducible subglandular large animal model which makes it 
possible to test non degradable (silicone) implants as well as degradable 
scaffolds in an in vivo environment that is very close to the human equivalent. 
This will allow researchers to iteratively improve the surface microstructures 
designs of both implants and scaffolds for tissue engineering leading to novel 
approaches that can limit the incidences of capsular contracture and can 
enhance regeneration of native adipose tissue.  
Perhaps the biggest economic significance of this project can be realised through the 
development of an integrated scaffold design and manufacturing system which can 
be used in a clinical setting. Demographic data reveals that due to the ageing 
population, breast cancer incidences will increase over the coming years [30, 31]. 
The drive, to develop implant design and surgical planning tools allowing an 
efficient communication of a desired cosmetic outcome between the surgeon and the 
patient, is an important cosmetic as well as therapeutic issue - especially considering 
that 15-30% of all surgeries require subsequent corrective surgeries to achieve the 
desired cosmetic outcome [7]. The additional burden on the healthcare system per 
patient per follow-on surgery is approximately AUD 5000 [32]. Since 70% of all 
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patients undergo an average of 2 follow-on surgeries [33], the total healthcare burden 
on the Australian healthcare system alone amounts to AUD 273 million per year. By 
giving the surgeons access to a sophisticated regenerative-medicine based 
personalised scaffold system which effectively communicates the desired shape and 
contours of the breast prior to and during the surgery our proposed technology 
demonstrates an adequate cost effectiveness ratio and is therefore expected to be 
driven forward to broad clinical use within a short span of time. Using a 
sophisticated simulation model of the adoption rate of our technology, we estimate 
that at a mere 50% adoption rate, the potential efficacy savings for both inpatient and 
outpatient care in Australia alone could average in the range of $75 million to $100 
million per year. 
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2.1 Current approaches aimed at breast reconstruction 
Currently, there are 3 main surgical approaches for reconstructive surgery following 
lumpectomy or mastectomy: reconstruction with autologous tissue (reconstruction 
with silicone implants, free/pedicled flaps and lipofilling). 
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Chapter 3: Research Design 
The overall aim of this PhD project was to develop a novel additive manufacturing 
technology platform enabling fabrication of patient-specific breast scaffolds and test 
their adipogenic potential within an in vivo environment. The overall aim was then 
further sub-divided into 4 smaller sub-aims: 
1) Investigate whether surface modifications of breast implants on a microscopic 
level influence cellular behaviour, foreign body response and capsular 
contracture.  
2) Development of a methodology to reproducibly fabricate highly customised 
patient-specific biodegradable scaffolds. 
3) Assessment of adipogenic potential of small volume TECs within a 
subcutaneous nude-rat small animal model.  
4) Assessment of adipogenic potential of scaled-up large volume TECs within a 
subglandular minipig large animal model.  
Fig 3.1 shows the flow of activities undertaken and methodologies developed as part 
of this PhD project. 
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Figure 2.9.1 Visualisation of project flow 
3.1 Investigate whether surface modifications of breast implants on a 
microscopic level have a major influence on the cellular behaviour and 
foreign body response leading to capsular contracture 
After a thorough literature review, minipigs were found as appropriate model 
animals to study breast TE due to their tissue makeup being comparable to humans. 
Along with the aim of establishing a large animal model, a sub-aim of this project 
was to study the interactions between the implant surface and surrounding tissue in 
order to minimise the chances of an adverse fibrosis reaction. The study evaluated 
the impact of three different surface structures on the development of fibrosis and 
subsequent capsular contracture. These three surface morphologies consisted of a 
smooth surface, a textured surface with large pores and a textured surface with small 
pores. It was hypothesised that the data obtained in terms of surface roughness and 
its impact on tissue adhesion and fibrosis would provide unique insights which 
would influence the design of porous biodegradable scaffolds from a completely 
different point of view. 
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For the purposes of establishment of the animal model, commercially available 40cc 
silicone implants (kindly provided by Mentor LLC) were used. The implants were 
manufactured with 3 different surfaces: one surface with 100 pores per inch, having 
an average surface pore diameter of 57.71 microns (Small pores – SP); one surface 
with 65 pores per inch, having an average surface pore diameter of 95.52 microns 
(Large pores – LP) and one with a smooth surface (S). Six female adult Ellegaard 
Göttingen Minipigs were randomly allocated to two groups: a 10-weeks and a 20-
weeks group. N=6 implants were placed in separate subglandular pockets in each 
animal.  
The operation was well tolerated by all animals. No clinical signs of infection were 
noticed and the blood level of leucocytes was not elevated at any time of the study. 
At the end of the 20 week implantation period, it was observed that capsules derived 
from LP implants had the highest stiffness, followed by SP while S implants showed 
the lowest stiffness. Corresponding with capsule stiffness, LP implants also had a 
significantly higher stiffness compared to both SP and S implants (p<0.01). In terms 
of tissue makeup, S group showed the least amount of collagen at 10-week time point 
while SP group were found to have the highest concentration. At 20-week time point, 
the collagen expression in S and LP group increased while it decreased in case of SP 
implants. Immunohistological staining performed on the tissue sections showed that 
at 10-week time point, S group had the highest concentration of alpha smooth muscle 
actin (SMA) while SP had the lowest; whereas at 20-week time point LP implants 
had the highest expression of alpha SMA and SP still showing the lowest expression. 
At 10-week time point, SP group showed the highest expression of Integrin B1 while 
S implant had the least expression. None of the groups showed any major expression 
of osteopontin at any of the time points. 
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Using the newly developed minipig model, we showed that there exists a correlation 
between the surface microtopology of a breast implant and the tissue response. 
However, this effect, at least within the experimental time period, did not improve 
the outcome of capsular contracture significantly when compared to smooth 
implants, suggesting that it may be challenging to guide the cellular response on the 
surface of the implants by modifications in surface design.  
Therefore, based on our observations and those made by previous research studies, 
whereby it was shown that porous polyurethane foams are effective at significantly 
reducing the onset the capsular contracture[243-246], it was concluded that a porous 
biodegradable implant based on tissue engineering principles would provide an 
effective solution to many of the challenges posed by current generation of silicone 
implants. The following sections describe, in a step-by-step way, the novel 
methodologies developed within this PhD project to design and fabricate such porous 
highly customised scaffolds for breast reconstruction. 
3.2 Development of a methodology to design and fabricate highly customised 
patient-specific biodegradable scaffolds  
3.2.1 Conversion a medical imaging data set into a CAD format suitable for 
additive manufacturing 
3D data can be obtained from a variety of medical imaging options including MRI 
scans, CT scans and laser digitiser scans. A methodology needed to be established to 
convert this data into CAD models in a format suitable for additive manufacturing. 
Beyond breast tissue engineering, it is evident that such a methodology will be 
appropriate for generating 3D models for potentially any defect in the human body. It 
was therefore decided to test the versatility of the method on medical imaging scans 
of a different region of the human body. High resolution CT scans (segment 
thickness of 1mm) of the breast region of a female patient and of a patient having a 
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skeletal tumour in the hip region were kindly provided by collaborators at the 
Department of Plastic Surgery and Department of Orthopaedic Surgery, Klinikum 
Rechts der Isar (Technical University Munich). In order to differentiate the soft 
tissue from bone within the imaging data, thresholding technique was employed 
[247]. Using the thresholding technique, a preliminary surface model of the region of 
interest (ROI) was generated using GNU 3D reconstruction software Invesalius 3.0 
(Brazilian Public Software Portal). In order to create a 3D model suitable for additive 
manufacturing purposes, the model size needed to be reduced from approximately 
1GB to 10MB or less. Re-meshing of the model, to reduce the number of triangles in 
the model without causing a loss to the overall structure of the object, was 
undertaken using the method of quadric error metrics [248].  
Automatic functionality of open source software, Meshlab, was then employed to 
perform repairs on the CAD model. Such repairs included closing of holes on the 
surface, removal of duplicate faces, unifying normals for all triangles and removal of 
degenerate faces. The resultant file was deemed appropriate for additive 
manufacturing. 
3.2.2 Generation of computer numerical code (CNC) from CAD models 
Computer numerical code (CNC) is a programming language which controls the 
movements of most additive manufacturing systems. Therefore in order to fabricate a 
scaffold using a 3D printer, it becomes important to convert the 3D CAD model into 
a series of 2D cross-sectional slices and to program the movements of the 3D printer 
using these 2D slices as a guiding template – a process called slicing. A custom 
software/algorithm was therefore developed to slice the CAD models into CNC 
codes.  
 72 Chapter 3: Research Design 
The developed software works in 3 successive steps. In the first step, the algorithm 
slices the CAD model saved in the Standard Tesselation Language (STL) format into 
2D slices separated in the Z-axis by a distance defined by the user. The X/Y/Z 
coordinates of the outlines of these slices is saved in Scalable Vector Graphics 
(SVG) format. Once the layer contours are obtained, the next step would be to fill 
these outlines with an infill pattern. The current version of this slicing software can 
only implement line-based rasters. The spacing between these lines is defined by the 
user. Once the raster line generation process is complete, the raster lines of every 
layer are still aligned parallel to each other – compromising fluid flow and 
mechanical properties within the scaffolds. In order to generate the criss-cross 
rastering-based pattern commonly used in scaffolds, a rotational matrix has been 
implemented. Finally, the X/Y/Z coordinates of the rotated and aligned raster line 
segments are connected into a continuous line and saved in the CNC machining code 
format.  
3.2.3 Development of automated algorithms to rapidly generate finite element 
models of a set of scaffolds varying in porosity, pore geometry, filament 
thickness, and pore interconnectivity directly from the CNC machining 
code 
Using the scaffold design software described in the previous section, the porosity and 
pore sizes of the scaffolds can be tailored independently by changing the laydown 
pattern. The optimal porosity is always determined by a trade-off between 
mechanical properties and pore volume available for tissue ingrowth, as increasing 
porosity inevitably leads to reduction in mechanical stiffness[249]. Stiffness and 
strength should be sufficient in the context of breast tissue engineering, as the 
scaffold should be sufficiently robust to not only resist changes in shape in vitro as a 
result of cell contraction forces yet also the wound contraction forces which will be 
invoked during tissue regeneration. Furthermore, the breast region is also subjected 
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to high biomechanical loads during sleeping and sports activities, and the TECs must 
be able to withstand those forces over a long period of time. 
Current methods of optimally designing a scaffold to balance mechanical strength 
and porosity depend largely on heuristic-based approaches, whereby scientists 
fabricate a large number of scaffold design candidates in the hope that one candidate 
will display suitable mechanical and physical properties when subjected to 
compression/tensile/torsional testing. However, this approach is inherently inefficient 
as the time needed to fabricate a single scaffold can range from 30 minutes to >5 
hours depending on the size of the scaffold and print resolution. Moreover, the 
current approach also lends itself to increased cost of expensive biomaterials and 
waste (if proper biopolymer recycling systems are not in place). 
Therefore, we developed automated algorithms to integrate in silico FEA-based pre-
testing methods into the scaffold design process. 
Parameters such as laydown pattern, filament spacing and filament thickness, which 
primarily control the mechanical properties of the scaffold are controlled by the 
software controlling the Fused Deposition Modelling (FDM) machine and are 
described within the CNC machining code. The movement of the FDM head, and 
consequently the final architecture, entirely depends on the CNC code. Therefore, 
generation of a finite element mesh directly from the CNC has the potential to 
recapitulate the final architectural properties of the scaffold. 
A custom algorithm was therefore developed to generate finite element models 
(FEM) of scaffolds directly from the CNC code. Output from the software was 
directly fed into commercial finite element analysis (FEA) software Abaqus v12.0 
(Dassault Systemes) to perform in silico compression testing of n=15 breast scaffold 
candidates with variations in laydown pattern, filament spacing and filament 
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thickness. Scaffold designs whose mechanical properties were deemed to be 
appropriate for breast tissue engineering were fabricated using a commercial 3D 
printer (Replicator, Makerbot industries, New York, USA). These fabricated 
scaffolds underwent compression testing using an Instron 5848 microtester fitted 
with a 500N load cell (Instron, Norwood, USA) to validate their mechanical 
properties. From the data obtained from the compression testing, one was chosen for 
further in vitro and in vivo testing.  
3.3 Breast tissue engineering and in vivo assessment 
3.3.1 In vivo test for subcutaneous adipogenesis and vascularisation in a nude 
rat model 
Here we investigated patient-specific breast scaffolds fabricated from poly(D,L)-
lactide polymer with pore sizes >1 mm for their potential use in long-term sustained 
regeneration of high volume adipose tissue. 
The scaffold geometry was obtained via laser scanning from a mastectomy patient. 
All scaffolds (n=5), fabricated using Fused Deposition Modelling and, observing the 
tissue response towards textured surfaces described in Section 2.2, were etched with 
0.5M NaOH for 5 minutes to introduce surface roughness and texture. Scaffolds 
were seeded with human umbilical cord perivascular cells and cultured under static 
conditions for 4 weeks and subsequently 2 weeks in a biaxial rotating bioreactor. 
These tissue-engineered constructs were then seeded with Human Umbilical Vein 
Endothelial Cells and implanted subcutaneously into athymic nude rats for 24 weeks.  
Angiogenesis and adipose tissue formation were observed throughout all constructs 
at all timepoints. The percentage of adipose tissue compared to overall tissue area 
increased from 37.17% to 62.30% between week 5 and week 15 (p<0.01), and 
increased to 81.2% at week 24 (p<0.01). The stiffness of the constructs decreased by 
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66% over 24 weeks, while the seeded endothelial cells self organised to form a 
functional capillary network. 
3.3.2 De novo adipose tissue generation using a scaffold-based body-as-a-biorector 
approach 
In our previous study, we undertook a progenitor-cell based approach towards 
adipose tissue regeneration. However, these cell-based approaches also lead to 
several disadvantages – ranging from problems with scaling up of tissue culture to 
requiring complex GMP-certified laboratories for tissue culturing  [250-256]. 
Therefore, in this study we devised a concept of delayed fat injection combined with 
an empty biodegradable scaffold. 3 study groups were included in this study: 
1) Empty scaffold. 
2) Scaffold containing 4 cm3 lipoaspirated adipose tissue. 
3) Empty scaffold + 2 week prevascularisation period. After 2 weeks of 
prevascularisation, 4 cm
3
 of lipoaspirated adipose tissue was injected into 
scaffolds. 
6 implants were placed in each animal (n = 2 per group) and the animals were 
sacrificed after 24 weeks. Histological evaluation showed that multiple areas of well 
vascularised adipose tissue were found in all groups. The negative control empty 
scaffold group had the lowest relative area of adipose tissue (8.31% ± 8.94) which 
was significantly lower than both lipoaspirate-only (39.67% ± 2.04) and 
prevascularisation + lipoaspirate group (47.32% ± 4.12) and also compared to native 
breast tissue (44.97% ± 14.12) (p<0.05, p<0.01 and p<0.01 respectively). However, 
there was no statistically significant difference in relative adipose tissue area between 
the native breast tissue, lipoaspirate-only and prevascularisation + lipoaspirate group. 
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In this study, we have shown regeneration of de novo autologous adipose tissue 
by injecting a small volume of lipoaspirated tissue with no additional growth factors, 
cell transplantation or ligated vascular pedicles by introducing a completely novel 
prevascularisation technique that uses the patient’s own body as a bioreactor and a 
source of blood vessels. 
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Thesis Progress: 
The following figure shows the flow of activities undertaken and methodologies 
developed as part of this PhD project. This study will aim to investigate whether 
surface modifications of breast implants on a microscopic level have a major 
influence on the cellular behaviour and foreign body response leading to capsular 
contracture 
 
4.1.1 Introduction 
Breast cancer is a major cause of illness for women, being responsible for more than 
230,000 cases in 2011 in the US alone [257]. The most common surgical procedures 
to remove the tumor are lumpectomy, which is a partial removal of breast tissue, and 
total mastectomy, which is a total removal of the breast. Such procedures have a 
negative psychological effect on the well-being of the patient. They induce a 
psychological syndrome marked by “anxiety, insomnia, depressive attitudes, 
occasional ideas of suicide, and  feelings of shame and worthlessness” [9]. There are 
several surgical approaches undertaken to reconstruct the aesthetic form of the 
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breast, of which the use of silicone breast implants continues to remain the 
reconstructive method of choice [258]. Among local complications experienced by 
women who have undergone reconstruction with silicone breast implants in the 
ensuing years, capsular contracture is the most common problem [259]. Capsular 
contracture refers to a foreign body reaction resulting into the formation of a capsule 
of rigid fibrous tissue around the implant [37-40]. Cell mediated contracture of this 
capsule ultimately leads to a spherical appearance of the breast and restricted 
shoulder or arm movement [41]. The frequency of occurrence of capsular contracture 
ranges from 15-45% depending on the study and the patient cohort that is 
investigated [10, 42-44]. The risk rises significantly when the breasts are irradiated 
following the implantation [45-48].  
Capsular contracture is classified according to the Baker classification system [260], 
as follows: grade I, breast absolutely natural; grade II, minimum contracture; grade 
III, moderate contracture; and grade IV, severe contracture.  
The pathophysiologic sequence of events leading to capsular contracture is still open 
to debate. A number of factors, including foreign body reaction, hematoma, and peri-
implant infection, have been suggested to be the important in the pathologic process 
[261, 262]. Several lines of evidence suggest a role of subclinical peri prosthetic 
infection in capsular contracture pathogenesis [262-265]. In this process, local skin 
flora (e.g., coagulase-negative staphylococci, Propionibacterium acnes, and 
Corynebacterium species) may gain access to breast implants during or following 
placement. Bacterial biofilms on the implant then stimulate fibrosis around the 
implant, ultimately leading to capsular contracture [266, 267].  
Ever since it was revealed that polyurethane-coated implants have lower rates of 
capsular contracture [243-246, 268, 269], research and industrial efforts have been 
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directed towards determining new ways of surface modifications to improve the 
outcome of silicone implants. Several studies have attempted subcutaneous and 
submuscular implantation of textured implants into animal models and evaluated the 
histology of the subsequently formed capsules. While some studies reported evidence 
of tighter and thicker capsules around textured implants compared with smooth 
implants [243, 270, 271], others showed a reduced occurrence of contracture with 
textured surface implants [272, 273].  
To investigate these issues further, we designed an experimental model in the 
Göttingen Minipig using a bilateral subglandular pocket, with the only experimental 
variable being surface morphology. The surface morphologies consisted of a smooth 
surface, a textured surface with large pores and a textured surface with small pores.  
The aims of the study were to (1) establish a Göttingen Minipig model that 
developed capsular contracture and was reproducible, (2) biomechanically analyse 
the elastic modulus of the capsules and the implants to assess the degree of overlying 
soft-tissue contracture, and (3) assess the effect of surface texturing in this model 
histologically.  
4.1.2 Materials and Methods 
Silicone Implants 
All implants were kindly provided by Mentor LLC (Santa Barbara, USA), each 
having a volume of 40cc and a filling with Mentor Memory Gel™ Cohesive I™. The 
implants were manufactured with 3 different surfaces: one surface with 100 pores per 
inch, having an average surface pore diameter of 57.71 µm, another surface with 65 
pores per inch, having an average surface pore diameter of 95.52 microns, and one 
with a smooth surface (data supplied by the manufacturer – see Supplementary Table 
1).  Hereon, the implants with an average pore diameter of 57.71 µm will be referred 
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to as Textured Small Pores (or SP abbreviated), implants with an average pore 
diameter of 95.52 µm will be referred to as Textured Large Pores (or LP 
abbreviated), while non-textured smooth implants will be referred to as Smooth (or S 
abbreviated).  
Surgical procedure 
The animal experiments were approved by the Animal Ethics Committee of the State 
of Bavaria, Germany. Eight female adult specific-pathogen-free (SPF) Ellegaard 
Göttingen Minipigs were used in this study. The minipigs were randomly allocated to 
two groups: a 10-weeks and a 20-weeks group. The operation was performed under 
general anesthesia, following the standard protocol of sterility requirements for 
breast augmentation procedures. During the implantation procedure of the first two 
minipigs just one big separate pocket was created on each side through a 20 cm 
incision in the middle of the abdomen. With this approach, the implants came into 
contact with each other in the middle of the pocket and formed a combined capsule. 
Therefore a separate evaluation of the capsules was not possible and the two 
minipigs were excluded from the study. Consequently, we modified the procedure in 
the remaining 6 minipigs by dissecting three separate subglandular pockets per side, 
one for each implant (Supplementary Fig. 1). 6 implants were placed in each animal 
(2 SP, 2 LP, 2 smooth). After the placement of the implants each pocket was closed 
up, so that the implants were fixed inside their separate pockets and had no contact to 
each other. Afterwards the tissue was closed in layers, the skin with a continuous 
subcuticular suture and three additional simple interrupted stitches.  
Clinical evaluation of capsular contracture 
The animals were monitored daily until the 14th postoperative day and subsequently 
weekly for postoperative complications and incidence of capsular contracture 
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according to the Baker score. At time of explantation the scoring was performed by a 
second surgeon. 
Explantation 
The explantation operation was performed under sterile conditions. Before washing 
the operation area, a microbiological swab from this skin area was taken. Through a 
lateral incision on both sides, each implant was removed en bloc along with its 
surrounding capsule (Supplementary Fig. 2). Directly after dissociating the implant 
from the capsule, a microbiological swab was taken from one half of the implant. 
The capsule from this half was sent for histological examination. From the remaining 
half, a capsule sample was taken for microbiological culturing and SEM scanning. 
Mechanical Testing and Scanning Electron Microscopy 
Compression testing was performed on the explanted scaffolds using an Instron 5848 
microtester fitted with a 500N load cell (Instron, Norwood, USA). In order to 
minimise mechanical damage to the samples, the testing protocol comprised of a 
50% compression in the case of silicone implants and 15% compression in the case 
of fibrotic capsules – both at a rate of 1mm/min.  
The surface morphology of the implants and the fibrous capsules was examined 
using scanning electron microscopy (SEM) (Quanta SEM/FIB) at 10 kV. The 
samples were prepared according to our standard operating protocol for scanning 
electron microscopy (SEM) sample preparation: After collection the samples were 
fixed in 3% Glutaraldehyde at 4°C for at least 2d, subsequently washed with PBS, 
dehydrated in graded ethanol series and sputtered with gold.  
Histological stainings 
Hematoxylin & Eosin (H & E) 
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Implants were harvested from the pigs after 10 and 20 weeks. After explantation, 
tissue samples were fixed with 4% PFA, dehydrated and embedded in paraffin wax 
using a tissue processor (Excelsior ES, Thermo Scientific, Waltham, USA). 
Constructs were horizontally sliced to 7µm thickness, deparaffinised with Rotihistol, 
rehydrated with a decreasing series of ethanol and stained with H & E. Stained slides 
were scanned with the SCN400 slide scanner (Leica, Solms, Germany) at 20x 
magnification. 
Massons Trichrome 
The slides were deparaffinised with Xylene, rehydrated with a decreasing series of 
ethanol and re-fixed in Bouin’s solution at room temperature overnight. After rinsing 
in tap water for 10 minutes, the slides were stained in Weigert’s iron haematoxylin 
for 10 minutes, rinsed in running warm tap water, stained in Biebrich scarlet-acid 
fuchsin solution for 10 minutes and transferred directly into aniline blue solution and 
stained for 10 minutes. The slides were rinsed briefly in distilled water and 
differentiated into 1% acetic acid solution for 5 minutes.  
Immunohistochemical staining 
Endogenous peroxidase activity was blocked by incubating the slides with 3% H2O2 
at room temperature. Slides were washed thrice with Tris-HCL (pH 7.4) for 2 
minutes and placed in tri-sodium citrate buffer for 20 min at 95
 o
C in a decloaking 
chamber. The slides were incubated with 2% bovine serum albumin (BSA) for 60 
minutes at room temperature and incubated with pre-diluted corresponding primary 
antibody overnight at 4
o
C. All primary antibodies used are listed in Supplementary 
Table 2. The slides were then incubated with immunoglobulin as secondary antibody 
as part of the DAKO Envision Dual Link System-HRP (Ref: K4061, Dako, Glostrup, 
Denmark) for 30-45 min at room temperature. The slides were washed 3 times with 
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Tris-HCl and colour was developed by incubating the slides with 3,3'-
Diaminobenzidine (DAB) solution (1:50) [DAKO liquid DAB+ substrate 
Chromagen System, Ref: K3468, Dako, Glostrup, Denmark]. Finally, the slides were 
washed once with Tris-HCl for 2 minutes and counter-stained with Haematoxylin for 
2 minutes followed by 30 second immersion in 0.1% Ammonium Hydroxide.  
All histological evaluations were performed blinded. 
Histomorphometry 
Histomorphometrical analysis to determine capsule thickness was undertaken using a 
semi-automated approach. The measurements were performed blinded on 10 
consecutive sections from each sample at each timepoint. The slides were relabelled 
by a co-worker who kept the ID key throughout the measurement period. Tiled 
images representing the entire section were imported as a batch in ImageJ (National 
Institute of Health, Bethesda, USA) and measurement lines, approximately 50µm 
apart, were defined on the fibrotic capsule. Thickness of the fibrotic capsule was 
derived from the average lengths of these measurement lines.  
Microbiology 
For the capsule tissue dissociation test, 1 cm
2 
biopsy from each fibrous capsule was 
dissociated in 1ml Phosphate-buffered saline (PBS) with gentle MACS™ Dissociator 
(Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) under sterile conditions. 
From the dissociated capsule tissue as well as from the swabs mentioned in the 
explantation section a microbiological differentiation was performed.  
Statistics 
All data are represented as mean ± SD and are subjected to one-way analyses of 
variance (one-way ANOVA) and Tukey’s post-hoc test (Sigmaplot 12.5). 
Significance levels were set at p<0.05. 
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4.1.3 Results 
Microbiological Analysis 
No clinical signs of infection were noticed and the blood level of leucocytes was not 
elevated at any time of the study. The bacteria found on the implants and capsules 
corresponded to the bacterial skin flora of the minipigs. In the 10-weeks group no 
microbiological swabs from the textured small implant surfaces showed any bacterial 
growth. However, in 3 of 4 (75%) capsules prepared by dissociation technique a 
moderate growth of Staphylococcus lugdunensis was detected. In 2 of 4 (50%) large 
textured surfaces a moderate growth of bacteria was found, Staphylococcus xylosus 
with both methods and Staphylococcus lugdunensis only by dissociation. Bacteria 
(Staphylococcus hyicus) in the smooth surface group were found in 1 of 4 (25%) 
fibrous capsules biopsies. The swabs were negative.  In the 20-weeks group in 1 of 8 
(12.5 %) textured small surfaces an isolated growth of Staphylococcus hyicus in the 
swabs was observed. The same bacteria were found in the collagen capsule of this 
implant after dissociation. In addition a growth of Staphylococcus xylosus was 
detected only by dissociation technique. In 3 of 8 (37.5 %) fibrous capsules from 
large textured surfaces a bacterial growth (Staphylococcus hyicus, Streptococcus 
viridans, Staphylococcus epidermidis) was detected. All the microbiological swabs 
were negative. 2 of 8 (25%) fibrous capsules from smooth implants showed positive 
bacterial growth (Staphylococcus capitis, Staphylococcus warneri) in the biopsy. In 
this group all the microbiological swabs were negative as well. Overall more bacteria 
were detected with the dissociation technique than with the conventional swab 
method. 
Clinical Observations 
The operation was well tolerated by all animals, the wound healing process had no 
complications and no clinical signs of infection were apparent.  The first palpable 
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capsular contracture occured 6 weeks post implantation. After 10 weeks most of the 
implants developed a Baker II capsular contracture, only 25% of the SP implants 
showed a Baker III capsular contracture. Corresponding to the macroscopic 
observations the number of severe capsular contracture (Baker III/IV) increased in all 
groups after 20 weeks. The smooth surface implants showed with 37% the lowest 
occurrence of severe capsular contracture (Baker III/IV), followed by implants with 
small pores with 50%. Most frequently we could observe severe capsular contracture 
around implants with large pores (62.5%). However, the differences between the 
three groups were not significant.  
 
Figure 4.1.1 Gross morphology of S, SP and LP implants prior to implantation 
SEM 
The scanning electron microscopy illustrates the different surface architecture of the 
three different surface types (Fig. 4.1.1). The surface of the LP implants consists of 
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irregularly arranged peaks and valleys building the pore structure. The SP implants 
show very similar pore architecture, albeit smaller sized pores. The corresponding 
capsules reveal a complementary imprint of the pores indicating tissue ingrowth 
inside these pores (Fig. 4.1.2).  
 
Figure 4.1.2 SEM images of the surface of the LP implants consisting of irregularly arranged peaks 
and valleys building the pore structure at 20 week time point. The SP implants show very similar pore 
architecture, however, smaller sized. The corresponding capsules reveal a complementary imprint of 
the pores indicating tissue ingrowth inside these pores. Red scale bars represent 500µm. Yellow scale 
bars represent 100µm 
Biomechanical testing 
Biomechanical analysis of intact implants revealed that all devices remained intact 
and compliant throughout the experimental period. 20 weeks post-implantation, the 
increase in stiffness of the S and SP implants was not statistically significant, while 
we observed a statistically significant increase in stiffness in the LP implants (Fig 
4.1.3a; p < 0.05). At the end of the experimental period, SP implants had the highest 
stiffness, followed by LP implants, while the S implants had the lowest stiffness. The 
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intra-group differences in stiffness at week 20 were all statistically significant (p < 
0.05 between S-LP; p < 0.01 between LP-SP and S-SP). 
In case of capsules, the specimens had both geometrical as well as structural non-
linearities, therefore a stiffness modulus cannot be defined. However, a plot of 
Reaction Force vs Strain shown in Fig 4.1.3b provides an idea of the inherent 
stiffness of the capsules (data averaged for n=15 samples – 2000 data points per 
sample). Only average values have been shown. Standard deviations for individual 
data points have not been shown to preserve legibility). Concurring with the stiffness 
data of intact implants, capsules extracted from the S implants had the lowest 
stiffness, followed by SP. Contrary to the observation in the intact implants, capsules 
extracted from the LP implants showed the highest stiffness.   
Capsule Thickness 
Within the 10-week time point, no significant differences were observed in the mean 
capsule thicknesses (Fig 4.1.3c). The thickness was determined to be around 
2000µm. However, significant inter-group differences were observed in the thickness 
of the capsule samples extracted at the 20-week time point. Overall, capsules 
extracted from 20-week time point were significantly thicker compared to those 
extracted from 10-week time point. The thickest capsule was observed in case of LP 
implants – corresponding well with the biomechanical testing data. Large variability 
was observed in the specimen capsule thickness from the SP implants and the 
difference in the capsule thickness between S and SP implants was not statistically 
significant.   
 89 
Chapter 4: Research Reports 89 
 
Figure 4.1.3 (A) Bar graph showing the Young’s moduli of unused silicone implants and used 
implants after 20 weeks of in vivo implantation. Prior to implantation, SP implants had the highest 
overall stiffness, while S and LP implants had similar stiffnesses. However, after 20 weeks 
implantation, the stiffness value of SP implants grew significantly while those of S and LP implants 
remained relatively constant. (B) Line graph showing Force vs Displacement plots from the 
compression testing of extracted capsules surrounding the implant. LP capsules showed the highest 
stiffness, while the stiffnesses of S and SP implants were similar. (C) Box and Whiskers plot of 
capsular thicknesses at 10 week and 20 week time points. At the 10 week time point, the capsular 
thicknesses of all implants was the same; however, after 20 weeks, the thickness of capsules from all 
groups was seen to increase. LP capsules were found to be the thickest, whereas there was no 
statistically difference between the thicknesses of S and SP capsules. 
Tissue Morphology 
10 weeks time point: 
Masson’s Trichrome Staining showed that at the 10-week time point (Fig 4.1.4 a-c) S 
implants had the lowest accumulation of collagen throughout the thickness of the 
capsule (Fig 4.1.4a). SP implants had the highest overall accumulation (Fig 4.1.4c). 
Also, the collagen fibres seemed to align continuously parallel to the implant surface. 
Interestingly, the capsule-implant interface area did not show any collagen fibres. 
Capsules from LP implant showed an intermediate distribution of randomly aligned 
collagen fibres (Fig 4.1.4b). Similar to the capsules from SP implants, the capsule-
implant interface was devoid of collagen.  
20 weeks time point: 
Overall, capsules derived at the 20-week time point (Fig 4.1.4 d-f) showed a higher 
accumulation of collagen in all specimens. A trend reversal was also observed where 
S capsules showed the highest accumulation of well-aligned collagen fibres 
throughout the thickness of the capsule (Fig 4.1.4d). SP and LP capsules displayed a 
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non-aligned and discontinuous collagen fibre network at the tissue-implant interface 
(Fig 4.1.4 e-f). The density and the alignment of these fibres increased with 
increasing distance from the interface.  
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Figure 4.1.4 (A-C) Masson’s Trichrome staining showing representative images of tissue morphology 
of fibrous capsules from implants removed at 10 week time point. Blue boxes and arrows show the 
regions at the tissue-implant interface and green boxes show capsular regions distal to the implant. S 
implants had the lowest accumulation of collagen throughout the thickness of the capsule (A). On the 
other hand, SP implants had the highest overall accumulation (C). Also, the collagen fibres seemed to 
align continuously parallel to the implant surface. The capsule-implant interface area did not show any 
collagen fibers.  Capsules from LP implant showed an intermediate distribution of randomly aligned 
collagen fibres (B). Similar to the capsules from SP implants, the capsule-implant interface did not 
contain collagen.  All error bars represent 100µm. 
 (D-F) Masson’s Trichrome staining showing representative images of tissue 
morphology of fibrous capsules from implants removed at 20-week time point. 
Overall, capsules derived at the 20 week time point showed a higher accumulation of 
collagen in all specimens. A trend reversal was also observed where S capsules 
showed the highest accumulation of well-aligned collagen fibers throughout the 
thickness of the capsule (D). SP and LP capsules displayed a non-aligned and 
discontinuous collagen fiber network at the tissue-implant interface (E, F). The 
density and the alignment of these fibers increased as the distance from the interface 
increased. All error bars represent 100µm. 
 
Immunohistology 
10 weeks time point: 
As observed with Trichrome staining, S capsules showed the least amount of 
Collagen 1 through the thickness of the capsule, while SP capsules the highest 
amount (Fig 4.1.5 d-f).  
On the other hand, staining for Alpha SMA showed an opposite trend, with S 
capsules showing the highest concentration throughout the thickness, followed by LP 
and with SP capsules having the least concentration of Alpha SMA (Fig 4.1.5 g-i).  
Integrin B1, which plays an essential role in cell adhesion [274-277], was present all 
across the thickness of the SP capsules – including the tissue-implant interface. On 
the other hand, S capsules only showed an Integrin B1 expression at the tissue-
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implant interface. Finally, the expression in LP capsules was limited to areas 
considerably further away from the tissue-implant interface (Fig 4.1.5 j-l). 
Expression of Osteopontin, which has been shown to be involved in the regulation of 
pathological mineralisation [278], was also tested (Fig 4.1.5 m-o). Only SP capsules 
showed isolated patches of Osteopontin expression. S and LP capsules did not show 
any evidence of Osteopontin expression.  
20 weeks time point: 
As described previously, the collagen expression in all samples increased between 
10- and 20-week time points (Fig 4.1.6 d-f).  
As the collagen 1 levels increased, the expression of Alpha SMA decreased 
concomitantly (Fig 4.1.6 g-i). LP showed the largest spread of Alpha SMA however 
the regions which did show its expression were small and scattered. On the contrary, 
SP capsules showed smaller regions of Alpha SMA which were concentrated near 
the tissue-implant interface.  
Integrin B1 expression pattern remained the same in case of S and LP capsules (Fig 
4.1.5 j-l); however, it was seen to increase considerably in case of SP capsules. 
While the highest concentration of Integrin B1 expression was seen at the tissue-
implant interface of SP capsules, less intense expression was also noted throughout 
the thickness of the capsule.  
No sample at the 20-week time-point showed a significant expression of Osteopontin 
(Fig 4.1.5 m-o).  
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Figure 4.1.5 Representative immunological staining images of protein expressions in capsules 
extracted at 10 week time point. S capsules showed the least amount of Collagen 1 through the 
thickness of the capsule (D), while SP capsules the highest amount (F). Staining for Alpha SMA 
showed an opposite trend, with S capsules showing the highest concentration throughout the thickness 
(G), followed by LP (H) and with SP (I) capsules having the least concentration of Alpha SMA. 
Integrin B1 was present all across the thickness of the SP capsules – including the tissue-implant 
interface (j-l). On the other hand, S capsules only showed an Integrin B1 expression at the tissue-
implant interface (J). Finally, the expression in LP capsules was limited to areas considerably further 
away from the tissue-implant interface. Only SP capsules showed isolated patches of Osteopontin 
expression. S and LP capsules did not show any evidence of Osteopontin expression. All error bars 
represent 1mm. 
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Figure 4.1.6 Representative immunological staining images of protein expressions in capsules 
extracted at 20 week time point. It is noteworthy to observe that Collagen 1 was detected near the 
tissue-implant interface in all groups (D-F). The levels of Alpha SMA decreased in all groups (G-I). 
LP showed the largest spread of Alpha SMA however the regions which did show its expression were 
small and scattered (H). On the contrary, SP capsules showed smaller regions of Alpha SMA which 
were concentrated near the tissue-implant interface (I). Integrin B1 expression pattern remained 
relatively unchanged from Week 10 in case of S and LP capsules (J, L); however, it was seen to 
increase considerably in case of SP capsules (L). While the highest concentration of Integrin B1 
expression was seen at the tissue-implant interface of SP capsules, less intense expression was also 
noted throughout the thickness of the capsule. No samples at the 20 week time-point showed a 
significant expression of Osteopontin (M-0). 
4.1.4 Discussion 
Tissue interaction with implant surfaces is of critical importance for the 
biocompatibility of biomaterials and prosthetic implants. The foci of this study were 
on establishing a minipig model to study capsular contracture and determining the 
effect of implant surface topology on fibrosis around the silicone implant. When 
silicone implants are placed in the human body, they elicit a chronic inflammatory 
response characterised by a fibrotic capsule that eventually contracts. Studies have 
shown that this capsule does not adhere to the implant surface itself, allowing for 
relative sliding and friction between tissue and implant [279]. It has been speculated 
that this friction, in turn, promotes the accumulation of inflammatory cells at the 
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implant-tissue interface and thereby causes significant clinical problems. In their 
topical review on implant surfaces, Recum and van Kooten [279] propose that, if 
connective tissue adhesion can be achieved, it would anchor the implant in its tissue 
bed, eliminate the dead space surrounding it and alleviate the problems associated 
with the formation of a chronic inflammatory tissue capsule. Ratner further reviewed 
various surface modifications which could lead to a better adhesion between the 
implant and tissue and concluded that surface roughness on a micrometer scale has a 
significant effect on the cellular response and behaviour [280]. 
In this study, we have created a reproducible porcine subglandular model of capsule 
formation which allows a comparison of histology with biomechanics. According to 
Clugston et al.,[273] some characteristics of the skin of small animals such as rats 
and rabbits differ greatly from those of humans due to the ample mobility of the 
panniculus carnosus area. Pigs on the other hand have a well-differentiated epidermal 
structure, with a thick dermis that is rich in elastic fibres and more strongly attached 
to deeper tissues. In other words, they have certain similarities with humans, but 
structural differences persist that are inherent to the species [281, 282]. In addition, 
the study was directed towards evaluating whether or not implantation of smooth and 
textured implants could generate different tissue responses and lead to different 
capsule stiffness. Using this model, our results indicate that implant surface topology 
has a significant impact on the stiffness and composition of the fibrous capsules 
surrounding the implant. Capsules extracted from SP implants had stiffness values 
very close to that of those extracted from smooth implants. Capsules extracted from 
LP implants had the highest thickness and also the highest stiffness. Brohim et al 
[283] showed that pores smaller than 150µm in height or depth lead to formation of a 
continuous capsule which increases capsule thickness and the risk of capsular 
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contracture. Since the average pore-height in the SP and LP implants used in this 
study ranged from 63-75 µm, it seems likely that the pores were not sufficiently deep 
to have a major influence on capsular thickness and consequently capsular 
contracture. Future studies using SP and LP implants with pore depths ranging from 
50-200 µm are therefore required to provide further insights into the relationship 
between pore depth and capsular thickness. 
It has long been known that a major cause of capsular contracture is the presence of  
myofibroblasts characterized by abundant stress fibres and increased ECM 
production [284, 285]. Previous research has established that the most prominent 
marker of fibroblast to myofibroblast transition is αSMA and the high contractile 
behaviour generated by αSMA in stress fibers plays a fundamental role in 
remodelling injured tissue in wound healing [286, 287]. Results from our study 
indicate that alpha SMA expression levels significantly rose in case of capsules 
extracted from textured implants containing large pores. Based on the above cited 
research, it can be concluded that fibroblasts in these capsules are undergoing 
transformation into myofibroblasts, eventually leading to capsular contracture. This 
effect is clearly reflected in the biomechanical data, where capsules extracted from 
these implants also showed the highest stiffness. Although the capsules extracted 
from textured implants containing small pores show a high expression of alpha SMA 
at the 10 week time point, the expression levels decreased dramatically over the 
following 10 weeks – to the point where the regions expressing alpha SMA were 
localised near the tissue-implant interface which could perhaps be an indication of a 
stronger bond between the tissue and the implant. As described previously, a stronger 
tissue-implant bond is hypothesized to play a crucial role in alleviating the effects of 
capsular contracture. However, further research is needed to determine whether this 
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localized expression of alpha SMA does lead to better bonding at the tissue-implant 
interface.  
Perhaps Integrin B1 is a better indicator of a stronger bond at the tissue-implant 
interface. As mentioned previously, Integrins are a family of heterodimeric 
transmembrane glycoproteins that mediate cell attachment and adhesion [274-277]. 
While this protein has been studied extensively, there is a lack of studies specifically 
targeting its role in capsular contracture.  Our results, however, give a strong 
indication that different implant surface morphologies lead to distinct expression 
patterns of Integrin B1 which correlate with the capsule stiffness measurements. 
Interestingly, there was less collagen 1 detected using immunohistochemistry in LP 
samples compared to what was observed in the Trichrome staining. It is possible that 
other collagens (especially collagen III) play a role that are detected by Trichrome 
staining but not by the specific collagen I antibody [243]. 
Histomorphological analysis of the capsules in this study demonstrated a direct 
relationship between the thickness of the capsule and its stiffness, which corroborates 
previous studies [288, 289]. As expected, a reduction in alpha-smooth muscle actin 
and an increase in collagen also correlated with capsule stiffness. A review of the 
literature demonstrates studies that support [290, 291] and contradict [292, 293]  
these findings.  
The presented study can be classified as a simplified experimental model of a 
complex biological phenomenon seen in human tissue interactions with silicone 
implants; hence, while meaningful, the data may not be completely translatable. 
However, since all implants tested were composed of the same synthetic material, 
their inflammatory responses should be comparable. For future studies, it would be 
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interesting to test textured implants with a range of different pore sizes and also 
perhaps to run the experiment for a longer time period.  
4.1.5 Conclusion 
There exists a correlation between the surface microtopology of a breast implant and 
the tissue response. However, this effect, at least within the experimental time 
period, did not improve the outcome of capsular contracture significantly when 
compared to smooth implants.  
The reported in vivo model now makes it possible to test implants in an environment 
that is very close to the human equivalent. This will allow researchers to iteratively 
improve the surface microstructures designs and hopefully lead to novel approaches 
that can limit the incidences of capsular contracture.   
4.1.6 Supplementary Figures and Tables: 
Implant Surface 
 
Average diameter 
of the surface pore 
(micron) 
Average length of 
the peaks (micron) 
Average length of 
the valleys (micron) 
100ppi texture (SP) 57.71 63.30 56.15 
65ppi texture (LP) 95.52 70.02 74.36 
Smooth (S) no pores no pores no pores 
Supplementary Table 1: Implant suface characteristics of the three tested implant-
types; ppi: pores per inch; SP: Small Pores; LP: Large Pores; S: Smooth 
Primary Antibodies Description 
Collagen 1 Polyclonal Mouse Anti-Collagen: Ref 
ab90395 (Abcam, Cambridge, England) 
Smooth Muscle Actin Rabbit Polyclonal Anti-Alpha Smooth 
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Muscle Actin antibody: Ref ab5694 (Abcam, 
Cambridge, England) 
Integrin B1 Rabbit Polyclonal Anti-Integrin B1 antibody: 
Ref 4706P (Cell Signalling Technologies, 
Denver, USA) 
Osteopontin Rabbit Polyclonal Anti-Osteopontin 
antibody: Ref ab8448 (Abcam, Cambridge, 
England) 
Supplementary Table 2. List of primary antibodies. 
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4.2 STUDY TWO  
Thesis Progress: 
The following figure shows the flow of activities undertaken and methodologies 
developed as part of this PhD project. The previous study showed that textured 
implants did not improve the outcome of capsular contracture significantly when 
compared to smooth implants. It was concluded that a porous biodegradable implant 
based on tissue engineering principles would provide an effective solution to many 
of the challenges posed by current generation of silicone implants. This chapter 
details the methodologies developed as part of this PhD project to fabricate patient-
specific scaffolds using medical imaging scans.  
 
 
4.2.1 Development of a methodology to design and fabricate highly customised 
patient-specific biodegradable scaffolds 
4.2.1.1 Introduction 
For reconstructing a 3D model of a patient’s body region using medical imaging 
methods, 2 approaches are commonly used: generating 3-dimensional volume from a 
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surface scan (eg laser scanning) and generating a 3D surface out of a 3D volume scan 
(eg MRI/CT/Ultrasound). The methodology developed in this study is primarily 
related to merging the volume with the surface to yield a solid CAD model suitable 
for additive manufacturing purposes. In order to validate this novel methodology, 
two proof-of-concept trials were undertaken:  
1. Generating 3D volume of a breast from surface scans using a laser digitiser 
(described in detail by Melchels et al [91]) . Briefly, a Vivid 910 dot-laser 
scanner with built-in high precision camera (Konica Minolta, Marinouchi, 
Japan) was used to perform a 3D scan of the patient from three angles (0
o
 
frontal, and -30
o
 and +30
o
 oblique anterior). The images were imported in 
Rapidform2006 (Inus Technology, Seoul, South Korea) and merged into a 
single-shell object [81]. A custom surfacing algorithm was generated to 
model a virtual chest wall which was merged with the breast surface shell to 
obtain a watertight model of the solid breast. This watertight model was then 
meshed and exported as a Standard-Tesselation-Language (STL) file. 
2. Generating a high-fidelity 2D surface from a volume scanned using MRI/CT 
scans. Commercial software is then used to generate a 3D volume of the 
region of interest from a stack of 2D scan slices.  
a. Beyond breast tissue engineering, it is evident that such a 
methodology will be appropriate for generating 3D models for 
potentially any defect in the human body. It was therefore decided to 
test the versatility of the method also on medical imaging scans of a 
different region of the human body (the hip).  
b. Clinical high resolution CT scans (segment thickness of 1mm) of a 
patient having a skeletal tumour in the hip region were kindly 
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provided by collaborators at the Department of Orthopaedic Surgery, 
Klinikum Rechts der Isar (Technical University Munich, Germany). 
Approximately 3000 slices of the region were taken and saved in the 
DICOM format.  
4.2.1.2 Materials and Methods 
Software 
To render the surface of the scan region in 3D, free (GNU GPL 2) 3D reconstruction 
software Invesalius 3.0 (Brazilian Public Software Portal) was utilised.  
Region of Interest (ROI) 
A free-form region of interest (ROI) was sketched manually along the boundary of 
the hip bone.  
Thresholding 
In order to differentiate the soft tissue from the bone, thresholding technique was 
employed [247]. Bone was identified in the threshold range of -17 to 1802 
Hounsfield units (HU), while soft tissue was identified in the range of -590 to -370 
HU which is consistent with previously published studies [294, 295]. This distinction 
is important because the same technique can also be used be isolate the soft tissue in 
the breast region and reconstruct the surface of the breast.  
The quality of the 3D model changes with threshold level being used. Holes are 
generally seen in the model where the threshold levels have been too high to detect 
the sparser bone areas. While small-sized holes can be filled with a hole-filling 
algorithm, large sized holes can cause severe problems during the additive 
manufacturing process. Moreover, scan artefacts arising due to imperfections in the 
scan, metallic implants within the patient or patient movements during the scan are 
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more likely to be included in the 3D model when the threshold level is too low. Such 
artefacts are also problematic for the additive manufacturing process. Because the 
bone density in various bone-types is different, the threshold levels will vary from 
scan to scan. Therefore, the optimum threshold level will need to be determined by 
finding the right balance between the number of holes within the model and scan 
artefacts every time a model needs to be generated (see Fig 4.2.1). 
 
Figure 4.2.1 The effect of threshold levels on the quality of the 3D model. A - Threshold level at 1900 
Hounsfield units (HU) which is too high resulting in holes within the 3D model. B – Thresholding 
level at 100 HU resulting into artefacts arising out of imperfections in the CT scan. C – Optimum 
threshold level resulting into completely formed bone with minimum artefacts. 
Model re-meshing and repairing: 
The CAD model generated using Invesalius was approximately 1GB in file-size. 
Most currently available computer systems, due to memory and RAM limitations, are 
unable to process such large CAD files for purposes of additive manufacturing. 
Therefore, the file size needed to be reduced to 10MB or less. Therefore, the number 
of triangles within the STL file needs to be reduced without causing a loss to the 
overall structure of the object. Re-meshing of the model was undertaken using the 
method of quadric error metrics, explained in detail by Garland et al [248] with the 
aid of a MeshLab software (ISTI-CNR research centre, Rome, Italy). Briefly, the 
algorithm aims to merge edges shared between adjacent groups of triangles into one. 
When this operation is complete, all edges and faces connected to the removed 
vertices are connected to the newly formed vertex. In order to undertake the 
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simplification, the boundary preserving weight parameter of the algorithm was 
chosen to be 1.0 meaning that the boundary of the model has the same importance as 
the rest; whereas values higher than 1 raise the boundary importance and produce the 
effect of removing fewer vertices on the border. Using these settings, the CAD model 
was re-meshed down to a file-size of ~3MB.   
Automatic functionality of Meshlab was then employed to perform repairs on the 
CAD model. Such repairs included closing of holes on the surface, removal of 
duplicate faces, unifying normals for all triangles and removal of degenerate faces 
(Fig 4.2.2 shows the results of the re-meshing operation). The resultant CAD file was 
saved in the Standard Tesselation Language (STL) format to be used for further 
processing. 
 
Figure 4.2.2 Rendering of the 3D model before (A) and after (B) of the re-meshing process using 
quadratic edge collapse method. As evident from the images, the shape fidelity of the models was 
maintained despite the reduction in the number of triangles defining the model. In other words, the 
morphology of the final processed 3D model did not change during the re-meshing process.  
4.2.2 Establishment of a methodology to fabricate porous patient-specific 
scaffolds from solid 3D computer-aided-design (CAD) models obtained 
through medical imaging scans 
CAD models generated from medical imaging datasets are solid, water-tight 
structures with no porosity. Such models are inappropriate for use in tissue 
engineering because the host tissue cannot infiltrate the interior regions of the 
scaffolds. Therefore, a custom software was designed which takes a solid, non 
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porous CAD file as an input and introduces porosity in the model to make it suitable 
for tissue engineering purposes.   
As mentioned in Chapter 2, the size and shape of every human body is different. 
Therefore, the shape and size of every scaffold needs to be customised. Also, 
different tissues of the body have different requirements in terms of mechanical 
properties, porosity requirements etc. Additive manufacturing (AM) represents one 
of the few manufacturing platforms which can produce such highly customised 
products in an automated manner.  
Every AM machine fabricates the product in a layer by layer fashion (see Chapter 3 
for more details). Therefore, the software developed to fabricate porous models from 
solid CAD files using AM technologies works by slicing a solid 3D model into a 
number of 2D sections, generating an outline of every such 2D section and generate 
architectural patterns within these outlines. These outlines and generated patterns can 
be converted into a number of different file formats to suit different types of AM 
machines.  
The following sections describe the workings of the software developed to fabricate 
porous models from solid CAD files using AM technologies in more detail.  
1) Slicing CAD files to generate an array of 2D layer contours: 
In the first step, the algorithm slices the CAD file (in the Standard Tesselation 
Language – STL format) into 2D slices separated by a distance defined by the user. 
The X,Y,Z coordinates of the outlines of these slices is saved in Scalable Vector 
Graphics (SVG) format. The algorithm and process used to slice the STL files is 
given in Fig 4.2.3 and 4.2.4. Fig 4.2.5 shows a set of points defining a randomly 
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selected 2D slice. Fig 4.2.6 shows all 2D slices stacked on top of each other to form 
the complete 3D scaffold geometry.  
 
Figure 4.2.3 Flow diagram of the algorithm used to slice the 3D STL file into an 
array of 2D slices 
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Figure 4.2.4 Mathematical equation used to derive the coordinates of the points in the 3D model 
intersecting the slicing line 
 
 
 
Figure 4.2.5 Matlab plot of all points derived from a randomly selected layer 
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Figure 4.2.6 Visualisation of layer contours of all layers generated from a breast scaffold 
 
2) Adding rastering lines by plane sweep algorithm. 
As a second step, the algorithm produces n equally spaced imaginary lines 
intersecting the boundary of each layer. As shown in Fig 4.2.5, each boundary is 
defined by a set of unequally-spaced points. The spacing between these lines controls 
the porosity of the final structure.  
A naïve raster lines-adding algorithm would divide the layer into 2 segments by 
using a contour dividing line and then simply connect a point on the –X/-Y side of 
the symmetry plane to its corresponding point in the +X/+Y side of the plane (Fig 
4.2.7). Such a naïve implementation would work if all the points along the boundary 
of the layer are equally spaced. However, as mentioned previously, in most cases 
each layer is represented by a set of irregularly spaced points. Therefore, the naïve 
algorithm would output a set of lines whose spacing cannot be controlled (4.2.8). 
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Figure 4.2.7 Matlab-based visualisation of naïve algorithm for adding raster lines 
 
Figure 4.2.8 Matlab output of naïve algorithm showing irregularly spaced raster lines 
 
In order to solve the problem of irregularly spaced raster lines, a novel algorithm 
based on the principle of plane sweep was implemented. The problem set of the 
sweep algorithm is given as follows: 
 Problem: 
– Given the following sets:  
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a contour defined by an ordered set of points S = {{X1,Y1,Z1}, {X2, Y2, Z2}, {X3, Y3, 
Y3} ….. {Xn, Yn, Zn}}.  
– A set of L = {L1, L2, L3 … Ln} of n line segments in a 
plane separated by a distance x.  
– Our task is to compute all pairs of (Li, Lj), i≠j of segments that intersect.  
 Solution:  
– The main loop of our algorithm sweeps a vertical line L from –X to +X 
direction through the set S (see Fig 4.2.9 for an illustration of the sweep 
line algorithm).  
• The sweep increments i are defined by the filament distance provided by 
the user and is a major determinant of the final porosity. 
– The data structure R (which is initialised as empty) is used to store lines 
from S currently intersecting the vertical lines. 
– Whenever the sweep line (SL) intersects with a line defined by two 
adjoining points in S, the intersection points are entered into the data 
structure R. 
In lay terms, this sweep algorithm moves a line across the 2-dimensional Euclidean 
plane in which the points reside to find intersection points. If the line moves from –x 
to +x direction, all the intersecting points to the –x direction of the line have already 
been detected. As the sweep line passes through an intersecting point, it creates and 
updates a nested data structure consisting of the slope, XY intercept coordinates, the 
closest point to the –x direction of the sweep line and the closest point in the +x 
direction (Fig 4.2.9). At the end of the sweep, the Cartesian coordinates of the 
intersecting points are obtained from the data structure and saved as a text file. 
Readers are encouraged to read an excellent paper by Chazelle and Edelsbrunner 
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[296] explaining the variety of data structures that can be used with such sweep 
algorithms. 
 
Figure 4.2.9. Results of sweep line algorithm to generate raster lines plotted in Matlab. The sweep line 
(SL) moves from –X to +X position on the layer outline. The incremental steps are determined by the 
user and govern the overall porosity of the scaffold. Once the SL intersects with two opposite points 
on the layer contour, it saves their coordinates and generates a raster line connecting the two points 
3) Rotational matrices to generate pores. 
Once the raster line generation process is complete, the raster lines of every layer are 
still aligned parallel to each other – compromising fluid flow and mechanical 
properties within the scaffolds. In order to generate the “criss-cross” pattern 
commonly used in scaffolds, a rotational matrix needs to be implemented. The 
algorithm shown in Fig 4.2.10 governs the rotational matrices. 
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Figure 4.2.10 (LEFT) Algorithm governing rotational matrices. (RIGHT) Results from implementing 
the algorithm on a randomly selected layer (plotted using Matlab). 
 
 All algorithms described in this chapter were used sequentially on breast as well as 
hip CAD files to obtain porous models suitable for tissue engineering (Fig 4.2.11). 
  
 
 
 
 
Figure 4.2.11 Results showing fabrication of different 
types of scaffolds using the STL-Gcode conversion 
algorithm as a proof-of-concept. Left panel shows the 
original solid CAD files generated from medical imaging 
scans. Right panel shows porous scaffold designs 
generated using software described in section 4.2.2. 
Complementary structures were also designed in order to 
temporarily support overhangs in the scaffold geometries. 
The supporting structures were fabricated with a water-
soluble polymer polyvinyl alcohol (PVA) (diameter 
1.75mm, melting point 160-170oC, density 1.25-1.35 
g/cm3) (Kuraray USA, Houston, USA) and were dissolved 
by immersing the scaffolds in a water bath set at 37oC for 
30 minutes. 
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4.2.3 Development of a software package for rapid generation of finite element 
models from numerical-code programming languages  
4.2.3.1 Introduction 
Tissue engineering uses scaffolds that fill the defect, stimulate new tissue growth, 
and become resorbed over time as they are replaced by newly formed tissue [3]. 
Scaffolds intended for different anatomical sites within the human body require 
different physical and mechanical properties to ensure optimal tissue growth. In case 
of breast tissue engineering, the mechanical properties and stiffness of the scaffold 
should match the stiffness of the tissue in the breast region to minimize patient 
discomfort. Moreover, research has also shown that stiffness of the tissue engineered 
construct affects the differentiation of progenitor cells, less stiff implants promoting 
the differentiation of progenitor cells into adipose cells [169, 297]. Therefore, a 
scaffold intended for the reconstruction of such soft tissue needs to be elastomeric in 
nature, with a low overall stiffness. On the other hand, bone tissue engineering 
requires a scaffold architecture with high bulk modulus as the scaffold should be able 
to bear the load imposed during the early recovery period without collapsing. In a 
similar manner, biomaterial-based scaffolds for cartilage tissue engineering require 
flexible, elastomeric materials to match the properties of native cartilagenous 
environment. Several methods are currently being investigated to fabricate 
anatomically-shaped tissue engineering scaffolds with a high degree of precision. 
Among such methods, additive manfacturing methods, in particular the Fused 
Deposition Modelling (FDM) process, garners the highest amount of attention and is 
arguably the most feasible method of fabricating multi-material cell-laden tissue 
engineering constructs [4].  
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Current paradigm of additive manufacturing methods relies upon a certain set of 
established laydown patterns and filament thicknesses to modify the mechanical 
properties of tissue engineering scaffolds for various applications. However, much of 
the development still relies upon heuristic trial-and-error methods. Although several 
studies exist which demonstrate in silico modelling of different scaffold and unit cell 
architectures for a wide variety of anatomical sites, to our knowledge, these methods 
have not been consolidated towards the design and fabrication of geometric- and 
anatomically-shaped scaffolds containing optimal mechanical properties for in vitro 
and in vivo research purposes. Adding complexity to this problem is the fact that 
fabrication of scaffolds by FDM process often relies upon slicing of a solid CAD 
model with no inherent porosity. Parameters such as laydown pattern, filament 
spacing and filament thickness, which primarily control the mechanical properties of 
the scaffold are controlled by the software controlling the FDM machine and are 
described within the computer-numerical-code (CNC) machining code. The 
movement of the FDM machine, and consequently the final architecture, entirely 
depends on the CNC code. Therefore, generation of a finite element mesh directly 
from the CNC has the potential to recapitulate the final architectural properties of the 
scaffold. However, most recent literature concerned with FEA analysis of scaffolds 
manufactured by additive manufacturing relies on designing the final architecture of 
the scaffold using a 3D modelling software and then meshing it [298, 299]. Not only 
is this process time-consuming and labour intensive, the accuracy of the model also 
depends greatly on the skill of the person performing the modelling steps - which 
makes it inherently challenging for scientists not trained in 3D modelling. Moreover, 
a different 3D model needs to be generated and meshed for each modification in 
scaffold design parameters. 
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Therefore, as a part of this PhD project, development of automated computer 
programs that can rapidly generate finite element models of a set of scaffolds varying 
in porosity, filament thickness, and pore interconnectivity directly from the CNC 
machining code was undertaken. Such a technology platform in the future could 
enable even the non-engineers to perform a goal-driven parametric analysis of 
scaffold-designs containing different filament spacings, laydown patterns, filament 
thickness etc from a single solid CAD model in order to determine the optimum 
parameters and architectures tailored for their specific tissue engineering application.  
4.2.3.2 Materials and Methods 
CAD/FEA interfacing algorithm 
Slicing is the first step in generating nodes within a solid CAD model. The 3D solid 
model has to be converted into a series of two-dimensional (2D) slices (contours 
representing boundaries) depending on the slice thickness specified by the user as 
described in section 4.1.2. Data from these slices are converted in numerical-code 
programming language (NC G-code) and grouped into nodes. If the algorithm detects 
that the user has supplied a pre-generated CNC tool-path file, it parses the file to find 
the points used for linear interpolation of the raster toolpath and groups them into 
nodes. Fig 4.2.12 outlines the algorithmic steps designed to parse the nodes from a 
CNC tool-path file: 
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Figure 4.2.12 Algorithmic steps designed to parse the nodes from a CNC tool-path file 
 
The algorithm then asks the user to provide the following values: 
- Filament thickness  
- Loading conditions in terms of force/displacement. 
- Material properties (Young’s modulus and Poisson ratio).  
If the distance between two adjacent nodes is larger than the threshold level specified 
by the user, the algorithm generates additional equally-spaced nodes in-between the 
original adjacent pair to increase solution accuracy. Fig 4.2.13 shows a Matlab 
visualization of how nodes are split to increase result accuracy.  
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Figure 4.2.13 Matlab visualization of the node-split algorithm to increase result 
accuracy. Top left shows the original set of nodes parsed from the CNC output. Top 
Right shows an additional node generated between a pair of original nodes (2x split), 
Bottom Left shows a 4x split and Bottom Right shows an 8x split. 
 
Once all nodes are identified, the algorithm iteratively cycles through the set of 
nodes in each layer. For each node, it finds the succeeding node based on the raster 
toolpath and uses their coordinates to generate a 3-dimensional cylindrical beam 
element (3-noded quadratic BEAM188). Previous studies undertaken within our 
group have shown that BEAM188, which enables shear stress calculations through 
the elements using the Timoshenk beam theory, is the most accurate beam element 
and suits the filament geometry in our model [300, 301].  
A BEAM188 element is defined by nodes I and J in the coordinate system (see Fig 
4.2.14) while Node K is always required to define the orientation of the element. 
Since the coordinates of I and J are already determined in the previous step, 
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coordinates of Node K are found using basic trigonometry operations. The radius of 
the cylinder equals the filament radius provided by the user.  
 
 
Figure 4.2.14 Geometry, node locations and the coordinate system for BEAM188 3-
D Finite Strain Beam. Image adapted from [302].  
  
This cycle repeats for all layers within the geometry and once the sets of elements 
belonging to different layers have been formed, connections are made automatically 
by the FEA software (eg Abaqus, Ansys) between successive layers to form an inter-
connected geometry. The cross-sectional area of the beam elements is calculated 
using the filament thickness value entered by the user.  
Many scaffold shapes contain >1 closed contour loops separated by a non-extruding 
machine movement code (Fig 4.2.12) – this problem is especially exacerbated in case 
of Gcode flavors catering to continuous extrusion 3D printers as no distinction is 
made, in terms of Gcode, between extruding and non-extruding steps. In these cases, 
it becomes important to detect these non-extruding travelling steps and eliminate 
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them from further processing. An intelligent travel path sensing algorithm was 
therefore developed which could detect layers having >1 closed loops and 
subsequently separate the travelling movements from the final results (shown in Fig 
4.2.15, 4.2.16, 4.2.17, 4.2.18). 
 
Figure 4.2.15 Intelligent travel path sensing algorithm to detect layers having 
multiple closed loops 
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Figure 4.2.16 Matlab plot of a randomly selected layer containing two closed loops connected by a 
non extruding raster line 
 
Figure 4.2.17 (TOP) FE nodes and elements of a breast scaffold with travelling paths not separated. 
(BOTTOM) FE nodes and elements of a breast scaffold with travelling paths separated using the 
intelligent travel path sensing algorithm. 
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Figure 4.2.18 Differences in distribution of bending moments in FE meshes of scaffolds with different 
architectures. From LEFT to RIGHT: non-porous breast scaffold, porous breast scaffold with layer 
boundary shells, porous breast scaffold without layer boundary shells, picture of actual fabricated 
scaffold 
 
In the final step, the algorithm converts the nodes, elements, material properties, 
loading conditions and boundary conditions into an Abaqus Input file (.inp) which 
has a fully self-contained finite element model of the scaffold architecture and can 
directly be imported into almost any FEA program to obtain the desired results. 
The mesh density of an FE model must be selected to ensure a computationally 
efficient analysis is performed with suitable accuracy. A coarser mesh results in less 
precision of the results due to the reduced number of nodes at which a solution may 
be found and the necessity for interpolation of results across large distances between 
nodes. However, fine meshes significantly increase the degrees of freedom of the 
solution and therefore result in long computational times. Therefore, the use of an 
extremely fine mesh density will result in very high solution times with little benefit 
in terms of improved accuracy of results.  
To determine a suitable mesh density for the scaffolds, various meshes were analysed 
using a fixed loading condition – a 50% strain was applied in the –Z axis of a breast 
scaffold with a known young’s modulus and the results for axial stress generated 
within the model were compared. The in silico model was also designed to closely 
mimic the experimental setup of compressing the fabricated breast scaffolds shown 
in Fig 4.2.19.  
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Figure 4.2.19 TOP: Schematic diagram of the test setup used for compression testing of scaffolds. 
Due to the curved nature of the scaffold surfaces, special top and bottom surface attachments 
following the contours of the scaffolds were produced.  The top attachment links with the Instron 
microtester plunger providing uniform stress across the entire scaffold. The attachments were 
produced with non-porous acrylonitrile butadiene styrene (ABS) with a considerable higher stiffness 
compared to the 90% porous PDLLA scaffolds, to minimise their influence on the load readings. 
BOTTOM: Distribution of von Mises stresses in scaffolds with different internal architectures and 
filament thicknesses.  
 
Six different mesh densities were analysed: 
 No node splitting (1x1). 
 2 extra nodes added between 2 successive nodes (4x1). 
 3 extra nodes added between 2 successive nodes (6x1). 
 4 extra nodes added between 2 successive nodes (8x1). 
As expected, although with each split of the node sets, the solution accuracy 
increased dramatically, the computational time also increased exponentially (see Fig 
4.2.20), with the 8x1 split mesh displaying the best balance between solution 
accuracy and computational time (analysis was performed on a desktop computer 
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equipped with an Intel i7-2600 CPU clocking at 3.40 GHz and 8GB of system 
RAM).  
 
Figure 4.2.20 Mesh optimization study performed to test the accuracy of the meshes and the FEA 
method. Blue columns refer to the young’s modulus while the red line refers to the computational time 
axis. 
The final mechanical properties of a scaffold are a function of both the material 
property of the biopolymer and its architecture [3, 104]. In terms of base mechanical 
properties, presently there exists no suitable biodegradable polymer which can easily 
be processed using additive manufacturing whose mechanical property is appropriate 
for soft tissue engineering. Therefore, for all future studies, we selected the 
architecture which provided the most elasticity to the scaffold irrespective of the 
polymer and fabricated the scaffolds using a model biodegradable polymer (Poly-
D,L Lactide). Properties of this architecture are given in Table 4.2.1. In this project, 
our main focus was on the design and fabrication of anatomically-shaped patient-
specific scaffolds using a polymer that degrades over the time scale of 1-2 years; we 
did not aim to produce a scaffold whose mechanical properties matched those of 
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native adipose tissue. Our vision is that in the future when a suitable soft and 
elastomeric biopolymer has been discovered, its mechanical properties can be 
plugged directly into the Gcode-to-FEA software to design a scaffold optimised for 
breast tissue engineering. 
Material Porosity Laydown 
pattern 
Filament 
diameter 
Young’s 
Modulus 
Poly-D,L 
Lactide 
95% 0-60-120 0.4mm 3.068 MPa 
Table 4.1 Scaffold properties 
4.2.4 Overall Discussion 
There has been a palpable trend since mid-2000’s to transfer the CAD/CAM 
techniques from bench to bedside [303-306]. Clinicians have been employing 
custom-made metal prostheses for the treatment of various bone defects for over 20 
years [307, 308]. Such prostheses, which are often fitted with custom-made surgical 
guides, are produced using high resolution MRI or CT-scan data. Although they 
provide clinicians with many reconstructive options, their failure rates remain high 
[308]. A majority of breast reconstructions are also currently being performed using 
implantable prostheses composed of a vulcanised silicone rubber sac filled with 
saline or liquid silicone solution. Such implants, as explained in a previous section, 
often lead to formation of rigid, fibrous scar tissue surrounding the implant – a 
painful condition termed as capsular contracture. Transplantation of autologous free 
or pedicled flaps gives a natural appearance and feel; however, they such approaches 
for breast reconstruction are marred with problems of tissue resorption and necrosis. 
Therefore, a reconstructive method is needed which does not rely on the use of 
permanent prosthetic implants but rather on biodegradable and biocompatible 
materials supporting natural healing processes.  
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In this study, the feasibility to employ CAD/CAM as an aid for autologous tissue 
regeneration has been demonstrated. A versatile approach has been developed to 
generate patient-specific scaffolds not only for breast reconstruction, but also for 
virtually any defect. This approach allows for high level of automation and requires 
minimal manual handling. For this, we made use of freely available open-source 
software to convert high resolution MRI or CT scan data into 3D CAD models using 
the thresholding technique. The specific advantage of the thresholding technique is 
that it allows for relatively easy differentiation of tissue/area of interest from its 
surrounding region. Using this method, porous models mimicking the overall shape 
of a scanned tissue region can be generated.  
For most tissue engineering constructs, a suitable scaffold porosity lies between 70-
90% [3, 309] to allow optimum effective and efficient nutrient transport as well as 
vasculogenesis. The pore sizes, on the other hand, vary depending on the application. 
For regenerating small volumes of tissue 400µm pore sizes may be adequate, 
whereas pore sizes >1-2mm are required for regenerating large volumes of hypoxia-
sensitive tissue [310, 311].  
However, such high levels of porosity and large pore sizes are likely to compromise 
the mechanical strength of the constructs. While the considerations for high 
mechanical strengths bear less importance in the case of breast reconstructions, they 
become important if the scaffold is intended to be used at a load-bearing site. The 
overall porosity and pore sizes can also be precisely controlled using the inherent 
porosity inducing algorithm. However, these values are limited by the resolution and 
accuracy of the employed CAM method. Although in the past few months, 
proprietary software have been developed for FDM machines specialised for scaffold 
fabrication [312-314], such software are closed source, do not support the fabrication 
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of porous models and are unavailable for use with custom-made biofabrication 
machines. Moreover, it was found that such software packages have not yet achieved 
the level of sophistication and control over extrusion parameters required in the 
biofabrication industry. Using the presented method for fabricating scaffolds is not 
only versatile across almost all FDM or CNC machines. The cross-platform nature of 
all the software packages used also makes this process suitable for use with 
experimental additive manufacturing devices being developed.   
An independent method has already been developed by our research group to laser 
scan a breast surface, generate a 3D model and fabricate a porous prototype using 
non-biodegradable materials [91]. The method developed during the course of this 
PhD project complements this method in that it allows the fabrication of porous, 
biodegradable scaffolds using more ubiquitous MRI and CT scans. Combined 
together, these methods encompass an almost comprehensive range of avenues for 
generating porous patient-specific scaffolds.   
In this project, we have taken the idea of designing and fabricating porous patient-
specific scaffolds to the next level by incorporating in silico pre-testing methods into 
the design process. Currently, a majority of scaffold designs are generated using 
heuristic methods whereby scientists fabricate a range of scaffolds with different 
architectures in the hope that one candidate will display suitable mechanical and 
physical properties when subjected to compression/tensile/torsional testing. 
However, this approach is inherently inefficient as the time needed to fabricate a 
single scaffold can range from 30 minutes to >5 hours depending on the size of the 
scaffold and print resolution. In contrast, the Gcode-to-FEA program described in 
this chapter helps researchers, especially those without an engineering background, 
to predict the physical properties of their scaffolds before the fabrication process – 
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resulting in time and cost savings. The obtained results showed that the software is 
promising because of its efficiency and simplicity. At the same time, it is also 
important to be aware of some limitations of the software because biomaterial 
behaviour and physical properties in vivo are more complex than the simplified 
models currently being used in the software. The software designed uses BEAM188 
elements to model the scaffold filaments. Such elements have been previously used 
previous studies done in our group [301] and are based on the Timoshenko beam 
theory which is a first order shear deformation theory with the underlying 
assumption that transverse shear strain is constant through the cross section [302]. 
However one of the limitations of this approach is that only moderately thick beams 
can be analysed. Moreover, many FEA software packages do not provide options to 
calculate the torsional shear distribution on such cross sections. Other assumptions 
such as degradation kinetics, change in Young’s modulus and the effect of tissue 
infiltration on the mechanical properties were also excluded. However, it is expected 
that the development of this software will continue beyond the duration of this PhD 
project and future versions will incorporate more complex models of material 
behaviour and form a basis for future parametric studies to be investigated.  
4.2.5 Conclusion 
In conclusion, the designing of a scaffold that will yield the best possible properties 
to facilitate tissue regeneration is a complex problem and will require a multitude of 
in vitro and in vivo experiments. This chapter described a holistic methodology 
enabling a researcher to obtain optimally designed porous constructs directly from 
medical imaging scans in one streamlined approach, and in turn creating synergies 
between disparate research fields such as medical imaging, biomaterial science, 
additive manufacturing and in silico modelling. The ultimate goal of the presented 
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software is to evolve into a complex system that will integrate seamlessly with high-
end bioprinting hardware and enable a complete design process to facilitate 
fabrication of optimal scaffolds for not only the tissue engineering purposes, but also 
the broader advanced manufacturing and industrial design industries. 
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Thesis Progress: 
The following figure shows the flow of activities undertaken and methodologies 
developed as part of this PhD project. The previous study showed a versatile 
methodology developed to obtain patient-specific scaffolds suitable for tissue 
engineering purposes directly from medical imaging scans. This chapter will focus 
on testing the regenerative potential of the fabricated scaffolds in a small animal 
subcutaneous model.  
 
4.3.1 Introduction 
Breast cancer is a global problem and a major cause of morbidity, with an estimated 
number of approximately 300,000 new cases diagnosed in 2013 [315]. While 
treatment concepts have moved from radical mastectomy to lumpectomy and 
adjuvant therapies such as chemotherapy, radiation or hormone therapy, there is still 
a significant number of patients suffering from the consequences of surgical removal 
of breast tissue.  Such procedures often have negative psychological effects on the 
well-being of the patients. Earlier studies by Renneker et al. [9] showed that 
mastectomy is directly related to a psychological syndrome “marked by anxiety, 
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insomnia, depressive attitudes, occasional ideas of suicide, and  feelings of shame 
and worthlessness”  [9].  Although several new approaches exist today in order to 
anatomically reconstruct the breast, some women still report the feeling of an altered 
body image [316]. This might partly be due to the fact that reconstructive methods 
available today repair, yet do not regenerate native adipose tissue, which is necessary 
for restoring the natural shape and feel of a breast. Prosthetic silicone-based implants 
are associated with a high occurrence of foreign body response altering the shape of 
the breast [36, 37, 40]. Autologous fat tissue transplantation and free tissue flap 
transfers are also a popular option among plastic surgeons. However, they are 
associated with a high risk of tissue shrinkage, fat necrosis and/or oil cyst formation 
[52, 53].  
To overcome the limitations of current breast reconstructive techniques, impetus has 
been steadily growing towards cell-based regeneration of adipose tissue. Tissue 
Engineering and Regenerative Medicine (TE&RM) approaches aim to move the field 
away from methods to replace damaged tissue with permanent implants to more 
biological solutions that are able to restore structure and function of autologous 
tissue [311]. Since the publication of the pioneering research paper in year 1999 by 
Patrick et al. [73] who used preadipocyte-seeded polyglycolic acid (PLGA) scaffolds 
for regenerating small volumes of adipose tissue, many research groups around the 
world [16, 20-22, 317-321] have produced interesting results in the field. However, 
formation of sufficient volumes of mature adipose tissue remains a major problem 
and so far it has not been possible to maintain the structural entity of these constructs 
for more than 8-16 weeks [72, 322]. Current developmental efforts are therefore 
directed towards resolving problems that prevent the upscale of adipose tissue 
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engineering concepts towards clinically relevant volumes that can be maintained 
throughout the life of the patient.  
Previous studies undertaken in our laboratory have established a clinically viable 
methodology to design scaffolds for breast tissue engineering from patient-specific 
imaging data [91]. In this project, our main focus was on the design and fabrication 
of anatomically-shaped patient-specific scaffolds using a polymer that degrades over 
the time scale of 1-2 years. Previous reports have indicated that a scaffold made out 
of such a slow-degrading polymer provides a long-term stable platform for the 
adipose tissue to regenerate and to mature, remodel its environment and stabilise 
[323]. We hypothesised that a slow-degrading polymer with pore sizes in the range 
1-2 mm allows for efficient vascular in-growth and long-term sustained regeneration 
of high volume adipose tissue.  
4.3.2 Methods and Materials 
Image acquisition and Computer Aided Design (CAD) model generation 
A 3D cad file was generated based on a 3D laser scan performed on a 46 year old 
female patient who suffered from an invasive ductal carcinoma from a data set 
previously derived [91]. Briefly, a Vivid 910 dot-laser scanner with built-in high 
precision camera (Konica Minolta, Marinouchi, Japan) was used to perform a 3D 
scan of the patient from three angles (0
o
 frontal, and -30
o
 and +30
o
 oblique anterior). 
The images were imported in Rapidform2006 (Inus Technology, Seoul, South 
Korea) and merged into a single-shell object [81]. A custom surfacing algorithm was 
generated to model a virtual chest wall which was merged with the breast surface 
shell to obtain a watertight model of the solid breast. This watertight model was then 
meshed and exported as a Standard-Tesselation-Language (STL) file.  
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Design & Fabrication of scaffolds  
The volume of the original CAD model (194 cm
3
) was scaled down to 3 cm
3
. 
Skeinforge-55, open-source slicing software, was used to generate machining 
computer-numerical-control (CNC) code from the CAD file. Custom slicing software 
was designed to selectively remove the perimeter shells of each layer. The resultant 
CNC code was then used to fabricate the scaffolds using the Replicator 3D printer 
(Makerbot Industries, New York, USA). During extrusion of the scaffolds, the layer 
thickness was set to 0.37 mm, porosity value was set to 90%, operating flow rate and 
feed rate were matched to 41 mm/s and extrusion temperature was set to 220
o
C. 
MicroCT (µCT) evaluation of scaffolds 
The specimens were scanned on a Scanco µCT40 (Scanco AG, Brüttisellen, 
Switzerland), employing 55 kV and 145 µA with 250 ms exposure time. Porosity, 
pore-size and filament-size distributions were obtained by employing a modified 
trabecular bone histomorphometry algorithm.  
Isolation and culturing of primary human umbilical cord perivascular cells 
(HUCPVCs) 
HUCPVCs represent a rich source of human mesenchymal cells found in the 
perivascular region of the human umbilical cord [324] and have recently gained 
attention in the tissue engineering field due to their short doubling time, and high 
occurrence of colony-forming-unit-fibroblast (CFU-F). HUCPVCs isolated from 
consenting full-term caesarean section patients were obtained from Tissue 
Regeneration Therapeutics Inc. (Toronto, Canada). The HUCPVCs were isolated as 
reported previously [324] and were received in passage 2. HUCPVCs were 
maintained in Dulbecco’s Modified Eagle Medium (containing 4600 mg/L glucose) 
(Invitrogen, Carlsbad, USA) growth media supplemented with 10% (v/v) fetal 
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bovine serum (Lonza, Basel, Switzerland) and 1% (v/v) Penicillin (10,000 U/ml) – 
Streptomycin (10,000 μg/ml) (Invitrogen, Carlsbad, USA) in a humidified incubator 
at 37
o
C and 5% (v/v) CO2.  
Culturing of primary human umbilical vein endothelial cells (HUVECs) 
HUVECs were obtained from American Type Culture Collection (Rockville, MD, 
USA) and maintained in F12K medium (Invitrogen, Carlsbad, USA)  supplemented 
with 0.1 mg/ml heparin (Sigma, St Louis, USA), 0.05 mg/ml Endothelial Cell 
Growth Supplement (Millipore, Billerica, USA), 10% (v/v) fetal bovine serum  
(Lonza) and 1% (v/v) and Penicillin (10,000 U/ml) – Streptomycin (10,000 μg/ml) 
(Invitrogen, Carlsbad, USA), in a humidified incubator at 37
o
C and 5% (v/v) CO2. 
HUVECs were used between passages 2 and 8.  
Production of GFP Lentiviruses and transduction of HUVECs 
HUVECs were labelled with enhanced green fluorescent protein (eGFP) using a 
pLenti CMV GFP Puro (658-5) plasmid (Addgene 17448) and packaged with 
plasmids pRSV-Rev, pMDLg/pRRE and pMD2.G (contains VSV.G gene) (Addgene 
12253, 12251 and 12259). The pLenti CMV GFP Puro plasmid were amplified in 
Escherichia coli and purified using W/Endo-free Qiagen Maxi-Prep Kit (Promega) 
according to the manufacturer’s instructions and packaging plasmids were amplified 
in Escherichia coli and purified using Maxi-Prep Kits (Qiagen). Packing cell line 
293T cells (GenHunter Corp.) in a T75 flask were transfected with 6.6 mg pLenti 
CMV GFP Puro (empty) and 3.3 mg of each packaging plasmids pRSVRev, 
pMDLgpRRE and pMD.G in 133 μl 1.25 M CaCl2, 0.5 ml H2O and 0.66 ml 2 x 
HEPES buffered saline and the cells were incubated at 37°C/ 5% CO2. Four hours 
later, the medium was removed, cells were washed twice with warm phosphate-
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buffered saline (PBS) and replaced with 5 mL of complete DMEM. The cell culture 
supernatant was harvested 48 hr later by centrifugation at 850 g for 7 min at 4°C, 
followed by filtration of the supernatant through a 0.45 μm filter. The viral 
supernatant was concentrated 80-100 times using Amicon Ultra 15 ml centrifugal 
filter units (Millipore). The lentiviral stocks were stored in small aliquot at -80°C for 
titration and cell transfection. Titer of the concentrated lentivrial was determined by 
plating 4x10
5
 293T cells in 6-well plate and infecting the cells with serial (10-fold) 
dilutions of concentrated lentivirus. After 48 hours, cells were trypsinised, washed 
three times with cold PBS and fixed with 1% paraformaldehyde (PFA) for 30 mins. 
The fixed cells were analyzed using FACSCalibur for eGFP expression and for a 
typical preparation, the titer was approximately 10
7
 to 10
8
 infectious units per ml. 
GFP                                                                                                                                                                                                                                                                                                                                                                                                  
HUVECs (2x10
6
) in T175 flask were infected with 10 infectious units per cell in 5 
ml of complete DMEM with polybrene (8 μg/ml) (Santa Cruz biotechnology) for 1 
hr incubation at 37°C/ 5% CO2 before the addition of 15 ml of complete 
DMEM/polybrene. Incubation was continued for 24 hrs before DMEM/polybrene 
media was replaced by complete DMEM. 48 hours post-transduction, the media was 
replaced with DMEM complete with 0.5 μg/mL of puromycin (Invitrogen), as 
determined previously by a puromycin kill curve (0.2-4 μg/mL) with HUVECs, in 
order to select for eGFP positive cells.   
Preparation of cell-seeded TECs 
Breast-shaped PDLLA scaffolds were first washed with sterile PBS and for 
sterilisation immersed in 70% ethanol overnight. Once the ethanol evaporated, the 
scaffolds were subjected to UV-irradiation for 30 minutes on each surface. Sterilised 
scaffolds were later placed in PBS overnight to pre-wet them. HUCPVC were 
 138 Chapter 4: Research Reports 
detached using 0.25% trypsin, washed with PBS and resuspended in culture media. 
20x10
6 
HUCPVC were seeded onto each scaffold within a fibrin matrix (Baxter, 
Toongabbie, Australia) to improve cell attachment. After trypsinisation, the cell 
suspension was diluted with thrombin solution at a ratio of 1:1. 600 µL of 
cell/thrombin suspension was mixed with 600 µL fibrinogen solution and seeded on 
each scaffold. Cell-seeded scaffolds were cultured at 37
o
C and 5% CO2 in complete 
DMEM.  
After 4 weeks of static culture, all scaffolds were subjected to a dynamic culture 
environment for 2 weeks utilising the TisXell biaxially rotating bioreactor (QuinXell 
Technologies, Singapore) for 8 hours per day at 5 rpm. The bioreactor setup has been 
previously described elsewhere [325, 326].  
In vivo implantation into athymic nude rats 
The animal experiments were approved by the Animal Ethics Committee of the 
Queensland University of Technology (ethics approval number: 11-147). Three 7-
weeks old male athymic nude rats were purchased from the Animal Resources 
Centre (Perth/Australia). Rats were anaesthesized with a mixture of Ketamine (100 
mg/kg) and xylazine (10 mg/kg). Surgeries were performed in a laminar hood under 
sterile conditions. A single 3 cm midline incision was made over the spine of the rats. 
Subcutaneous pockets were created on both flanks by blunt dissection and one 
scaffold was placed in each pocket. Before the wound was closed, scaffolds were 
injected with a solution of HUVEC encapsulated in Matrigel (1.3 x 10
6
 cells per 
scaffold). The wound was closed with clips and swabbed with sterile iodine. At the 
end of the surgery, analgesic (Buprenorphine at 0.05 mg/kg s.c.) was administered 
subcutaneously.  
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Fluorescent imaging 
In vivo imaging to detect the GFP signal from HUVEC was performed on the IVIS 
Spectrum imaging system (Caliper Life Sciences, Alameda, California) every 3 
weeks. Rats were anaesthetized with 5% isoflurane and remaining fur was gently 
removed. Imaging was performed by setting the emission filter at 540 nm, excitation 
filter at 500 nm, exposure time at 0.2 seconds and luminescent exposure at 2 seconds. 
The images were imported into IVIS Living Image (version 4.3.1) software (Caliper 
Life Sciences, San Jose, USA) and native tissue autofluorescence was subtracted 
using a spectral unmixing algorithm. Once the autofluorescence was subtracted, all 
images were normalised to a minimum colour scale of 800 counts. 
Mechanical Testing 
Compression testing was performed on the explanted TECs using an Instron 5848 
microtester fitted with a 500 N load cell (Instron, Norwood, USA). Since the top and 
bottom surfaces of the patient-specific scaffolds are convex in nature, a support and a 
loading mould (illustrated in Supplementary Fig 4.3.3) were fabricated in order to 
evenly distribute the forces on the TECs. The supporting structures were fabricated 
with Acrylonitrile butadiene styrene (ABS) polymer with a young’s modulus of 3.5 
GPa. In order to minimise mechanical damage to the soft tissue, the testing protocol 
comprised a 2 mm compression of the scaffold at a rate of 0.6 mm/min.  
µCT Angiography 
Scaffolds (n=3) were used for µCT angiography. All animals were euthanized by 
CO2 asphyxiation 6 months post implantation. Radiopaque contrast agent-enhanced 
µCT angiography was performed using a protocol adapted from Duvall et al. [327]. 
Briefly, a surgical catheter was inserted into the left ventricle of the heart and 
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advanced into the ascending aorta. Isotonic saline was perfused into the vascular 
system using a peristaltic pump until the blood was washed out. Following this 
procedure, a polymerizable, lead chromate-based, radiopaque contrast agent 
(Microfil MV-122, Flow Tech, Carver, USA) prepared according to manufacturer’s 
instructions was perfused into the vascular system. Animal carcasses were stored at 
4
o
C for 24 hours to allow polymerisation of the contrast agent. Scaffolds were then 
removed from the animals and stored in 4% PFA for 24 hours until µCT analysis.  
Histological and immunohistochemical analyses 
Hematoxylin & Eosin (H & E) 
Tissue was harvested from the rats after 5 and 15 weeks using a 5 mm biopsy punch 
penetrating through the entire height of the TECs (see Supplementary Fig 4.3.5). 
After explantation, TECs were fixed with 4% PFA, dehydrated and embedded in 
paraffin using a tissue processor (Excelsior ES, Thermo Scientific, Waltham, USA). 
Constructs were horizontally sliced to 5µm, deparaffinised with Xylene, rehydrated 
with a decreasing series of ethanol and stained with H & E. Stained slides were 
scanned with the SCN400 slide scanner (Leica, Solms, Germany) at 20x 
magnification. 
Immunohistochemical staining 
Endogenous peroxidase activity was blocked by incubating the slides with 3% H2O2 
at room temperature. Slides were washed three times with Tris-HCL (pH 7.4) for 2 
minutes and placed in tri-sodium citrate buffer for 20 min at 95
 o
C in a decloaking 
chamber. The slides were incubated with 2% bovine serum albumin (BSA) for 60 
minutes at room temperature and incubated with prediluted corresponding primary 
antibody overnight at 4
o
C. All the four primary antibodies used are listed in 
Supplementary Table 1. The slides were then incubated with immunoglobulin as 
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secondary antibody as part of the DAKO Envision Dual Link System-HRP (Ref: 
K4061, Dako, Glostrup, Denmark) for 30-45 min at room temperature. The slides 
were washed 3 times with Tris-HCl and colour was developed by incubating the 
slides with 3,3'-Diaminobenzidine (DAB) solution (1:50) [DAKO liquid DAB+ 
substrate Chromagen System, Ref: K3468, Dako, Glostrup, Denmark]. Finally, the 
slides were washed once with Tris-HCl for 2 minutes and counter-stained with 
Haematoxylin for 2 minutes followed by 30 second immersion in 0.1% Ammonium 
Hydroxide.  
Histomorphometry 
Histomorphometrical analyses were undertaken using two methods: a manual 
method and an automated approach. The manual method was undertaken using the 
Osteomeasure  histomorphometry analysis system (Osteometrics Inc., Decatur, GA, 
USA). All measurements were performed blinded on 4 consecutive sections from 
each scaffold at each time point. To determine the average adipose tissue area, the 
total area of the adipose tissue was first calculated (A). Secondly, the total area 
occupied by the scaffold struts was measured (S). Finally, the combined area of the 
tissue section was measured (C). The ratio of adipose tissue area to total tissue area 
(R) was calculated using the following formula: 
𝑅 =
𝐴
(𝐶 − 𝑆)
∗ 100% 
ImageJ (National Institutes of Health, MA, USA), in conjunction with Adipocyte 
Tools plugin developed by Montpellier RIO Imaging (Montpellier, France), was used 
for all automated calculations involving cell size distribution. The field of view 
(FOV) from each histological section was kept uniform at 4795 x 2282 µm. 
Background was first removed from each histological section by the pre-processing 
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macro within the Adipocyte Tools plugin using the thresholding method. Minimum 
size of each cell was chosen to be 40 µm, maximum size as 800 µm and the number 
of dilates were set to be 10. The same threshold was also chosen to automatically set 
regions of interest (ROI) around the adipose cells. The automated method generated 
a small number of ROI artefacts. Artefacts that could be detected visually were 
manually removed. In order to remove the remaining artefacts, 10% of the smallest 
and 10% of the largest ROIs were excluded from any further analysis. Visualisation 
of both the manual as well as the automatic method can be found in Supplementary 
Fig 4.3.2. 
Fibrotic capsules were identified from H & E stained histological sections as a dense 
layer of collagen fibres aligned parallel to the implant surface with a variable 
presence of fibroblasts and inflammatory cells [328]. 3 images chosen randomly 
from each scaffold were imported in ImageJ and measurement lines, approximately 
50 µm apart, were defined on the fibrotic capsule. Average thickness of the fibrotic 
capsule was derived from the average of such measurement lines.  
Statistical analysis 
All data are represented as mean ± SD and are subjected to one-way analyses of 
variance (one-way ANOVA) and Tukey’s post-hoc test (Sigmaplot 12.5). 
Significance levels were set at p< 0.05. All error bars represent standard deviation.  
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4.3.3 Results 
Characterisation of scaffolds 
 
 
Figure 4.3.1 Scaffold fabrication and characterisation. (a) Illustration of laser scanning performed on a 
patient suffering from invasive ductal carcinoma.  (b) The data from the laser scan was used to 
generate a CAD model of the patient’s left breast. (c) The CAD model was used to generate porous 
patient-specific scaffolds (shrunk down to 25% of their original size) showing high shape fidelity to 
the CAD model. (d) MicroCT scans of the fabricated scaffolds showed homogeneity of filament 
thickness across the entire volume of the scaffold. (e) Histogram of pore size measurements showing 
the distribution of pore sizes in the scaffolds. (f) Scaffolds fabricated with a highly reproducible 
porosity of 90 %. (g) SEM images showing the surface of the scaffold bars and struts 
        
The gross morphology of the fabricated PDLLA scaffolds was highly similar to the 
CAD file obtained from the laser scanning of the breast region (Fig 4.3.1. a-c) and 
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contained a regular array of interconnected pores. The axial pores of the scaffolds 
were larger than the transverse pores of the scaffolds. This observation was 
conﬁrmed by μCT measurements (Fig 4.3.1(e)), where the smaller pore sizes (200-
400 microns) reﬂected the transverse pores of the constructed scaffolds as seen in Fig 
4.3.1(d, right). The larger pore sizes (500-1000 microns) reﬂect the axial pores of the 
scaffolds as seen in Fig 4.3.1(d, left). The high porosity value of the scaffolds also 
implies more volume available for tissue/vascular ingrowth. From the 3D μCT 
reconstructed images it was also shown that the filament thicknesses across the entire 
scaffolds were largely homogeneous (Fig 4.3.1d).  
In vitro culture 
To improve the seeding efficiency of cells onto the large volume scaffolds, a 
clinically approved hydrogel system, namely fibrin glue, was used. A fibrinogen/cell 
suspension was mixed with thrombin and immediately added to the scaffolds so that 
the fibrin clot was formed in situ within the scaffold pores. The scaffolds were also 
pre-wet in sterile PBS overnight prior to seeding them with cells. Initially, when the 
cells were encapsulated in fibrin glue, they showed a rounded morphology, however 
as shown in the light microscopy image in Supplementary Fig 4.3.1a, after 24 hours, 
filopodia began to develop. After day 28 days of static culture cells were seen to be 
bridging across the pores of the scaffold (Supplementary Fig 4.3.1b). The rotational 
motion of the TisXell bioreactor leading to increased perfusion of nutrients 
facilitated cell growth, as observed from the size and number of bridges across the 
pores, which increased significantly in 2 weeks under dynamic culture 
(Supplementary Fig 4.3.1b, c).  
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Fluorescent imaging 
 
Figure 4.3.2 Fluorescence signal from the GFP-labelled HUVECs detected using an IVIS 
bioluminescence scanner. The signal from viable HUVECs increased steadily from week 2 until week 
17. 
Prior to the implantation of scaffolds into rats, the pre-cultured scaffold/cell 
constructs were further seeded with a suspension of GFP-labelled HUVECs in 
Matrigel in order to enhance the angiogenic potential of the TECs. The rats were 
subjected to in vivo fluorescence imaging every 3 weeks to detect the fluorescent 
signal from the implanted GFP-labelled HUVECs. The fluorescence signal could not 
be distinguished from the background noise on week 0. On week 2, the signal was 
localised at the right wing of the scaffold (Fig 4.3.2a). Over the next 15 weeks, the 
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signal persisted at the initial location and seemed to invade towards the central 
regions of the scaffold (Fig 4.3.2 b-f).  
Scaffold explantation and degradation 
 
Figure 4.3.3 (a) Scaffolds explanted after 24 weeks showed good integration with the host tissue with 
no observable signs of inflammation and fibrotic encapsulation.  (b) Perfusing the animals with 
Microfil allowed the visualisation of all blood vessels within the scaffold and the surrounding tissue 
areas. The arrows in yellow show large blood vessels supplying oxygen and nutrients to the tissue 
within the scaffolds. (c) 3D image obtained from microCT reconstruction of the scaffolds explanted 
from Microfil-perfused animals showing a well-established network of capillaries throughout the 
entire volume of the scaffold. (d) Top view and (e)side view of fabricated scaffold (left) and explanted 
tissue engineered constructs (TECs) (right) after 24 weeks. The distribution of capillaries can be 
qualitatively visualised on the explanted TECs. 
 
No postoperative infections or macroscopic signs of foreign body reaction to the 
TECs occurred over the entire period of implantation. After 6 months of 
implantation, the TECs were retrieved for histological analysis. Upon visual 
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examination, it was shown that the scaffolds were well integrated into the host body 
with no apparent major inflammatory reaction (Fig 4.3.3 a). Visual examination of 
the Microfil perfused samples revealed a widespread invasion of host vasculature 
into the engineered adipose tissue (Fig 4.3.3 b, c, d). MicroCT angiography of the 
scaffolds revealed a high degree of vascularisation equally distributed throughout the 
architecture (Fig 4.3.3c). Furthermore, it was also found that the scaffolds did show, 
as anticipated, significant degree in weight loss (Fig 4.3.3 e). Our tissue engineering 
concepts [329] are based on the principle that the overall shape of the scaffold 
remained intact (Fig 4.3.3d). 
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Formation of vascularised adipose tissue 
 
Figure 4.3.4 (a, b, c, d) Hematoxylin and Eosin (H&E) staining of tissue samples explanted at week 5 
(a,b) and 15 (c,d) show a well vascularised adipose tissue and no signs of major inflammation or cyst 
formation. (e, f, g, h) H&E staining of samples explanted at Week 24. The scaffolds were sectioned in 
two orientations: transverse (e, g) and longitudinal (f, h). Representative sections are shown. 
Widespread regeneration of well-vascularised adipose tissue was observed throughout the length, 
breadth and height of the scaffolds. No regions of necrosis, major inflammation or cysts were 
observed 
 
H & E staining revealed formation of adipose tissue and blood vessels across all time 
points (Fig 4.3.4 a-h). H&E staining of tissue samples explanted at week 5 (Fig 4.3.4 
a & b) and 15 (Fig 4.3.4 c & d) showed a well vascularised adipose tissue construct. 
H&E staining of tissue samples explanted at week 24 demonstrated widespread 
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regeneration of well-vascularised adipose tissue throughout the length, width and 
height of the scaffolds. No regions of necrosis, inflammation or cysts were observed. 
All constructs showed the formation of a thin fibrotic capsule around the constructs. 
Adipose cells could be identified microscopically by their typical ring-like 
morphology and a large vacuole in the middle of the cell. These characteristics 
enabled quantification of the area of fat tissue.  
 
Figure 4.3.5 (a) Box and whiskers plot showing the adipose tissue area relative to total tissue area over 
24 weeks. Adipose tissue area increased significant (p<0.01) from approximately 40% on Week 5 to 
approximately 60% on Week 15 finally reaching almost 80% on week 24 (p<0.01). The variability 
across the samples was low, especially in the Week 24 tissue extracts. (b) Graph showing the 
compressive Young’s modulus of scaffold pre- and post-implantation. Mechanical properties of the 
scaffold decreased significantly (p<0.01) from 3MPa to 1MPa over 24 weeks in vivo implantation. 
The stiffness of native adipose tissue is represented by the red dashed line [330] .  (c) Box and 
whiskers plot showing mean thicknesses of the fibrous capsule surrounding the scaffold. As the 
scaffold degraded the thickness of the capsule decreased significantly (p<0.01) from 400µm to 300 
µm between weeks 5 and 15 and down to 200 µm in week 24. The variability in the samples was high 
on week 15.  (d) Histogram showing the distribution of adipose cells according to the cell surface 
area. Generally, the number of adipose cells increased significantly from week 5 to 24. At week 5, a 
majority of the cells had a surface area between 200 and 500 µm2. On week 15, the cells generally 
shrunk in area, with the majority of cells having an area between 150 and 350 µm2. Finally on week 
24, the cells once again expanded in area and the majority had surface area between 200 and 500 
µm2.*** statistically significant, p< 0.01. 
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The percentage of adipose tissue compared to overall tissue area increased from 
37.17% to 62.30% between week 5 and week 15, and grew to 81.2% between week 
15 and week 24 (Fig 4.3.5a). The stiffness of the TECs decreased significantly from 
3 MPa to 1 MPa over 24 weeks of in vivo implantation (Fig 4.3.5b). The results from 
the fibrotic capsule thickness measurements are displayed in Fig 4.3.5c. The semi-
quantitative analysis of the thickness revealed that the size of the capsule increased 
from approximately 350 µm to 450 µm between week 5 and 15. However, as the 
scaffold degraded over time, the size of the capsule decreased to 200 µm as observed 
at week 24.  
Quantification of adipose cell area allowed the visualization of the distribution of 
different-sized cells as a histogram (Fig 4.3.5d). At week 5, the majority of the cells 
had a surface area between 200 and 500 µm with the histogram skewing towards the 
right and a small number of outliers.  At week 15, the number of cells counted 
increased considerably, but the histogram continued to remain skewed to the right 
with a higher number of outliers compared to those at week 5. The majority of cells 
had a surface area between 100 and 300 µm at week 15. The histogram at week 24 
was more balanced compared to week 5 and 15, however it had the highest spread of 
values, having a considerably higher number of cells with a surface area larger than 
1000 µm. The cell count also increased significantly between week 5 and 15.  
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Figure 4.3.6 Histological staining of scaffolds explanted on week 24. (a) Haematoxylin and Eosin (H 
& E) staining of scaffolds showing overall tissue morphology. (b & c) CD68 staining showing the 
presence of macrophages near the scaffold strands. Density of macrophages was low in areas away 
from the scaffold strands. (d) Anti-vWF staining for the blood vessels showing a well vascularised 
tissue. (e & f) Anti-GFP staining for the presence of GFP-labelled HUVECs showing the assembly of 
HUVECs into functional capillaries. (g) isotype control. (h & i) Staining for human mitochondria 
showing the host-origin of the regenerated tissue. Human fat cells (black arrow) were localised in 
small islands near the scaffold strands.  Scale bars = 100µm 
     
Immunohistochemical staining for anti-human-mitochondria antibodies showed that 
a majority of the adipose tissue within the scaffold was of host origin, with human 
adipocytes aggregating into a small number of islands near the scaffold strands (Fig 
4.3.6 h , i). Staining for anti-GFP showed that a significant number of HUVECs self-
organised into a functional capillary network within the scaffold strands (Fig 4.3.6 e , 
f). A majority of the capillaries formed by HUVECs had a diameter less than 100 
µm, were clustered into domains approximately 800 µm x 400 µm in size and 
localised on the periphery of the TECs. All such capillaries also had presence of red 
blood cells, indicating their functional nature. Anti-CD68 staining showed that the 
scaffolds invoked an unspecific inflammatory response in close proximity to the 
scaffold strands (Fig 4.3.6 b, c). CD68-positive macrophages were not found more 
than 400 µm away from the nearest scaffold strand showing that unspecific immune 
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reaction was not widespread and localised within a radius of approximately 400 µm 
of the scaffold strands.  
4.3.4 Discussion 
The overall goal of breast reconstruction after mastectomy is to restore the patient’s 
breast with functional tissue interfaces, and to maintain tactile sensation. The shape 
and size of the breast is different for each patient, hence the scaffold supporting the 
regeneration of the tissue interfaces needs to be customised. Here, the translation of 
scaffold-based tissue engineering applying the toolbox provided by Computer-
Aided-Design and Computer-Aided-Manufacturing (CAD/CAM) opens up new 
vistas for scaffold-based patient-specific breast reconstruction. In this article, we 
present an integrated strategy where images are first taken of the breast region of a 
mastectomy patient using medical imaging techniques. The images captured can then 
be processed into a patient-specific 3D computer-aided design (CAD) model which 
is then sent to a 3D printer to be fabricated into a highly porous biodegradable 
scaffold. The porosity and pore sizes can be tailored independently by changing the 
laydown pattern. The optimal porosity is always determined by a trade-off between 
mechanical properties and pore volume available for tissue ingrowth [249]. Stiffness 
and strength should be sufficient in the context of breast tissue engineering, as the 
scaffold should be sufficiently robust to not only resist changes in shape in vitro as a 
result of cell contraction forces yet also the wound contraction forces which will be 
invoked during tissue regeneration. Furthermore, the breast region is also subjected 
to high biomechanical loads during sleeping and sports activities, and the TECs must 
be able to withstand those forces over a long period of time.  
Patrick et al. were among the first to study adipose tissue engineering in vivo [73]. 
Since then several research groups have developed different approaches to engineer 
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fat tissue using different types of cells and/or scaffolds. Most of these studies used 
small volume scaffolds and implants (Supplementary Fig 4.3.4); therefore, there is a 
direct need of sustained regeneration of clinically relevant high-volume adipose 
tissue. Furthermore, very few studies have analysed the long-term behaviour of tissue 
engineered breast constructs to date. To our knowledge, we present the first such 
study utilising a large-volume patient-specific TEC in an in vivo model and 
achieving a sustained regeneration of adipose tissue up to 24 weeks.   
The volume of the originally designed patient-specific scaffold (194 cm
3
) was scaled 
down for the rodent experiment to 3 cm
3
 (Table 3); yet it is important to note that it 
is a considerably larger volume than reported in most previous studies (for a 
comparison of volumes of scaffolds used for adipose tissue engineering, please see 
Supplementary Fig 4.3.4) was reconstructed. Furthermore, a 3 cm
3
 scaffold leads to a 
breast/body volume of 0.84% in a rodent, considerably larger than that of an average 
human female (0.63%). For a detailed comparison, see Supplementary Table 2.  
It is important to note here that, based on our tissue engineering philosophy[310, 
329] we did not aim to produce a scaffold whose mechanical properties matched 
those of native adipose tissue. PDLLA has been also been used previously to 
engineer adipose tissue [331, 332]. PDLLA is a aliphatic polyester which 
characterized by bulk degradation and has a modulus of 1.5 GPa [333, 334]. Our 
hypothesis was that the highly porous scaffold would maintain its shape and volume 
for at least 9-12 month without showing any signs of mass loss so that the 
regenerated tissue stably remodels several times in the highly porous scaffold 
architecture without being influenced by any degradation by products. 
As the scaffolds showed qualitative signs of degradation, their mechanical properties 
also changed significantly over a period of 8 month (2 month in vitro and 6 month in 
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vivo). Measurement of the Young’s modulus after explantation revealed that the 
TECs had 33% of the Young’s modulus compared to the orginal scaffold values; 
however, the form stability and integrity and form specificity remained unchanged, 
with the TEC recovering shape and volume completely after being subjected to 10% 
compression. The stiffness of the scaffold was measured at 3 MPa in comparison to 
the TEC which had a stiffness of 1 MPa post-implantation (Fig 4.3.5b) which is 2 
orders of magnitude stiffer compared to native adipose tissue. As PDLLA  
degradation occurs throughout the whole via bulk degradation, the scaffolds did lose 
its stiffness uniformly throughout its volume [335]. However, as per our hypothesis, 
the biodegradable scaffold was able to withstand the contraction forces for at least 6 
months in vivo and did not show any mass loss or volume contraction.   
Scaffold architecture has a major impact on adipose tissue formation. Scaffolds 
morphologies formed by Fused Deposition Modelling (FDM) are homogeneously 
organised with precisely deposited struts and contain a highly interconnected channel 
network. Previous work within our group [336] and elsewhere [72] have shown that 
scaffolds containing small pores and pore interconnections are unsuitable for high 
volume adipose tissue regeneration. Diffusion of oxygen from the surrounding 
tissues is sufficient only over a distance up to approximately 150 µm [175]. 
Therefore, in tissue constructs without adequate vascularization, autologous adipose 
tissue loses up to 60% of its volume post-transplantation because the cells in the 
centre of the graft are inadequately supplied with nutrients and transport of waste is 
not possible  [176, 177]. Pore sizes of 1.5 mm used in the presented study allowed 
vascular ingrowth into the scaffold during the early stages of the implantation which 
helped sustain the adipose volume for an extended period of time.  
 155 
Chapter 4: Research Reports 155 
Our results from anti-CD68 staining show the presence of macrophages, primarily 
bordering the scaffold strands which can be interpreted as an unspecific immune 
reaction. The invasion of these macrophages may have had a large role to play in the 
subsequent adipogenesis and vasculogenesis. Moldovan [337] and Anghelina et al. 
[338, 339] have shown that upon implantation, monocytes and macrophages first 
invade the extracellular matrix around the graft and form tunnels while clearing 
ECM along their path. Subsequently, endothelial cells and adipocytes are visualised 
in these macrophage-lined tunnels, indicating their development into functional 
capillary-like structures and vascularised adipose tissue. However, further 
investigations done by Debels et al. [340] have found no conclusive evidence of 
macrophages playing a direct role in neoadipogenesis and claim that the perceived 
neoadipogenesis is simply a result of increased angiogenesis, without further 
involvement of macrophages.  
Immunohistochemistry on paraffin embedded explants samples with human-specific 
mitochondria antibody confirmed the host derivation of the newly formed adipose 
tissue, indicating that the regeneration process is dependent on inductive factors 
embedded within Matrigel or excreted by the transplanted cells, rather than direct 
tissue formation by provided precursor cells. This finding complies with a study 
performed by Stillaert et al. [341] who also used Matrigel in combination with FGF2 
and concluded that such an inductive graft causes the recruitment and differentiation 
of host-derived precursor cells into adipose cells. Previous studies [342, 343] have 
shown that adult adipose tissue houses a significant number of mesenchymal stem 
cells with pluripotential characteristics. There is a high likelihood that these cells 
were significantly involved in the neoadipogenesis process. Athymic nude rats are 
characterised by their lack of normal thymus and functionally mature T cells and are 
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therefore useful in xenograft models [344]. However, they still possess allo- and 
xeno-reactive natural killer cells that can recognise and kill major histocompatibility 
complex (MHC) incompatible cells through the recognition of both mismatches in 
the classical (RT 1.A) and non-classical (RT1.C/E) MHC class 1 regions. With 
increasing age, nude rats develop leukocytes, for example dendritic cells, T-like cells 
and T-cell receptors which may also contribute to specific innate immune responses 
[344]. At the time of implantation, it is reasonable to assume that the HUCPVC were 
mostly localised on the scaffold strands, which is also the region encapsulated by 
fibrous tissue and granulomatose reaction. It is therefore likely that the implanted 
HUCPVC were constantly triggering a response by the innate immune system of the 
host and did not survive long-term.  
As described previously, one of the goals of this research project was to construct a 
human vascular bed within a nude rat model. The aims of such a pursuit are not 
limited to tissue engineering applications where vasculogenesis by means of 
precursor cell induction can provide nutrition to adipose cells, but also to basic 
cancer research whereby humanised vascular structures can be used as a model to 
study the growth and proliferation of cancer metastases [345].  In situ fluorescent 
imaging showed that on week 2, the eGFP signal from the implanted HUVECs was 
localised onto to the right wing of the scaffold. This observation was unexpected 
since the HUVECs were distributed homogeneously throughout the scaffold. One 
argument is that the movement of the rat and gravitational forces caused the cells to 
accumulate on the bottom region of the scaffold. Another possibility is that the 
HUVECs in the core regions of the scaffolds perished due to hypoxia, while those on 
the periphery survived owing to a greater nutrient exchange at these sites.  
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Anti-GFP staining showed that in contrast to HUCPVC, GFP-labelled HUVECs 
survived the 6-month implantation process all throughout the scaffolds. However, 
their self-assembly into capillaries of diameters less than 100 µm was observed only 
around the periphery of the scaffold. The clustering of cells in the posterior regions 
of the scaffold may have led to increased cell-to-cell contact in these regions, which 
is a very important factor determining the extent of capillary network formation with 
a minimum critical density required for optimal capillary bed formation [346, 347]. 
Although further investigation is needed, the maintenance of such a humanised 
capillary bed in a nude rat model for 24 weeks in vivo opens up the possibility of 
generating vascular networks spanning a greater area for many tissue engineering 
approaches. 
4.3.5 Conclusion 
We have demonstrated a clinically viable route to design and fabricate biodegradable 
patient-specific scaffolds directly from 3D imaging data sets. To our knowledge this 
is the first study showing a sustained regeneration of high volume adipose tissue over 
a long period of time using a patient-specific biodegradable scaffold. While the 
mechanical properties of the TECs, in particular the stiffness, remain to be desired 
closer to native breast tissue, the presented approach of fabricating patient-specific 
scaffolds using 3D patient body scans represents a facile approach towards 
engineering clinically relevant and stable volumes of adipose tissue for breast 
reconstruction. These scaffolds, that contain large pores and pore interconnections, 
facilitate the ingrowth of host vasculature throughout the entire scaffold architecture 
which is crucial for long-term sustenance and viability of adipose tissue.  
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4.3.7 Supplementary Tables and Figures  
Primary 
Antibodies 
Description 
Anti-Von 
Willebrand factor 
Polyclonal Rabbit Anti-Human Von 
Willebrand Factor: Ref A 0082 
(DAKO, Glostrup, Denmark) 
Anti-CD68 Monoclonal Mouse Anti Rat CD68: 
Ref MCA341GA (AbD Serotec, 
Oxfordshire, UK) 
Anti-GFP Rabbit Polyclonal Anti-GFP antibody: 
Ref AB290 (Abcam, Cambridge, UK) 
Anti-human 
mitochondria 
Mouse monoclonal anti-human 
mitochondria antibody: Ref AB92824 
(Abcam, Cambridge, UK) 
Table 4.2 List of primary antibodies 
 
Type of Tissue Volume (cm
3
) Breast/Body Volume Ref 
Whole human body 66,400 
0.63% 
[348] 
Human breast volume 420 [349] 
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Whole rat body 353 
0.84% 
[350] 
Breast scaffold 
volume 
3  
Table 4.3 Comparison of breast/body volumes of humans and rodents 
 
Figure 4.3.7 (a) Cell morphology on day 1 post seeding suspended in fibrin glue. Cells do not remain 
rounded and are seen to spread and connect with neighbouring cells. (b) 28 days post culture the cells 
begin to form wide bridges across the gaps of the scaffolds (dotted by yellow triangles). (c)  DAPI-
Phalloidin staining of cells at 28 days post-culture to visualise cells forming a continuous sheet along 
the scaffold strands. Blue (DAPI): cell nuclei, Red (Phalloidin): cell actin filament. 
 
 
Figure 4.3.8 (a-c) Images depicting the workflow of the automated algorithm to count the number of 
adipose cells on a histology section and also their cell surface areas. (d-f) Images depicting the 
workflow showing manual demarcation of adipose tissue areas using Osteomeasure software.  
 
 
Figure 4.3.9 Schematic diagram of the test setup used for compression testing of scaffolds. Due to the 
curved nature of the scaffold surfaces, special top and bottom surface attachments following the 
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contours of the scaffolds were produced. The top attachment links with the Instron microtester plunger 
providing uniform stress across the entire scaffold. The attachments were produced with non-porous 
acrylonitrile butadiene styrene (ABS) with a considerable higher stiffness compared to the 90% 
porous PDLLA scaffolds, to minimise their influence on the load readings 
 
 
Figure 4.3.10 Graph showing comparison of volumes of scaffolds used for adipose tissue engineering 
research. Volume of the scaffold used in the present study is dotted by a horizontal line showing that it 
is considerably higher than the volumes used in most other studies 
 
 
Figure 4.3.11 Illustration showing the position of the samples collected using biopsy punch outs at 
weeks 5 and 15. Areas shaded in dark purple represent tissue excised by the biopsy punch 
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4.4 STUDY FOUR (MANUSCRIPT IN PREPARATION) 
Breast Reconstruction using Computer Aided Design and Biomanufacturing – 
towards engineering clinically relevant volumes of adipose tissue.  
 
Thesis Progress: 
The following figure shows the flow of activities undertaken and methodologies 
developed as part of this PhD project. The previous study showed positive adipose 
tissue regeneration outcome in a small animal model. This study aimed to scale up 
the volumes of regenerated tissue within a subglandular pig model.  
 
4.4.1 Introduction 
In recent years, there have been significant advances in medical techniques for the 
replacement and/or reconstruction of lost body tissues, mostly due to innovative 
developments in the fields of surgery, material science and bioengineering. There are 
various medical conditions where replacement or reconstruction of lost body tissues 
becomes an important treatment option. Such medical conditions include trauma, 
tumor removal, diverse chronic diseases and certain congenital anomalies. 
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A typical example of a medical condition where tissue replacement/reconstruction is 
often carried out is breast cancer. Breast cancer is a major cause of illness for 
women, with an estimated number of approximately 300,000 new cases diagnosed in 
2013 [315, 351]. Unfortunately, currently available clinical treatments and filler 
materials for breast reconstruction or augmentation yield unsatisfying results [30, 
34]. Reconstruction using silicone-based implants leads to severe medical 
complications such as formation of a rigid fibrous tissue surrounding the implant, 
causing significant soft tissue irritation via capsular contracture and giving, from a 
cosmetic point of view, an unnatural appearance to the breast [352]. A second 
reconstruction method which is popular among surgeons is lipofilling. In this case, 
the surgeon isolates fat from a donor site within the patient’s body via liposuction 
and injects it back into the breast region. However, without a structural support, the 
newly injected fat quickly gets remodelled by the body after 2-3 months – thus 
requiring 3-4 additional lipofilling sessions before the tissue stabilises [353]. 
Therefore, impetus has been gradually growing towards cell-based regeneration of 
adipose tissue for breast reconstruction.  
Stem cell-based approaches are very promising for complete regeneration of breast 
tissue; however, they also lead to several disadvantages – ranging from problems 
with scaling up of tissue culture to requiring complex GMP-certified laboratories for 
tissue culturing  [250-256]. Furthermore, it is challenging to efficiently vascularise 
large clinically relevant scaffolds whose volumes can reach up to 150 cm
3
.  
In order to solve the aforementioned problem of vascularization and adipose tissue 
remodeling, we have devised the concept of delayed fat injection combined with an 
acellular biodegradable scaffold. In this method of implantation, the scaffold is first 
implanted with no fat tissue into the implantation site. A fibrin clot is formed 
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immediately after implantation of the scaffold from the hematoma caused by the 
surgical procedure [354, 355]. The clot consists of platelets embedded in a mesh of 
cross-linked fibres, together with a growth-factor rich cocktail of fibronectin, 
vitronectin and thrombospondin. We hypothesise that the fibrin clot and the 
associated growth-factor cocktail would stimulate a strong angiogenic response and 
induce highly organized connective tissue to penetrate into the scaffold [356, 357]. 
After a fixed period of time, fat is isolated from a donor site within the patient’s body 
and injected into the scaffold (see Fig 4.4.1 for a visualization of this process). The 
amount of fat that can be harvested from the patient without encountering donor site 
morbidity depends on the body composition of the patient – whereby a larger volume 
of fat can be extracted from patients with higher body fat percentage. In this study, 
based on the expertise of our surgical team, 4 cm
3
 of adipose tissue was considered 
to be the maximum amount that can be harvested from a patient with a very low 
body fat percentage without encountering donor-site complications. Therefore, the 
scaffolds were seeded with 4 cm
3
 of fat isolated from the donor – representing 5.23% 
of the total volume of the scaffolds. We further hypothesise that the presence of a 
pre-formed bed of connective tissue and vasculature would allow the injected fat to 
remain stable within the implantation site with minimal tissue necrosis and 
resorption.  
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Figure 4.4.1 Overall concept of the prevascularisation and delayed fat injection. Empty scaffold is first 
implanted at the breast region without the addition of any cells or growth factors. Over the next 2-3 
weeks, connective tissue and vasculature invades within the scaffold volume forming a bed of 
capillaries within the pores. Fat is then injected into the pores of the scaffold. Owing to the presence 
of the pre-formed vascular bed would allow the fat to remain stable at the implantation sites. 
 
This study evaluated adipose tissue retention in large 75 cm
3
 acellular 
polycaprolactone-based scaffolds subjected to a delayed fat injection for a period of 
24 weeks.  
4.4.2 Materials and Methods 
Design & Fabrication of scaffolds  
Rapid prototyped hemisphere-shaped shell-shaped polycaprolactone-based scaffolds 
were designed and manufactured by Osteopore International (Singapore). All 
scaffolds were produced under GMP conditions.  
MicroCT (µCT) evaluation of scaffolds 
Biopsy punch-outs of the scaffolds (r=5 mm) were taken at randomly selected spots 
(n=6 per scaffold x 3 scaffolds). The resultant specimens were scanned on a Scanco 
µCT40 (Scanco AG, Brüttisellen, Switzerland) at 8 µm resolution, employing 55 kV 
and 145 µA with 250 ms exposure time. Porosity, pore-size and filament-size 
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distributions were obtained by employing a modified trabecular bone 
histomorphometry algorithm.  
In vivo implantation into minipigs 
The animal experiments were performed under GMP conditions at PWG 
Laboratories, Singapore with ethical approval from National University of 
Singapore. Two female adult immunocompetent minipigs were used in this study. 
The operation was performed under general anesthesia, following the standard 
protocol of sterility requirements for breast augmentation procedures. Careful 
homeostasis was also maintained throughout the surgical procedure. 3 separate 
subglandular pockets were created on each side of the mammary region via a 
longitudinal incision. 6 implants were placed in each animal. Prior to implantation, 
all scaffolds were trimmed and re-shaped at the operating table by the surgeon in a 
careful but non standardised manner to ease the implantation process and gain access 
to the inner pores by removing the outer shells of the scaffolds. To test our 
hypothesis, 3 study groups were included in this study: 
1) Empty scaffold (n=4). 
2) Scaffold containing 4 cm3 lipoaspirated adipose tissue (n=4). 
3) Empty scaffold + 2 week prevascularisation period. After 2 weeks of 
prevascularisation, 4 cm
3
 of lipoaspirated adipose tissue was injected into 
scaffolds (n=4). 
In groups 2 and 3, a midline incision was made and adipose tissue was obtained via 
the Tulip system (Tulip Medical Products, San Diego, USA). The lipoaspirated fat 
was injected directly into the interconnected pore architecture of the scaffolds- using 
a 10-cm
3
 Tulip cell-friendly injector. 
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After the placement of the implants each pocket was closed with absorbable vicryl 
sutures, such that the implants were fixed stably and had no contact to each other. 
Finally, the skin was sutured with interrupted 2.0 Ethilon sutures.  
Histological and immunohistochemical analyses 
Hematoxylin & Eosin (H & E) 
Implants were harvested from the minipigs after 24 weeks and TECs were fixed with 
4% PFA, cut into 10mm x 10mm cube sections, dehydrated and embedded in 
paraffin using a tissue processor (Excelsior ES, Thermo Scientific, Waltham, USA). 
Constructs were horizontally sliced to 5µm, deparaffinised with Xylene, rehydrated 
with a decreasing series of ethanol and stained with H & E. Stained slides were 
scanned with a BIOREVO BZ-9000 microscope (Keyence, Itasca, USA) at 5x 
magnification. 
Massons Trichrome 
The slides were deparaffinised with Xylene, rehydrated with a decrasing series of 
ethanol and re-fixed in Bouin’s solution at room temperature overnight. After rinsing 
in tap water for 10 minutes, the slides were stained in Weigert’s iron hematoxylin for 
10 minutes, rinsed in running warm tap water, stained in Biebrich scarlet-acid 
fuchsin solution for 10 minutes and transferred directly into aniline blue solution and 
stained for 10 minutes. The slides were rinsed briefly in distilled water and 
differentiated into 1% acetic acid solution for 5 minutes.  
Histomorphometry 
Histomorphometrical analyses were undertaken the Osteomeasure histomorphometry 
analysis system (Osteometrics Inc., Decatur, GA, USA). All measurements were 
performed blinded on 4 consecutive sections from each scaffold from each group. To 
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determine the average adipose tissue area, the total area of the adipose tissue was 
first calculated (A). Secondly, the total area occupied by the scaffold struts was 
measured (S). Finally, the combined area of the tissue section was measured (C). The 
ratio of adipose tissue area to total tissue area (R) was calculated using the following 
formula [358]: 
𝑅 =
𝐴
(𝐶 − 𝑆)
∗ 100% 
ImageJ (National Institutes of Health, MA, USA), in conjunction with Adipocyte 
Tools plugin developed by Montpellier RIO Imaging (Montpellier, France), was used 
for all automated calculations involving cell size distribution. The field of view 
(FOV) from each histological section was kept uniform at 4795 x 2282 µm. 
Background was first removed from each histological section by the pre-processing 
macro within the Adipocyte Tools plugin using the thresholding method. Minimum 
size of each cell was chosen to be 80 µm, maximum size as 800 µm and the number 
of dilates were set to be 10. These threshold values were kept constant across all 
samples and groups. The same threshold was also chosen to automatically set regions 
of interest (ROI) around the adipose cells. The automated method generated a small 
number of ROI artefacts. Artefacts that could be detected visually were manually 
removed. In order to remove the remaining artefacts, 10% of the smallest and 10% of 
the largest ROIs were excluded from any further analysis. 
In order to calculate the blood vessel density, all blood vessels that showed red 
erythrocytes within the lumen were counted. The number of blood vessels was 
divided by the total tissue area to get the density. Values based on 4 stitched 
microphotographs from each scaffold per experimental condition.  
 168 Chapter 4: Research Reports 
Statistical analysis 
All data are represented as mean ± SD and are subjected to one-way analyses of 
variance (one-way ANOVA) and Tukey’s post-hoc test (Prism 6, GraphPad, San 
Diego, USA). Significance levels were set at p< 0.05. All error bars represent 
standard deviation.  
4.4.3 Results 
Clinical Observations 
The surgery and implant placement were tolerated well by all animals and no 
apparent clinical signs of infection were apparent throughout the implantation period. 
12 weeks after the initiation of the study, one scaffold was observed to have seroma 
accumulation in the surgically-created pocket and was therefore excluded from 
further analysis.  
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Scaffold characterization 
 
Figure 4.4.2 (a, b) Rendering of the CAD model used to fabricate the scaffold. (c) Original form of the 
scaffold once 3D printed. (d) Final scaffold form after being processed by the surgeon at the operating 
table to trim the outer boundary shells. 
The shape and volume of the scaffold was similar to that of a silicone implant used 
for breast augmentation and its gross morphology was highly similar to the CAD file 
used to design it (Fig 4.4.2). Further gross morphological evaluation also showed that 
scaffold contained a regular array of interconnected pores, which was confirmed 
using microCT measurements. The high porosity value of the scaffolds implies that 
more volume is available for tissue ingrowth. 
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As described in Study 2, the fabrication of scaffolds containing overhangs requires a 
sacrificial support structure. Osteopore International does not have capabilities of co-
extruding a sacrificial polymer which could act as such a supporting material. 
Therefore, the dome-shaped scaffolds were produced by placing a solid dome, whose 
dimensions matched those of the inner hollow lumen of the scaffolds, into the 
extrusion chamber and fabricating the actual scaffold around this structure. After the 
fabrication step, the solid dome was detached manually to obtain the final scaffold 
structure. 
Furthermore, due to software limitations, the scaffold contained boundary shells on 
the exterior edges which hindered access to the pores in the interior regions of the 
scaffold. Therefore, the surgeon trimmed the sides of the scaffolds at the operating 
theatre to remove these outer shells.  
The scaffold also contained an access cut-out and a hollow region to enable insertion 
of an arterio-venous shunt loop; however, such a loop was unnecessary for the 
purposes of this study and these features were not utilized.  
The stiffness values of the scaffold, obtained from the manufacturer, were 3 orders of 
magnitude higher than those of native breast tissue (the Young’s modulus of natural 
breast tissue is ~30kPa [330]).  
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Figure 4.4.3 Implantation process of the scaffolds. (a) Liposuction procedure near the abdominal 
midline incision. (b, c) Process of injecting fat into the pores of the scaffold placed in the lipoaspirate 
only group. (b) an empty scaffold while (c) a completely filled scaffold. (d) process of injecting fat 
into the prevascularisation + lipoaspirate group scaffolds. The scaffolds are placed empty into the 
implantation site and 2 weeks later, fat is injected into the scaffold pores while the scaffold remains 
implanted. (e) the final form of the scaffolds conforms highly to the natural breast shape. 
 172 Chapter 4: Research Reports 
 
Figure 4.4.4 Explantation images showing the integration of TECs with the host tissue. Green arrow 
point out major blood vessels supplying blood to the TEC. (d, g) show empty scaffold-only group (e, 
h) show lipoaspirate-only group (f, i) show prevascularisation+lipoaspirate group. All scaffolds show 
good integration with the host tissues and large areas of fat (marked with +) and vascularisation 
(marked with ¶) were observed qualitatively on all scaffolds. 
 
Scaffold explantation and degradation   
After 6 months of implantation, the TECs were retrieved for histological analysis. 
The scaffolds were well integrated with the surrounding tissue and there was a 
widespread invasion of host vasculature into the constructs (Fig 4.4.4a-c). Visual 
examination revealed that the overall shape of the scaffolds did not change 
drastically over the implantation period. All scaffolds showed good integration with 
the host tissues and large areas of fat and vascularisation were observed qualitatively 
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on all scaffolds. Visually, it was also clear that prevascularisation+lipoaspirate group 
(Fig 4.4.4 f, i) had the highest degree of vascularisation and fat tissue deposits, 
followed by lipoaspirate-only group (Fig 4.4.4 e, h). Although empty scaffold-only 
group also showed deposits of adipose tissue (Fig 4.4.4 d, g) they were not as 
widespread as in the other groups. 
Formation of vascularized adipose tissue 
 
Figure 4.4.5 Representative images showing H&E staining of tissue explanted from the empty 
scaffold group (superficial layers). A majority of the tissue can be identified as being connective tissue 
and collagen with only very small patches of fat tissue. 
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Figure 4.4.6 Representative images showing H&E staining of tissue explanted from the empty 
scaffold group (deep layers). Adipose tissue is only seen at the edges of the construct and not in the 
central regions of the scaffold. Lymphatic structures (right panel, marked by red arrows) were also 
observed in all groups mainly localised near scaffold strands. They were identified by comparing the 
micrograph to a reference image dataset obtained from Nassar [1] and using the surgical team’s 
expertise. A representative image from the reference dataset has been shown 
 
Figure 4.4.5-10 show representative H&E stained images of all scaffold groups after 
24 weeks in vivo. All sections showed typical ring-like morphology of fat tissue. 
Overall, multiple areas of well vascularised adipose tissue were found in all groups. 
H&E staining of tissue explanted from the empty scaffold group showed that 
although the newly infiltrated tissue was highly vascular, a majority of the tissue was 
connective tissue and collagen with only very small patches of fat tissue (Fig 4.4.5, 
6) (identified in the micrographs by their typical ring-like morphology and the empty 
vacuole in the middle of the cell – see Fig 4.4.7 for an H&E stained slide of native 
breast tissue). The deeper layers of the empty scaffolds also showed similar results. 
Reference Image 
sourced from Nassar 
[1] 
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Figure 4.4.7 Representative images showing H&E staining of tissue explanted from native breast 
tissue. Morphology is characterised by adipose tissue regions interspersed between regions of 
connective tissue 
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Figure 4.4.8 H&E stained sections of lipoaspirate-only group (superficial layers). Overall, a higher 
percentage of fat tissue compared to overall tissue area, compared to empty scaffold group, was 
observed in this group. 
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Figure 4.4.9 H&E stained sections of lipoaspirate-only group (deep layers). Deeper layers of the 
scaffold showed lower relative adipose tissue areas and lower degrees of vascularisation. 
Fig 4.4.8, 9 show the H&E stained sections of lipoaspirate-only group. Overall, a 
higher percentage of fat tissue compared to overall tissue area (referred from here on 
as relative tissue area) was observed in this group. The superficial layers of the 
scaffold especially showed widespread distribution of adipose tissue whose relative 
tissue area matched closely to that of native breast tissue. However, the deeper layers 
of the scaffold showed lower relative adipose tissue areas and lower degrees of 
vascularisation (Fig 4.4.9).  
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Figure 4.4.10 H&E stained sections of prevascularisation + lipoaspirate group (superficial layers). 
This group showed the highest accumulation of adipose tissue interspersed between connective tissue. 
Tissue morphology also showed similarities with native tissue. 
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Figure 4.4.11 H&E stained sections of prevascularisation + lipoaspirate group (deep layers). Adipose 
tissue area was the highest among all other groups. Adipose tissue regions seemed to be better 
connected to each other and formed interconnected structures. 
Fig 4.4.10, 11 show the H&E stained sections of prevascularisation + lipoaspirate 
group. This group showed the highest amount of fat tissue compared to all other 
groups. There were large highly vascularised regions of fat tissue interspersed 
between connective tissue. This tissue morphology was highly similar to that of 
native breast tissue. Furthermore, the relative adipose tissue area was also 
considerably higher in the deeper layers of this group compared to all other groups 
(Fig 4.4.10). Unlike the superficial layers however, the adipose tissue regions seemed 
to be better connected to each other and formed interconnected structures (Fig 
4.4.11).  
While no major signs of chronic inflammation were observed in the tissue sections or 
in the gross morphology of the constructs, non-specific localised low-grade 
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granulomatose reactions were observed in the vicinity of the localised scaffold 
strands (Fig 4.4.12). Lymphatic structures (Fig 4.4.6 right panel, marked by red 
arrows) and leucocytes were also observed in all groups localised mainly near 
scaffold strands. These structures were identified by comparing the micrograph to a 
reference image dataset obtained from Nassar [1].  
 
Figure 4.4.12 Representative H&E-stained micrographs of regions around the scaffold strands 
showing non-specific minor granulomatose reactions. (a) shows empty scaffold-only group, (b) shows 
lipoaspirate-only group (c) shows prevascularisation+lipoaspirate group. Yellow arrows point to 
macrophages 
 
To identify the nature and composition of the connective tissue, Masson’s trichrome 
staining was performed (Fig 4.4.13 a-c). Green colour indicates collagen fibres, red 
colour indicates muscle fibres and dark brown shows cell nuclei. As can be seen 
from the micrographs, besides the adipose tissue, a majority of the tissue filling the 
pores of the implant consisted of collagen fibres. 
Thin layers of smooth muscle tissue were also observed, however it was only lining 
the boundaries of the scaffold strands. These smooth muscle layers had the highest 
thickness in case of the prevascularisation + lipoaspirate group (Fig 4.4.13 c).  
In order to quantify adipose tissue regeneration, the total area of the adipose tissue 
relative to the total tissue area was counted on all slides. As expected, the negative 
control empty scaffold group had the lowest relative area of adipose tissue (8.31% ± 
8.94) which was significantly lower than both lipoaspirate-only (39.67% ± 2.04) and 
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prevascularisation + lipoaspirate group (47.32% ± 4.12) and also compared to native 
breast tissue (44.97% ± 14.12) (p<0.05, p<0.01 and p<0.01 respectively). However, 
there was no statistically significant difference in relative adipose tissue area between 
the native breast tissue, lipoaspirate-only and prevascularisation + lipoaspirate group. 
 
Figure 4.4.13 Representative images of Masson’s Trichrome stained tissue sections. Green colour 
indicates collagen fibres, red colour indicates muscle fibres and dark brown shows cell nuclei (a, d) 
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show empty scaffold group (b, e) show prevascularisation + lipoaspirate group (c, f) shows 
lipoaspirate-only group. Besides the adipose tissue, a majority of the tissue filling the pores of the 
implant consisted of connective tissue. Smooth muscle tissue was also detected lining the strands of 
the scaffold. These smooth muscle layers had the highest thickness in case of the prevascularisation + 
lipoaspirate group. (g) Column plot showing showing the adipose tissue area relative to total tissue 
area over 24 weeks. Negative control scaffold-only group had the lowest relative area of adipose 
tissue (8.31% ± 8.94) which was significantly lower than both lipoaspirate-only (39.67% ± 2.04) and 
prevascularisation + lipoaspirate group (47.32% ± 4.12) and also compared to native breast tissue 
(44.97% ± 14.12) (p<0.05, p<0.01 and p<0.01 respectively). No statistically significant difference in 
relative adipose tissue area was observed between the native breast tissue, lipoaspirate-only and 
prevascularisation + lipoaspirate group. (h) Graph showing blood vessel density in the tissue sections 
from different groups. Highest blood vessel density was observed in the prevascularisation + 
lipoaspirate group (38.01/mm2 ± 2.02), however the density was not statistically significantly higher 
than the scaffold-only (33.13/mm2 ± 12.03), lipoaspirate-only (26.67/mm2 ± 1.6) or control breast 
tissue (35.45/mm2 ± 1.93). (i) Histogram showing the distribution of adipose cells according to the 
cell surface area. In all groups, the histograms were skewed to the right suggesting that a majority of 
adipose cell surface areas lay in the range of 100-700 µm2. The distribution of the cell sizes in control 
breast tissue was considerably different compared to rest of the groups – with the highest percentage 
of cells in the 100-200, 300-400 and 500-600 µm2 range. The empty scaffold and lipoaspirate-only 
groups had a low number of adipose cells whose surface areas were larger than 800µm2; however, the 
prevascularisation + lipoaspirate group showed a more equalised distribution with a significantly large 
number of cells having a surface area larger than 1000µm2. 
 
To quantify neovascularisation, blood vessels were counted on all slides. These 
blood vessels were identified by a ring/tubular structure, with only those lined with 
red blood cells included in the count as functional blood vessels. In general, all 
constructs, including the empty scaffold-only group, showed a substantial ingression 
of neovascularisation. The highest blood vessel density was observed in the 
prevascularisation + lipoaspirate group (38.01/mm
2
 ± 2.02), however the density was 
not statistically significantly higher than the scaffold-only (33.13/mm
2
 ± 12.03), 
lipoaspirate-only (26.67/mm
2
 ± 1.6) or control breast tissue (35.45/mm
2
 ± 1.93). 
H&E sections of constructs also showed blood vessel on and parallel to the surface 
of the constructs, suggesting that new capillaries are likely to have sprouted from 
these larger vessels that penetrated into the scaffolds. 
Quantification of adipose cell area allowed the visualization of the distribution of 
different-sized cells as a histogram (Fig 4.4.13d). In all groups, the histograms were 
skewed to the right suggesting that a majority of adipose cell surface areas lay in the 
range of 100-700 µm
2
. The distribution of the cell sizes in control breast tissue was 
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considerably different compared to rest of the groups – with the highest percentage 
of cells in the 100-200, 300-400 and 500-600 µm
2
 range. The empty scaffold and 
lipoaspirate-only groups had a low number of adipose cells having a surface area 
larger than 800 µm
2
; whereas, the prevascularisation + lipoaspirate group showed a 
considerably higher number of cells having a surface area larger than 800 µm
2
. 
 
Figure 4.4.14 (a) Clustered column graph showing tissue composition at week 24 in various groups. 
Since the entire volume of the scaffold was filled with host tissue, it is reasonable to assume that each 
scaffold held 75 cm3 of total tissue volume at the end of the implantation period. From the relative 
adipose tissue fraction values shown in Fig 4.4.13(g), the estimated volume fraction of adipose tissue 
in each was calculated. TECs from empty scaffold group contained an average of 6.23cm3 (± 2.71) of 
adipose tissue, TECs from lipoaspirate-only group contained an average of 29.75cm3(± 1.53) of 
adipose tissue, whereas TECs from prevascularisation+lipoaspirate group contained an average of 
35.49cm3 (± 3.1) of adipose tissue. (b) Column graph showing fold increase in adipose tissue volume 
compared to initial injected lipoaspirate volume (4cm3) in the lipoaspirate-only and 
Prevascularisation+Lipoaspirate groups. Prevascularisation+Lipoaspirate group had a higher fold 
increase in adipose tissue volume compared to lipoaspirate-only group; however, the difference was 
not statistically significant (p=0.143). Data for empty scaffold group has not been included because 
lipoaspirate was not injected into these scaffolds. 
 
From data showing the percentage of adipose tissue area relative to total tissue area, 
the fold increase in adipose tissue volume was calculated (see Fig 4.4.14). 
Prevascularisation+Lipoaspirate group had a higher fold increase in adipose tissue 
volume compared to lipoaspirate-only group (6.44±0.38 vs 7.87±0.77); however, the 
difference was not statistically significant (p=0.143). 
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4.4.4 Discussion 
The ability to generate de novo adipose tissue for postmastectomy breast 
reconstruction is widely thought to revolutionise the field of breast reconstructive 
surgery [27, 77, 341, 353, 359]. Previous long-term rodent studies in our laboratory 
have shown sustained regeneration of high volumes of fat using cell-seeded 
anatomically shaped scaffolds [358]. These cell-based approaches are very promising 
for the regeneration of complex, living tissue; however, they also lead to several 
disadvantages with problems ranging from scaling up of tissue culture to requiring 
complex GMP-approved laboratories for tissue culturing. To circumvent these 
problems while scaling up the volumes of adipose tissue being regenerated, here we 
have followed the philosophy of implanting only a breast-shaped scaffold and using 
the patient’s body as a bioreactor. However, in the absence of a strong adipogenic 
stimulus, the scaffold gets filled with mostly non specific fibrovascular tissue [360, 
361].  
Here we have shown regeneration of de novo autologous adipose tissue by injecting a 
small volume of lipoaspirated tissue with no additional growth factors, cell 
transplantation or ligated vascular pedicles by introducing a completely novel 
prevascularisation technique that uses the patient’s own body as a bioreactor and a 
source of blood vessels. To our knowledge, no studies exist that provide a reliable 
reference on the maximum amount of volume that can be extracted from patients 
with low body fat percentage. This aspect is routinely determined in the clinic using 
the plastic surgeon’s experience and expertise. Based on our surgical team’s 
expertise, it was determined that 4 cm
3
 of adipose tissue is close to the maximum 
amount of fat that can be safely harvested from patients with low body fat. In terms 
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of percentage, it represents 5.3% of total volume of the scaffold at the time of 
implantation.  
The delayed lipo-injection technique allowed the formation of a bed of vascular and 
connective tissue within the scaffold volume. The presence of such vascular and 
connective tissue has previously been found to support early adipogenesis, provided 
sufficient mesenchymal stem cells or adipose progenitor cells have been recruited to 
the implantation site [361, 362]. Consequently, the adipose tissue, when injected into 
the already prevascularised scaffold, remained stably within the implantation sites 
with no tissue necrosis and resorption. Over a period of 24 weeks, this resulted into a 
fold increase of 6.44 (± 0.38) in case of lipoaspirate-only and 7.87 (± 0.77) in case of 
prevascularisation + lipoaspirate group. However, the final tissue composition 
requirements also depend upon the surgical procedure. If the surgery is done mainly 
for aesthetic breast augmentation, one of the main goals is to maintain the natural 
tactile sensation of the breast. For this reason, the regenerated tissue needs to consist 
mainly of adipose tissue with smaller amounts of organised connective tissue in 
order to mimic the natural tissue morphology of the breast region. In case of post-
mastectomy breast reconstruction, one of the major goals is to prevent a cancer 
relapse. In this case, adipose progenitor cells infiltrating into the scaffold may favour 
breast cancer recurrence via HGF/c-Met signalling [363]. Therefore, a majority of 
the regenerated tissue needs to be composed of highly organised connective tissue. 
The results of this study have demonstrated that the morphology of the regenerated 
tissue can be predicted depending on initial scaffold treatment strategy (empty 
scaffold vs prevasculartion + lipoaspirate) – whereby empty scaffolds yield highly 
organised connective tissue whereas scaffolds containing lipoaspirate yield tissue 
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rich in adipose tissue. In this way, scaffolds can truly be tailored for either an 
aesthetic augmentation procedure or a total reconstruction procedure. 
We believe that the stiffness of the constructs played a significant role in the 
neoadipogenesis process. Contrary to musculoskeletal systems, where tissue such as 
bone and muscle grow in response to mechanical forces [364, 365], adipogenesis 
seems to be inhibited by mechanical forces [366]. The scaffolds used in this study 
had a stiffness value that was 3 orders of magnitude higher than native breast tissue. 
We surmise that such mechanically robust scaffolds would exert a shielding effect on 
the newly formed adipose tissue and reduced the effects of the compressive, tensile 
and shear forces acting on the fat tissue. This decreased mechanical stimuli would 
have allowed the cells to maintain a round morphology which, in turn, would have 
promoted adipogenesis of the adipose progenitor cells [367].  
From a clinical point of view, the stiffness of the scaffolds must also be made 
dependent upon their placement. In case of most cosmetic augmentations whereby 
the implants are placed in a subglandular pocket, the scaffold needs to remain 
elastomeric and flexible so as to not cause patient discomfort; whereas in case of 
most post-mastectomy breast reconstruction procedures whereby the implants are 
placed in a submuscular pocket and no other supporting tissue remains, stiff implants 
must be used in order to properly support the regeneration of the entire breast region 
[368]. Indeed, the role that mechanical forces play in the regeneration of high 
volumes of fat tissue warrants further research and it would be interesting to test 
scaffolds with various stiffness properties and compare their regenerative capacities.  
Non-specific localised low-grade granulomatose reactions were observed in the 
vicinity of the localised scaffold strands, consistent with previous reports [358]. A 
granuloma is an organised collection of macrophages [369]. While the roles of 
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macrophages in angiogenesis are not yet completely understood, various research 
groups have shown that macrophages have the potential to contribute in angiogenesis 
[370-372]. More specifically, M1 macrophages secrete VEGF which initiates the 
process of angiogenesis, M2a macrophages secrete Platelet-Derived Growth Factor 
(PDGF)-BB known to be involved in later stages of angiogenesis, while M2c 
macrophages secrete high levels of Matrix Metallo-Proteinase (MMP)-9 known to 
have a role in remodelling of vasculature [373]. It has also been reported in the 
literature that macrophages can secrete alpha smooth muscle actin and can 
transdifferentiate into smooth muscle cells [374, 375]. All groups showed 
accumulation of smooth muscle tissue around the scaffold strands (Fig 4.4.13 a-c) 
which can perhaps be taken as an indirect evidence of the fact that macrophages may 
have played a role in angiogenesis and consequently higher adipogenesis in this 
group. Since the constructs were placed in PFA for an extended period of time post 
explantation, the proteins within the samples were denatured and immunohistology 
therefore could not be undertaken to provide direct evidence of this effect.  
While no major outward signs of chronic inflammation were observed clinically or in 
the gross morphology of the constructs, lymphatic structures and leucocytes were 
detected in the histology of all groups – which is to be expected because the study 
used an immunocompetent animal model. Although polycaprolactone has met FDA 
approval and been proven in multiple independent studies to be cytocompatible [98, 
253, 323, 376, 377], the increased leucocyte count may be explained by the fact that 
during the lipoaspiration process, adipose cells may have form non-viable aggregates 
in the syringe which, when injected into the scaffold, triggered an auto-immune 
reaction from the host aiming to break them down, ultimately leading to the 
ingression of lymphatic vessels.  
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Limitations of this study include the scaffold design. As described previously, owing 
to hardware and software limitations, the scaffold formation was a 3-step process – 
the first step being fabrication of the solid supporting dome, second step being the 
fabrication of the scaffold main body and the final step being manual trimming of the 
outer boundary shells to obtain a porous structure. In the real world, such a clinical 
solution is clearly impractical as the scaffold morphology is ultimately fixed by the 
surgeon and therefore is not reproducible. To overcome this limitation, software 
packages described in Study 2 were developed to fabricate completely patient-
specific scaffolds based on an Additive Biomanufacturing principle which can be 
fabricated using a support material of either a water-soluble polymer or a breakaway 
structure fabricated with the same material as the main structure. It is important to 
reiterate here that chronologically, this study, being a proof-of-principle study, was 
undertaken prior to the development of these software packages.  
Finally, the scaffold used in this study did not imbibe adequate design principles that 
would allow a surgeon to efficiently and accurately deposit the fat at predetermined 
regions in the scaffold. Indeed, this novel approach would be rendered impractical if 
the host connective tissue occupies a majority of the volume of the scaffold such that 
no further volume remains for the secondary injection of fat tissue. In this study, 
adipose tissue was injected directly into the vascular bed which may have caused 
localised tissue disruption. While such a tissue disruption may prove to enhance 
vascularisation [378], this phenomenon cannot be controlled within a clinical setting. 
Therefore, the scaffolds were completely redesigned using the software packages 
described in Study 2. The next generation scaffolds contain specialised channels 
which can act as recipients for the lipoaspirated tissue and are described in more 
detail in Appendix 1.    
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4.4.5 Conclusion 
This study, based on a foundation of previous small animal studies and clinical 
observations [336, 358], was used to provide proof of principle that the 
prevascularisation and delayed fat injection techniques can be used for efficient 
regeneration of large volumes of adipose tissue for long periods of time. It provides 
an important validation point for the regeneration of clinically relevant volumes of 
vascular-rich tissues in post-mastectomy breast reconstruction surgeries - paving the 
way for future clinical trials of scaffolds employing this principle. 
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Chapter 5: Discussion, Conclusions and 
Future Directions 
Breast cancer is the second leading form of cancer in women in Australia [351], 
affecting one in every eight women in western countries and one in every three 
women with cancer. Owing to the large number of clinical occurrences, breast 
reconstruction following lumpectomy (partial removal of breast tissue) or radical 
mastectomy (total removal of the breast) has become the sixth most common 
reconstructive procedure performed worldwide [315]. Lumpectomy defects of less 
than 25% of the total breast volume can typically be corrected by rearranging the 
local breast tissue [77]. Larger lumpectomies and mastectomies require more drastic 
reconstruction modalities. Reconstruction using silicone-based implants leads to 
formation of a rigid fibrous tissue surrounding the implant giving it an unnatural 
appearance. In such cases, the implant needs to be replaced. Lipofilling is another 
popular reconstruction method whereby the surgeon isolates fat from another region 
of the patient’s body via liposuction and injects it back into the breast region. 
However, without a structural support, the newly injected fat quickly gets remodelled 
by the body – requiring 3-4 additional lipofilling sessions before the tissue stabilises 
and the final form and volume are achieved [71]. Currently there exists no surgical 
platform that overcomes these problems and supports stable development of breast 
tissue. 
Therefore, this PhD project focused on the testing of surface-modified silicone 
implants to assess whether they reduce the severity of capsular contracture. 
Subsequently, the project was focused on the fabrication of a patient-specific 
biodegradable scaffold using additive manufacturing technology. We hypothesized 
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that a slow-degrading polymer with pore sizes >1.5 mm allows for efficient vascular 
in-growth and long-term sustained regeneration of high volume adipose tissue, 
thereby potentially providing an effective treatment for bone defects circumventing 
the shortcomings of current breast reconstruction techniques.  
5.1 Summary of Study 1 
Chapter Title: Evaluation of modified breast implant surfaces in a Minipig-Model  
This study aimed to establish a reproducible large animal subglandular model 
recapitulating the environment of a breast surgery in a healthy female patient and 
also, at the same time, evaluate the impact of three different surface structures on the 
development of fibrosis and subsequent capsular contracture. As mentioned 
previously, it was hypothesised that the data obtained in terms of surface roughness 
and its impact on tissue adhesion and fibrosis would provide unique insights which 
would influence the design of porous biodegradable scaffolds from a completely 
different point of view.  
The implants were manufactured and kindly provided by Mentor LLC with 3 
different surfaces: one surface with 100 pores per inch, having an average surface 
pore diameter of 57.71 µm (Small pores – SP); one surface with 65 pores per inch, 
having an average surface pore diameter of 95.52 µm (Large pores – LP) and one 
with a smooth surface (S). Six female adult Ellegaard Göttingen Minipigs were 
randomly allocated to two groups: a 10-weeks and a 20-weeks group. N=6 implants 
were placed in separate subglandular pockets in each animal.  
It was observed that the minipigs developed Baker Grade 3 and 4 capsular 
contractures after 10 weeks of implantation. At the end of the 20 week implantation 
period, it was observed that capsules derived from LP implants had the highest 
stiffness, followed by SP while S implants showed the lowest stiffness. 
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Corresponding with capsule stiffness, LP implants also had a significantly higher 
stiffness compared to both SP and S implants (p<0.01). In terms of tissue makeup, S 
group showed the least amount of collagen at 10-week time point while SP group 
were found to have the highest concentration. At 20-week time point, the collagen 
expression in S and LP group increased while it decreased in case of SP implants. 
Immunohistological staining performed on the tissue sections showed that at 10-
week time point, S group had the highest concentration of alpha smooth muscle actin 
(SMA) while SP had the lowest; whereas at 20-week time point LP implants had the 
highest expression of alpha SMA and SP still showing the lowest expression. At 10-
week time point, SP group showed the highest expression of Integrin B1 while S 
implant had the least expression. None of the groups showed any major expression of 
osteopontin at any of the time points. 
On one hand, the established subglandular in vivo model now makes it possible to 
test silicone implants as well as scaffolds in an environment that is very close to the 
human equivalent. This will allow researchers to iteratively improve the surface 
microstructures designs and hopefully lead to novel approaches that can limit the 
incidences of capsular contracture. On the other hand, the effect of different surface 
topologies, at least within the experimental time period, did not improve the outcome 
of capsular contracture significantly when compared to smooth implants.  
It was concluded that a porous biodegradable implant based on tissue engineering 
principles would provide an effective solution to many of the challenges posed by 
current generation of silicone implants. Therefore, further work undertaken as part of 
this PhD thesis focused on developing novel methodologies to design and fabricate 
such highly customised scaffolds for breast reconstruction following a tissue 
engineering and personalized medicine approach.  
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5.2 Summary of Study 2 
Chapter Title: Development of a methodology to fabricate highly customised 
patient-specific biodegradable scaffolds 
The first part of Study 2 focused on establishing a streamlined methodology to 
convert medical imaging data sets into high-fidelity 3D CAD models appropriate for 
additive manufacturing. To this end, a versatile approach was developed to generate 
patient-specific scaffolds not only for breast reconstruction, but also for virtually any 
defect site in the body. This approach allows for a high level of automation and 
requires minimal manual handling. For this, we made use of freely available open-
source software to convert high resolution MRI or CT scan data into 3D CAD 
models using the thresholding technique. The specific advantage of the thresholding 
technique is that it allows for relatively easy differentiation of tissue/area of interest 
from its surrounding region. Using this method, porous models mimicking the 
overall shape of a scanned tissue region were generated. 
Second part of Study 2 focused on converting a 3D CAD model into scaffold 
architectures suitable for tissue engineering purposes. Although in the past few years, 
proprietary software have been developed for FDM machines for fabricating solid, 
watertight 3D structures [312-314], such software are closed source, do not support 
the fabrication of porous models and are unavailable for use with custom-made 
bioprinters. Moreover, such software packages have not yet attained the level of 
sophistication and control over extrusion parameters required in the biofabrication 
industry. Using our method for fabricating scaffolds is not only versatile across 
almost all FDM or CNC machines, but the cross-platform nature of all the software 
packages used also makes this process suitable for use with experimental additive 
manufacturing devices yet to be developed. An independent method has already been 
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developed by our research group to laser scan a breast surface, generate a 3D model 
and fabricate a porous prototype using non-biodegradable materials [91]. The method 
developed during the course of this PhD project complements this method in that it 
allows the fabrication of porous, biodegradable scaffolds using more ubiquitous MRI 
and CT scans. Combined together, these methods encompass an almost 
comprehensive range of avenues for generating porous patient-specific scaffolds 
from medical imaging data sets.   
5.3 Summary of Study 3 
Chapter Title: Sustained Regeneration of High-volume Adipose Tissue for Breast 
Reconstruction using Computer Aided Design and Biomanufacturing  
Adipose tissue engineering offers a promising alternative to the current breast 
reconstruction options. Our hypothesis was that a scaffold would maintain its shape 
and volume for at least 9-12 months post implantation without showing any signs of 
mass loss so that the regenerated tissue stably remodels several times in the highly 
scaffold architecture without being influenced by any degradation by-products.  
In this work, patient-specific scaffolds with large pore sizes and pore 
interconnections were fabricated with a biodegradable poly(D,L)-lactide polymer. 
Human umbilical cord perivascular cells were isolated from human umbilical cord 
and seeded onto the breast-shaped scaffolds. The tissue engineered constructs (TEC) 
were cultured under static conditions for 4 weeks and subsequently 2 weeks under 
dynamic conditions in a biaxial rotating bioreactor before being combined with 
Human Umbilical Vein Endothelial Cells (HUVEC) and implanted subcutaneously 
into athymic nude rats for 6 months. 
Angiogenesis and adipose tissue formation were observed throughout all constructs 
at all timepoints. The percentage of adipose tissue compared to overall tissue area 
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increased from 37.17% to 62.30% between week 5 and week 15 (p<0.01), and 
increased to 81.2% at week 24 (p<0.01). The stiffness of the constructs decreased by 
66% over 24 weeks, while the seeded endothelial cells self organised to form a 
functional capillary network. 
Adipose tissue has been reported to be highly vascular [174]. In fact, Patrick [77] 
reports that each adipocyte is connected to at least one capillary – with the volume of 
capillary beds in adipose tissue being higher than even muscular tissue. Furthermore, 
adipose cells die within 3 hours when deprived of oxygen  [77]. This occurs because 
the diffusion of oxygen from the surrounding tissues is sufficient only over a distance 
up to ~150 µm for adipose tissue [175]. Therefore, in tissue constructs without 
adequate vascularization, autologous adipose tissue loses up to 60% of its volume 
post-transplantation because the cells in the centre of the graft are inadequately 
supplied with oxygen [176, 177]. Hence, it becomes important to ensure that the 
tissue engineered constructs have access to an adequate vascular network. Since the 
diameters of a large number of rat blood vessels infiltrating into a tissue-engineered 
construct lie in the 500-1500µm range [379], we hypothesized that a slow-degrading 
polymer with pore sizes in the range 1000-2000µm mm allows for efficient vascular 
in-growth. However, as pore sizes increase, the overall shape fidelity of the 3D 
printed scaffold decreases and so do the scaffold stability and mechanical properties 
(see Fig 5.1). The scaffolds fabricated in this study provided the best compromise 
between pore sizes, shape fidelity and mechanical properties and were therefore 
chosen as the final design candidates. 
The long term strategy of our research group with respect to the above mentioned 
vascularisation problem is to allow the infiltration of the host vasculature into the 
scaffold. We have already published a study where we fabricated polycaprolactone 
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and polyurethane-based scaffolds with an average pore-size of 450-560 microns 
[336], seeded them with adipose-derived MSCs and implanted them into nude rats. 
Our results showed <10% of adipose tissue survived a 4-week implantation period. 
Retrospectively, we surmised that one of the main causes leading to the tissue 
remodelling was a lack of widespread infiltration of blood vessels from the host into 
the scaffolds.  
The presented approach of fabricating patient-specific scaffolds using 3D scans 
represents a facile approach towards engineering clinically relevant volumes of 
adipose tissue for breast reconstruction. We have demonstrated a clinically viable 
route to design and fabricate biodegradable patient-specific scaffolds directly from 
3D imaging data sets. To our knowledge this is the first study showing a sustained 
regeneration of high volume adipose tissue over a long period of time using a 
patient-specific biodegradable scaffold. These scaffolds, which are optimised for 
large volume adipose tissue regeneration, contain large pores and pore 
interconnections, facilitate the ingrowth of host vasculature throughout the entire 
scaffold architecture which is crucial for long-term sustenance and viability of 
adipose tissue. 
5.4 Summary of Study 4 
Chapter Title: Breast Reconstruction using Computer Aided Design and 
Biomanufacturing – towards engineering clinically relevant volumes of adipose 
tissue. 
Progenitor cell-based approaches are very promising for complete regeneration of 
breast tissue; however, they also lead to several disadvantages – ranging from 
problems with scaling up of tissue culture to requiring complex GMP-certified 
laboratories for tissue culturing  [250-256].  
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To overcome these limitations, we have devised a concept of delayed fat injection 
combined with an empty biodegradable scaffold. According to this concept, an 
empty scaffold is first placed at the implantation site and allowed to remain for 2 
weeks during which time connective tissue and host vasculature is expected to 
penetrate into the scaffold pores. After the prevascularisation time, a pre-determined 
volume of autologous lipoaspirated adipose tissue is injected into the pores of the 
scaffold. The presence of a pre-formed bed of connective tissue and vasculature 
would allow the injected fat to remain stable within the implantation site with 
minimal tissue necrosis and resorption. 
To test this hypothesis, 3 study groups were included in this study: 
1) Empty scaffold. 
2) Scaffold containing 4 cm3 lipoaspirated adipose tissue. 
3) Empty scaffold + 2 week prevascularisation period. After 2 weeks of 
prevascularisation, 4 cm
3
 of lipoaspirated adipose tissue was injected into 
scaffolds. 
6 implants were placed in each animal (n = 2 per group) and the animals were 
sacrificed after 24 weeks. Histological evaluation showed that multiple areas of well 
vascularised adipose tissue were found in all groups. The negative control empty 
scaffold group had the lowest relative area of adipose tissue (8.31% ± 8.94) which 
was significantly lower than both lipoaspirate-only (39.67% ± 2.04) and 
prevascularisation + lipoaspirate group (47.32% ± 4.12) and also compared to native 
breast tissue (44.97% ± 14.12) (p<0.05, p<0.01 and p<0.01 respectively). However, 
there was no statistically significant difference in relative adipose tissue area between 
the native breast tissue, lipoaspirate-only and prevascularisation + lipoaspirate group. 
The highest blood vessel density was observed in the prevascularisation + 
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lipoaspirate group (38.01/mm
2
 ± 2.02), however the density was not statistically 
significantly higher than the scaffold-only (33.13/mm
2
 ± 12.03), lipoaspirate-only 
(26.67/mm
2
 ± 1.6) or control breast tissue (35.45/mm
2
 ± 1.93). 
While no major signs of chronic inflammation were observed in the tissue sections or 
in the gross morphology of the constructs, non-specific localised low-grade 
granulomatose reactions were observed in the vicinity of the localised scaffold 
strands. Lymphatic structures and leucocytes were also observed in all groups 
localised mainly near scaffold strands.  
In this study, we have shown regeneration of de novo autologous adipose tissue by 
injecting a small volume of lipoaspirated tissue with no additional growth factors, 
cell transplantation or ligated vascular pedicles by introducing a completely novel 
prevascularisation technique that uses the patient’s own body as a bioreactor and a 
source of blood vessels.  
5.5 Limitations and recommendations for future work 
In this project, a foundation, in terms of methodologies, animal models and scaffold 
designs, has been laid which may accelerate the research into the field of breast 
tissue engineering. However, there remain many avenues open for further 
development and more work needs to be done to get a clearer understanding of how 
to optimise the breast scaffolds to promote vascularisation. The limitations of this 
PhD project along with the recommended future work are discussed hereafter: 
5.5.1 Biopolymer characteristics and degradation models were simplified for the 
FE analysis 
Establishing a comprehensive model of biomaterial behaviour, degradation and 
physical properties in vivo is a lengthy and complex exercise, perhaps requiring a 
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research project of its own. Therefore in this project, it was assumed that the 
biomaterials have a perfectly linear elasticity and that they follow Hooke’s law (the 
linear elastic isotropic model). Other parameters such as polymer viscosity, 
degradation kinetics, change in Young’s modulus and the effect of tissue infiltration 
on the mechanical properties were also excluded. The development of this software 
will continue beyond the duration of this PhD project and future versions will 
incorporate more complex models of material behaviour and form a basis for future 
parameteric studies to be investigated. 
5.5.2 Scaffold mechanical properties  
During the process of designing a scaffold for tissue engineering, a balance must be 
achieved between the porosity and the mechanical integrity – see Fig 5.1 for an 
illustration of the relationship between porosity, pore sizes, cellular response and 
mechanical strength.  
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Figure 5.1 Illustration of the relationship between porosity, pore sizes, cellular response and 
mechanical strength. Adapted from Holzapfel et al  [311]. The mechanical properties of the scaffolds 
can be controlled in 2 ways: by controlling the overall porosity of the scaffold and by controlling its 
internal architecture. Increasing the overall porosity reduces the mechanical properties, but it also 
increases the density of cells and ECM in pore architecture since there is less surface area available on 
the scaffold strands. On the other hand, a macroporous scaffold can also be made mechanically 
stronger/stiffer by altering its pore architecture – which fundamentally alters the stress distribution 
within the scaffold.  
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Stiffness and strength properties of the scaffold should also be optimised to allow it 
to resist changes in shape in vivo when the breast region is subjected to high 
biomechanical loads during sleeping and sports activities.  
On the other hand, patient comfort, quality of life and tissue irritation are also three 
of the major concerns which are insufficiently addressed. Also, from a clinical point 
of view, the stiffness of the scaffolds must be tailored dependent upon their 
placement. In case of most cosmetic augmentations whereby the implants are placed 
in a subglandular pocket, the scaffold needs to remain elastomeric and flexible so as 
to not cause patient discomfort; whereas in case of most post-mastectomy breast 
reconstruction procedures whereby the implants are placed in a submuscular pocket 
and no other supporting tissue remains, stiff implants must be used in order to 
properly support the regeneration of the entire breast region [368] (see Fig 5.2).  
 
Figure 5.2 Graphic showing subglandular vs submuscular placement of implants. Figure adapted from 
Myckatyn [380]  
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PROPERTY AESTHETIC BREAST 
AUGMENTATION 
TOTAL BREAST 
RECONSTRUCTION 
Scaffold 
Placement 
Scaffold normally placed 
above the pectoral 
muscles but below the 
mammary gland 
(subglandular placement). 
Such a placement gives 
the most aesthetically 
appealing outcome.   
Scaffold normally placed below the 
pectoralis major muscle such that the 
muscle covers the upper half of the 
implant (submuscular placement). Such 
a placement shields the implant from the 
irradiated breast tissue and prevents it 
from causing capsular contracture.  
Tissue 
constitution 
One of the main goals is to 
maintain the natural tactile 
sensation of the breast. 
For this reason, the 
regenerated tissue needs to 
consist mainly of adipose 
tissue with smaller 
amounts of organised 
connective tissue.  
 
All total breast reconstructions are 
undertaken after mastectomy or tumour 
abscission. One of the major goals is to 
prevent a cancer relapse. In this case, 
adipose progenitor cells infiltrating into 
the scaffold may favour breast cancer 
recurrence via HGF/c-Met signalling 
[363]. Therefore, a majority of the 
regenerated tissue needs to be composed 
of highly organised connective tissue.  
Scaffold 
mechanical 
properties 
Scaffold needs to be soft, 
elastomeric and flexible to 
minimise patient 
discomfort since there is 
no muscle layer shielding 
the scaffold from the inner 
layers of skin.  
Following mastectomy, almost all of the 
breast tissue is abscised. Therefore, the 
scaffold needs to be mechanically stable 
enough to bear the biomechanical forces 
of the entire region. Also, the scaffold is 
normally placed behind the muscle, 
which acts as a barrier - reducing patient 
discomfort. 
Scaffold In case of young patients In case of patients undergoing 
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Degradation 
Rate 
undergoing augmentation, 
the tissue is healthy and 
hasn’t undergone radiation 
therapy. Therefore, the 
body has a higher rate of 
regeneration and the 
scaffold needs to degrade 
faster 
reconstructive breast surgery post 
tumour resection, the tissue is heavily 
damaged due to radiation therapy. 
Hence the regenerative capacity of the 
body is compromised and the scaffold 
needs to stay intact for longer periods of 
time. Additional research is needed to 
determine optimum degradation rate.  
 
In order to further progress such composite scaffolds into real world applications, 
one would need to find a balance between suitable scaffold mechanical properties, 
bioactivity, and porosity. One way to improve the scaffold mechanical strength while 
not compromising the scaffold bioactivity and porosity is to explore the different 
scaffold architectures by varying the scaffold lay-down pattern. Research performed 
previously in our lab has proven that a change in the scaffold laydown pattern can 
significantly alter the mechanical properties of the scaffold owing to a difference in 
the stress distribution[381]. Alternatively, one can produce a composite scaffold 
formed out a slow degrading highly porous polymer backbone acting as a skeleton 
for a soft degradable hydrogel-based material. Indeed, it is planned that future 
extensions of this PhD project would focus on addressing the problem of scaffold 
mechanical properties using the tools and methodologies developed in this project.  
5.5.3 Scaffold in vivo degradation behaviour 
In this PhD project, we validated the degradation rate of various scaffolds by using 
their mechanical properties as a benchmark. The changes in the molecular structure 
of the polymer chains also need to be investigated – especially in cases of novel 
biopolymers. Furthermore, when implanted in vivo, the scaffolds not only undergo 
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hydrolytic degradation, but also enzymatic degradation facilitated by macrophages 
[110]. Therefore, longer term in vivo studies are required to fully characterise this 
behaviour at the mammary sites. Such a long-term study would ideally employ 
methods such as evaluation of mechanical properties of the scaffold as well as the 
crystallinity and changes in the molecular structure of the biopolymer chains as 
measures of degradation.  
 
Figure 5.3 Schematic illustrating the interdependence of molecular weight loss and mass loss of a 
slow-degrading PCL scaffold plotted against time, which corresponds with tissue regeneration. 
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Scaffold, as shown by SEM (A) is implanted at t = 0 (B) with lower figures (C-E) showing a 
conceptual illustration of the biological processes of adipose tissue formation over time. The scaffold 
is immediate filled with a hematoma on implantation (C) followed by vascularization (D) and 
gradually new adipose tissue is formed within the scaffold (E). As the scaffold degrades over time 
there is increased tissue remodelling within the implantation site until eventually the scaffold pores are 
entirely filled with stable adipose tissue and vascularity. SEM of scaffold degraded over time (G) with 
associated schematic visualization of how PCL scaffolds degrade via long-term bioerosion process, 
which takes up to 36 months in vivo (h). Figure adapted from Woodruff et al [310]. 
 
5.5.4 Characterisation of tissue morphology and make-up 
In studies 2, and 4, we primarily focused on the morphology of the adipose tissue, 
localised fibrotic reactions and presence of blood vessels. However, other aspects of 
tissue make-up such as the interactions between the macrophages and the implanted 
cells, changes in blood leucocyte count, intracutaneous reactivity, acute systemic 
toxicity and hemolysis fell out of the scope of these two studies. It is expected that 
once an optimum tissue engineered construct is found which could mimic the 
properties of native adipose tissue, all aspects of tissue morphology and 
immunological behaviours towards the constructs will be studied in detail.  
5.5.5 Scaffold form in study 4 was not adequate for delayed fat injections 
The hemispherical shell-based scaffold used in study 4 did not imbibe adequate 
design principles that would allow a surgeon to efficiently and accurately deposit the 
fat at predetermined regions in the scaffold. Indeed, this method would be rendered 
impractical if the host connective tissue occupies a majority of the volume of the 
scaffold such that no further volume remains for the secondary injection of fat tissue. 
Therefore, we have developed a system of removable space-occupying structures 
within the scaffold which can be removed prior to injection of the fat (see Appendix 
1). These space-occupying structures, when removed, would create voids within the 
scaffold which can then be used to inject the fat.  
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5.5.6  Drug Delivery using biodegradable scaffolds 
The applications of biodegradable breast scaffolds could also be extended to anti-
cancer drug delivery applications – an application of particular interest both to breas 
augmentation patients and post-cancer mastectomy patients. In case of young 
patients choosing to undergo aesthetic breast augmentation procedures, the scaffold 
can be loaded with adipogenic growth factors which may stimulate a faster 
regenerative response from the body. One of the simplest strategies to immobilise 
growth factor particles onto a scaffold is through crosslinking of a biodegradable 
polymer coating loaded with growth factor (GF) molecules onto the scaffold surface 
[382]. Another approach could be a combination of GF -releasing microspheres and a 
macroporous scaffold [383, 384]. This approach could be useful in cases where the 
scaffold biomaterial is not suitable for controlled release of GF molecules. Interested 
readers are encouraged to read a review on these growth factor delivery applications 
by Mourino et al to obtain further information [385]. 
On the other hand, this strategy must be used with caution in case of post-
mastectomy breast reconstruction patients. One of the major issues currently 
unresolved in this field is the fact that after tumour removal, cancerous cells may still 
remain inside the breast region. If the scaffold triggers excessive angiogenic or 
proliferative signals (due to presence of MSCs or GF), the remaining cancerous cells 
in the region may trigger a malignant tumour formation. Therefore, in such cases, the 
scaffold can be loaded with anti-cancer drugs to balance the proliferative effects of 
the growth factor molecules. This aspect of breast tissue engineering warrants further 
research to determine the perfect balance between GF and anti-cancer drugs. 
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5.6 Overall discussion and conclusion 
An upcoming clinical area for the application of adipose tissue reconstruction is 
breast reconstruction post-mastectomy. Currently, a majority of breast 
reconstructions are performed with the use of non-degradable prosthetic implants or 
by transplantation of autologous free or pedicled tissue flaps consisting of skin, 
muscle and connected vasculature [51]. A different, more promising approach 
towards the reconstruction of breast volume has been proposed in this PhD project. 
This method advocates for the use of personalised biodegradable scaffolds fabricated 
by additive manufacturing. Since the publication of the highly cited research paper 
by Patrick[27, 204] that used preadipocyte-seeded polyglycolic acid (PLGA) 
scaffolds for regenerating small volumes of adipose tissue, many research groups 
around the world [3-11] have produced interesting results in respect to the 
regeneration of adipose tissue using cell-based approaches. These cell-based 
approaches are very promising for the regeneration of complex, living tissue; 
however, they also lead to several disadvantages – ranging from problems with 
scaling up of tissue culture to requiring complex GMP-approved laboratories for 
tissue culturing. Furthermore, it is inherently challenging to embrace the 
complexities and intricacies of a human body and distil them down to highly 
controllable experimental variables to be used in an in vitro culture model.  
To avoid using such cells and biological factors, and alternatively to achieve an 
adipoconductive polymer-based scaffold, one approach is to implant the scaffold 
acellularly and subsequently introduce autologous tissue into the pores of the 
scaffold. Although not used in breast tissue engineering research, this so-called 
“body as a bioreactor” approach has been successfully implemented in bone and 
cartilage tissue regeneration [250-256]. The advantage of such an approach is its 
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simplicity as it does not rely on the delivery of exogenous growth factors and/or cells 
which is especially important in case of adipose tissue engineering whereby large 
volumes of adipose tissue needs to be harvested and cultured for long periods of time 
in order to generate cell numbers sufficient to populate the large volume scaffolds 
(see Table 5.1).  
 
 
 
STRATEGY ADVANTAGES DISADVANTAGES 
Silicone Implants Can be manufactured in a broad range 
of sizes, contours, profiles and textures. 
Easy to handle and implant. Surgery 
times are lower compared to breast 
reconstruction surgeries using 
autologous tissue. 
Capsular contracture. 
Elevated siloxanes and 
platinum levels are 
detrimental to patient’s health.  
High likelihood of repeat 
surgeries being needed to 
replace leaking implants or 
remove fibrous capsule.  
Cell/Growth 
Factor-laden 
scaffolds 
Have the potential to regenerate 
complex hierarchical tissues and mimic 
cellular organization of natural tissues.  
By seeding endothelial cells, it is 
theoretically possible to generate a 
vascular bed in vitro within the 
scaffolds prior to implantation.  
Manual cell seeding and 
culturing of cell-laden large 
volume scaffolds is time 
consuming, user-dependent, 
semi-efficient and, therefore, 
economically unviable [4]. 
Regulatory approvals and 
Quality Assurance guidelines 
for cell-laden constructs are 
complex and expensive. 
Cell/Growth Manual cell seeding not required. As of yet, this technique is 
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Factor-free 
scaffolds 
Therefore, the production process can 
be upscaled in case of large volume 
scaffolds and be made economically 
viable with fewer obstacles.  
Permeable entry barriers. Quality 
Assurance guidelines are significantly 
less complex and expensive. 
Using the “body as a bioreactor” 
approach [256], it is possible to induce 
infiltration of vasculature from the host 
body.  
unsuitable for use to give rise 
to complex hierarchical tissue 
organisation. 
  
Therefore, in this PhD project, and indeed for future in vivo studies, we ultimately 
aimed to pursue the cell-free scaffold concept in the field of adipose tissue 
engineering.  
In this PhD project, patient-specific biodegradable scaffolds were fabricated using a 
unique computer-aided-tissue-engineering (CATE) strategy encompassing: 
- Conversion of medical imaging scans into CAD models suitable for 
additive manufacturing.  
- Conversion of solid CAD models into scaffold architectures for use in 
tissue engineering.  
- Direct conversion of porous scaffold geometries into finite elements for in 
silico mechanical testing.  
It was shown in vitro that the scaffolds showed good cell compatibility and aided in 
the proliferation of multipotent cells in 3 dimensions. Cell-seeded constructs were 
later implanted in nude rats for 24 weeks, after which we observed that although 
widespread regeneration of adipose tissue was observed throughout the spans of the 
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constructs, the newly regeneration fat was of host origin while a majority of the 
grafted cells did not survive the implantation process. We also obtained positive 
results in a scaled-up minipig model whereby cell-free scaffolds were implanted into 
the test subjects combined with lipoaspirated autologous fat tissue extracted during 
the surgery. Efficient and anatomically relevant regeneration of adipose tissue was 
once again observed within this minipig model.  
Taking all this into consideration, the implications of a cell-free patient-specific 
biodegradable scaffold for breast tissue engineering are far-reaching. Throughout the 
world, academic, clinical, and industrial efforts are increasingly being directed 
toward the use of regenerative medicine-based therapies for the diagnosis and 
treatment of a range of pathologies and injuries. In a cost-controlled healthcare 
environment, new technologies must be assessed on the basis of their potential to 
improve patient quality of life relative to the additional cost burden placed on the 
health system. Only those technologies that demonstrate adequate cost effectiveness 
ratios will be driven forward to broad clinical application. Our approach of using 
cell-free scaffolds represents a next generational approach in the field of breast tissue 
engineering with the clear potential to meet this criterion – with potential to restore 
the natural form and feel of breast tissue without the need for ongoing treatment and 
support. The work presented in this thesis, when furthered in the future by world-
class research teams, will enable the establishment of a world leading research 
program in soft tissue engineering and regenerative medicine. 
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Epilogue 
This thesis is not only an embodiment of 3 years of work, and as much as I’d like to 
boast that I am a one-man-army handling all aspects of this project single-handedly, 
saying so would be blatantly false. Indeed, without the contribution of tens of people 
in Brisbane, Utrecht and Germany and their unwavering support, I would not have 
been able to accomplish even half the work that I’ve been able to show here. I will 
not try to mention all students, postdocs and staff members I’ve shared good times 
with by name, as I’m sure I will forget some. I thank you all! Instead, in this 
Epilogue, I will focus on persons who really were influential in setting the directions 
of this thesis.  
My first thanks go to Edward Ren, for had it been some other RA on that fateful 
night in October 2011, perhaps you would not be reading this thesis today. I’d like to 
thank Ed not only for coaxing me into a PhD, but also for teaching me the necessary 
skills of tissue sectioning and immunohistology – without these skills the directions 
of this thesis would have been radically different. After initially submitting my PhD 
application in October 2011, there was a period of 3 months when I was effectively 
unemployed. During this time, I asked my future Associate Supervisor, Dr. Ferry PW 
Melchels, if I could come in anyway and learn some 3D printing skills. I thought 
even if I didn’t get into the PhD programme, I would be a legend among my circle of 
friends if I told them I knew how to 3D print. Luckily, Ferry agreed to teach me how 
to 3D print over the next few months and fortunately, I was accepted into the PhD 
programme. Ferry, since that time, you have put a lot of work in converting me from, 
as you Dutchmen say, a clueless prutser to a scientist. I remember coming to your 
desk Friday every week with an “improved” scaffold design and a smug look on my 
 213 
Chapter 4: Discussion, Conclusions and Future Directions 213 
face – thinking I’d made some real breakthrough. You nearly always went “nah, not 
good enough mate” and that would give me some fuel to produce the next 
improvement in the coming week. When finally, in September 2012, we made the 
first porous breast scaffolds (used in Study 3), you went “Wow! These look 
awesome” and the look on your face was reward enough for all the previous work. I 
cannot put a count on the number of things I learnt from you, and for me you will 
always remain a mentor. Thank you so much for guiding me in this journey.  
One of the first things I learned, apart from 3D printing, was tissue culture. Dr. Anna 
Taubenberger was the resident expert on cell culture and my training started with 
pipetting a known volume of water onto a weighing tray and matching the dispensed 
volume with the weight. If volume = weight, I was doing it right. I was a born natural 
at this – as, I suspect, is 99.99% of the population. But the lessons got more complex 
following that and another PhD student, Jeremy Baldwin, got involved into my 
training. Jeremy, I am very thankful for your fastidious cell culture training, which 
helped me immensely in my 2
nd
 year, when I was juggling ~100 T75 flasks like a 
professional. I also thoroughly enjoyed our time as desk-neighbours. Listening to 
your multitude of good ideas about tissue engineering indeed fascinated me (truth) 
and gave me an avenue to discuss my own project with someone else. Thank you 
also for the miniature Jefferson, Bruce Lee and the unforgettable Pet-Rock.  
Animal experiments followed cell culture. It is here that I got to collaborate with 
another good friend of mine, Boris Holzapfel. Boris, you really took the fear of 
handling those frightening rats out of my mind by bringing in the barbeque glove. I 
am very grateful for that. I am also thankful for showing me how important it is to 
think about the clinical aspects of their strategies and view things from a surgeon’s 
point of view. This new thinking really served as a guide for the rest of my PhD 
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(Study 4 and beyond). I hope we can continue having these discussions even after 
you go back to Germany.  
I would also like to thank Ingo Fehr for showing me how to put the “engineering” in 
Tissue Engineering. You are still the best roommate I’ve ever had and amongst the 
brightest engineers I’ve met. The crazy ideas about scaffold manufacturing you gave 
me towards the end of this project, I suspect will play a major role in the coming 
years. Vielen Dank for the wine tasting lessons and the great time I’ve spent with 
you during our shared lunch sessions and our road-trips in Australia, India and 
Germany.  
To be able to work hard, I am really grateful for the support of Patrina Poh. From our 
first meeting during the shared lunch sessions, you have constantly been a source of 
forward momentum and fresh perspectives for me. You pushed me and enabled me 
to do things I often I would never accomplish. You showed me how little things, 
when added together, could add up to produce great effects – both good and bad. 
This realization shaped this PhD journey more than anything else and for this I owe 
an inexpressible load of gratitude to you. Finally, I apologise for making you listen to 
all of my sometimes crazy ideas and for making sure they were made sense before 
presenting them to Dietmar.  
Every person mentioned in this Epilogue played a major influence on this project. 
But the one person without which none of this would have been possible is Dietmar. 
Dietmar, firstly I thank you for assuming the courage to hire such a wet-behind-the-
ears student as part of such an ambitious team. Apart from all the science, I have 
learnt so much about being a leader and an innovator from you – knowledge that will 
inspire me throughout my career. You have always found the time to review texts 
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and presentations, coming up with innovative ideas and showing me the big picture 
when I was lost in details. In doing this, you have truly brought credence to the term 
“Doktorvater”. Thank you very much for all the interesting talks about football, 
cooking tips, stock market and also for opening your house to me when I was 
apartment-hunting. For this, I will forever be grateful.  
For many, the end of their PhD is the beginning of a new era. So many things 
learned, so many experiences lived – bringing about a yearning to make one’s own 
mark in the world of science. For me it is no different, this thesis is only a milestone 
in the bigger picture, for I have many more promises to keep, and miles to go before 
I sleep.  
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[277] Tate MC, Garcıá AJ, Keselowsky BG, Schumm MA, Archer DR, LaPlaca MC. 
Specific β< sub> 1</sub> integrins mediate adhesion, migration, and differentiation 
of neural progenitors derived from the embryonic striatum. Molecular and Cellular 
Neuroscience. 2004;27:22-31. 
[278] Mazzali M, Kipari T, Ophascharoensuk V, Wesson J, Johnson R, Hughes J. 
Osteopontin—a molecule for all seasons. Qjm. 2002;95:3-13. 
[279] Von Recum A, Van Kooten T. The influence of micro-topography on cellular 
response and the implications for silicone implants. Journal of Biomaterials Science, 
Polymer Edition. 1996;7:181-98. 
[280] Ratner BD. New ideas in biomaterials science—a path to engineered 
biomaterials. Journal of biomedical materials research. 1993;27:837-50. 
[281] Johnson PE, Kernahan DA, Bauer BS. Dermal and epidermal response to soft-
tissue expansion in the pig. Plastic and reconstructive surgery. 1988;81:390-5. 
[282] Montagna W, Yun JS. The Skin of the Domestic Pig1. Journal of investigative 
dermatology. 1964;43:11-21. 
[283] Brohim RM, Foresman PA, Hildebrandt PK, Rodeheaver GT. Early tissue 
reaction to textured breast implant surfaces. Annals of plastic surgery. 1992;28:354-
62. 
[284] Joseph J, Variathu KT, Mohanty M. Mediatory role of interleukin‐6 in α 
smooth muscle actin induction and myofibroblast formation around silicone tissue 
expander. Journal of Biomedical Materials Research Part A. 2013;101:2967-73. 
[285] RUDOLPH R, ABRAHAM J, VECCHIONE T, GUBER S, WOODWARD M. 
Myofibroblasts and free silicon around breast implants. Plastic and reconstructive 
surgery. 1978;62:185-96. 
[286] Joseph J, Mohanty M, Mohanan P. Investigative study of myofibroblasts and 
cytokines in peri-implant tissue of silicone breast expander by RT-PCR in a rat 
model. Journal of Biomaterials Science, Polymer Edition. 2010;21:1389-402. 
[287] Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. Alpha-smooth 
muscle actin expression upregulates fibroblast contractile activity. Molecular biology 
of the cell. 2001;12:2730-41. 
[288] Adams Jr WP, Haydon MS, Raniere Jr J, Trott S, Marques M, Feliciano M, et 
al. A rabbit model for capsular contracture: development and clinical implications. 
Plastic and reconstructive surgery. 2006;117:1214-9. 
[289] Minami E, Koh IHJ, Ferreira JCR, Waitzberg AFL, Chifferi V, Rosewick TF, 
et al. The composition and behavior of capsules around smooth and textured breast 
implants in pigs. Plastic and reconstructive surgery. 2006;118:874-84. 
 232 Chapter 5: Discussion, Conclusions and Future Directions 
[290] Lossing C, Hansson H-A. Peptide growth factors and myofibroblasts in 
capsules around human breast implants. Plastic and reconstructive surgery. 
1993;91:1277-86. 
[291] Stump A, Holton III LH, Connor J, Harper JR, Slezak S, Silverman RP. The 
use of acellular dermal matrix to prevent capsule formation around implants in a 
primate model. Plastic and reconstructive surgery. 2009;124:82-91. 
[292] Hwang K, Sim HB, Huan F, Kim DJ. Myofibroblasts and capsular tissue 
tension in breast capsular contracture. Aesthetic plastic surgery. 2010;34:716-21. 
[293] Ko CY, Ahn CY, Ko J, Chopra W, Shaw WW. Capsular synovial metaplasia 
as a common response to both textured and smooth implants. Plastic and 
reconstructive surgery. 1996;97:1427-33. 
[294] Tuan HS, Hutmacher DW. Application of micro CT and computation modeling 
in bone tissue engineering. Computer-aided design. 2005;37:1151-61. 
[295] Hangartner T. Thresholding technique for accurate analysis of density and 
geometry in QCT, pQCT and ÌCT images. J Musculoskelet Neuronal Interact. 
2007;7:9-16. 
[296] Chazelle B, Edelsbrunner H. An optimal algorithm for intersecting line 
segments in the plane. Journal of the ACM (JACM). 1992;39:1-54. 
[297] Discher DE, Janmey P, Wang Y. Tissue cells feel and respond to the stiffness 
of their substrate. Science. 2005;310:1139-43. 
[298] Fang Z, Starly B, Sun W. Computer-aided characterization for effective 
mechanical properties of porous tissue scaffolds. Computer-aided design. 
2005;37:65-72. 
[299] Lal P, Sun W. Computer modeling approach for microsphere-packed bone 
scaffold. Computer-aided design. 2004;36:487-97. 
[300] Wang E, Nelson T, Rauch R. Back to elements-tetrahedra vs. hexahedra.  
Proceedings of the 2004 International ANSYS Conference2004. 
[301] Brown TD, Slotosch A, Thibaudeau L, Taubenberger A, Loessner D, Vaquette 
C, et al. Design and fabrication of tubular scaffolds via direct writing in a melt 
electrospinning mode. Biointerphases. 2012;7:13. 
[302] STU_Bratislava. BEAM188 3-D Linear Finite Strain Beam. 2010. 
[303] Ciocca L, De Crescenzio F, Fantini M, Scotti R. CAD/CAM and rapid 
prototyped scaffold construction for bone regenerative medicine and surgical transfer 
of virtual planning: a pilot study. Computerized Medical Imaging and Graphics. 
2009;33:58-62. 
[304] Cooke MN, Fisher JP, Dean D, Rimnac C, Mikos AG. Use of 
stereolithography to manufacture critical‐sized 3D biodegradable scaffolds for bone 
ingrowth. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 
2002;64:65-9. 
[305] Rohner D, Hutmacher D, See P, Tan K, Yeow V, Tan S, et al. [Individually 
CAD-CAM technique designed, bioresorbable 3-dimensional polycaprolactone 
framework for experimental reconstruction of craniofacial defects in the pig]. Mund-, 
Kiefer-und Gesichtschirurgie: MKG. 2002;6:162. 
[306] Liu Y, Zhang L, Zhou G, Li Q, Liu W, Yu Z, et al. < i> In vitro</i> 
engineering of human ear-shaped cartilage assisted with CAD/CAM technology. 
Biomaterials. 2010;31:2176-83. 
[307] Gradinger R, Hipp E. A custom-made adaptable pelvic prosthesis. New 
developments for limb salvage in musculosceletal tumors Springer, Berlin 
Heidelberg New York. 1989. 
 233 
Chapter 4: Discussion, Conclusions and Future Directions 233 
[308] Gradinger R, Rechl H, Hipp E. Pelvic osteosarcoma. Resection, reconstruction, 
local control, and survival statistics. Clin Orthop Relat Res. 1991;270:149-58. 
[309] Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and 
osteogenesis. Biomaterials. 2005;26:5474-91. 
[310] Woodruff MA, Lange C, Reichert J, Berner A, Chen F, Fratzl P, et al. Bone 
tissue engineering: from bench to bedside. Materials Today. 2012;15:430-5. 
[311] Holzapfel BM, Reichert JC, Schantz J-T, Gbureck U, Rackwitz L, Noeth U, et 
al. How smart do biomaterials need to be? A translational science and clinical point 
of view. Advanced drug delivery reviews. 2013;65:581-603. 
[312] Slic3r. Slic3r: Gcode generator for 3D printers. 2012. 
[313] Systems D. CATIA V5-6R2012 drives higher Design excellence. 2013. 
[314] GmBH N. netfabb Studio Professional. 2012. 
[315] Department-of-Defense. Department of Defense Breast Cancer Research 
Program, May 2013. Department of Defense; 2013. 
[316] Harcourt DM, Rumsey NJ, Ambler NR, Cawthorn SJ, Reid CD, Maddox PR, 
et al. The psychological effect of mastectomy with or without breast reconstruction: a 
prospective, multicenter study. Plastic and reconstructive surgery. 2003;111:1060-8. 
[317] Tabata Y, Miyao M, Inamoto T, Ishii T, Hirano Y, Yamaoki Y, et al. De novo 
formation of adipose tissue by controlled release of basic fibroblast growth factor. 
Tissue engineering. 2000;6:279-89. 
[318] Mian R, Morrison WA, Hurley JV, Penington AJ, Romeo R, Tanaka Y, et al. 
Formation of new tissue from an arteriovenous loop in the absence of added 
extracellular matrix. Tissue engineering. 2000;6:595-603. 
[319] Fischbach C, Seufert J, Staiger H, Hacker M, Neubauer M, Göpferich A, et al. 
Three-dimensional in vitro model of adipogenesis: comparison of culture conditions. 
Tissue engineering. 2004;10:215-29. 
[320] Kang X, Xie Y, Kniss DA. Adipose tissue model using three-dimensional 
cultivation of preadipocytes seeded onto fibrous polymer scaffolds. Tissue 
engineering. 2005;11:458-68. 
[321] Masuda T, Furue M, Matsuda T. Novel strategy for soft tissue augmentation 
based on transplantation of fragmented omentum and preadipocytes. Tissue 
engineering. 2004;10:1672-83. 
[322] Hemmrich K, von Heimburg D, Rendchen R, Di Bartolo C, Milella E, Pallua 
N. Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into nude 
mice to evaluate potential for soft tissue engineering. Biomaterials. 2005;26:7025-37. 
[323] Woodruff MA, Hutmacher DW. The return of a forgotten polymer—
polycaprolactone in the 21st century. Progress in Polymer Science. 2010;35:1217-56. 
[324] Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human 
umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. 
Stem cells. 2005;23:220-9. 
[325] Zhang Z-Y, Teoh SH, Chong W-S, Foo T-T, Chng Y-C, Choolani M, et al. A 
biaxial rotating bioreactor for the culture of fetal mesenchymal stem cells for bone 
tissue engineering. Biomaterials. 2009;30:2694-704. 
[326] Zhang Z-Y, Teoh SH, Teo EY, Khoon Chong MS, Shin CW, Tien FT, et al. A 
comparison of bioreactors for culture of fetal mesenchymal stem cells for bone tissue 
engineering. Biomaterials. 2010;31:8684-95. 
[327] Duvall CL, Taylor WR, Weiss D, Guldberg RE. Quantitative microcomputed 
tomography analysis of collateral vessel development after ischemic injury. 
American Journal of Physiology-Heart and Circulatory Physiology. 2004;287:H302-
H10. 
 234 Chapter 5: Discussion, Conclusions and Future Directions 
[328] Jensen C, Gurevich L, Patriciu A, Struijk J, Zachar V, Pennisi CP. Increased 
connective tissue attachment to silicone implants by a water vapor plasma treatment. 
Journal of Biomedical Materials Research Part A. 2012;100:3400-7. 
[329] Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. 
Biomaterials. 2000;21:2529-43. 
[330] Gefen A, Dilmoney B. Mechanics of the normal woman's breast. Technology 
and Health Care. 2007;15:259-71. 
[331] Neuss S, Apel C, Buttler P, Denecke B, Dhanasingh A, Ding X, et al. 
Assessment of stem cell/biomaterial combinations for stem cell-based tissue 
engineering. Biomaterials. 2008;29:302-13. 
[332] Sollazzo V, Lucchese A, Palmieri A, Zollino I, Iaccarino C, Carnevali G, et al. 
Polylactide-polyglycolide resorbable plates stimulates adipose tissue-derived stem 
cells towards osteoblasts differentiation. International journal of immunopathology 
and pharmacology. 2010;24:59-64. 
[333] Grijpma DW, Altpeter H, Bevis MJ, Feijen J. Improvement of the mechanical 
properties of poly (D, L‐lactide) by orientation. Polymer international. 2002;51:845-
51. 
[334] Hiljanen‐Vainio M, Karjalainen T, Seppälä J. Biodegradable lactone 
copolymers. I. Characterization and mechanical behavior of ε‐caprolactone and 
lactide copolymers. Journal of applied polymer science. 1996;59:1281-8. 
[335] Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable 
controlled drug delivery carrier. Polymers. 2011;3:1377-97. 
[336] Wiggenhauser PS, Müller DF, Melchels FPW, Egaña JT, Storck K, Mayer H, 
et al. Engineering of vascularized adipose constructs. Cell and tissue research. 
2011:1-11. 
[337] Moldovan NI. Role of monocytes and macrophages in adult angiogenesis: a 
light at the tunnel's end. Journal of hematotherapy & stem cell research. 
2002;11:179-94. 
[338] Anghelina M, Krishnan P, Moldovan L, Moldovan NI. Monocytes and 
macrophages form branched cell columns in matrigel: implications for a role in 
neovascularization. Stem cells and development. 2004;13:665-76. 
[339] Anghelina M, Krishnan P, Moldovan L, Moldovan NI. 
Monocytes/macrophages cooperate with progenitor cells during neovascularization 
and tissue repair: conversion of cell columns into fibrovascular bundles. The 
American journal of pathology. 2006;168:529-41. 
[340] Debels H, Galea L, Han X-L, Palmer J, Van Rooijen N, Morrison W, et al. 
Macrophages Play a Key Role in Angiogenesis and Adipogenesis in a Mouse Tissue 
Engineering Model. Tissue Engineering Part A. 2013;19:2615-25. 
[341] Stillaert F, Findlay M, Palmer J, Idrizi R, Cheang S, Messina A, et al. Host 
rather than graft origin of Matrigel-induced adipose tissue in the murine tissue-
engineering chamber. Tissue engineering. 2007;13:2291-300. 
[342] Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage 
cells from human adipose tissue: implications for cell-based therapies. Tissue 
engineering. 2001;7:211-28. 
[343] Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human 
adipose tissue is a source of multipotent stem cells. Molecular biology of the cell. 
2002;13:4279-95. 
[344] Rolstad B. The athymic nude rat: an animal experimental model to reveal 
novel aspects of innate immune responses? Immunological reviews. 2001;184:136-
44. 
 235 
Chapter 4: Discussion, Conclusions and Future Directions 235 
[345] Holzapfel BM, Thibaudeau L, Hesami P, Taubenberger A, Holzapfel NP, 
Mayer-Wagner S, et al. Humanised xenograft models of bone metastasis revisited: 
novel insights into species-specific mechanisms of cancer cell osteotropism. Cancer 
and Metastasis Reviews. 2013;32:129-45. 
[346] Saunders RL, Hammer DA. Assembly of human umbilical vein endothelial 
cells on compliant hydrogels. Cellular and molecular bioengineering. 2010;3:60-7. 
[347] Baldwin J, Antille M, Bonda U, De-Juan-Pardo EM, Khosrotehrani K, 
Ivanovski S, et al. In vitro pre-vascularisation of tissue-engineered constructs A co-
culture perspective. Vascular Cell. 2014;6:1-16. 
[348] Wolfram|Alpha. Volume human breast. 
http://wwwwolframalphacom/input/?i=volume+human+body. 2013;Access date: 19 
December 2013. 
[349] Bayer CM, Bani MR, Schneider M, Dammer U, Raabe E, Haeberle L, et al. 
Assessment of breast volume changes during human pregnancy using a three-
dimensional surface assessment technique in the prospective CGATE study. 
European journal of cancer prevention: the official journal of the European Cancer 
Prevention Organisation (ECP). 2013. 
[350] Hohl R, de Oliveira RB, de Macedo DV, Brenzikofer R. Apparatus for 
measuring rat body volume: a methodological proposition. Journal of Applied 
Physiology. 2007;102:1229-34. 
[351] Cancer IAfRo. World Cancer Report. International Agency for Research on 
Cancer; 2008. 
[352] FDA. FDA Update on the Safety of Silicone Gel-Filled Breast Implants 2011. 
[353] Patel P, Robb GL, Patrick Jr CW. Soft tissue restoration using tissue 
engineering. Semin Plast Surg. 2003;17:99-106. 
[354] Henkel J, Woodruff MA, Epari DR, Steck R, Glatt V, Dickinson IC, et al. 
Bone Regeneration Based on Tissue Engineering Conceptions-A 21st Century 
Perspective. 骨研究 (英文版). 2013. 
[355] Salgado AJ, Coutinho OP, Reis RL. Bone tissue engineering: state of the art 
and future trends. Macromolecular bioscience. 2004;4:743-65. 
[356] Martin P. Wound healing--aiming for perfect skin regeneration. Science. 
1997;276:75-81. 
[357] Clark RA. Fibrin and wound healing. Annals of the New York Academy of 
Sciences. 2001;936:355-67. 
[358] Chhaya MP, Melchels F, Holzapfel BM, Baldwin J, Hutmacher DW. Sustained 
Regeneration of High-volume Adipose Tissue for Breast Reconstruction using 
Computer Aided Design and Biomanufacturing Biomaterials [Accepted]. 2015. 
[359] Beahm EK, Walton RL, Patrick Jr CW. Progress in adipose tissue construct 
development. Clinics in plastic surgery. 2003;30:547. 
[360] Lokmic Z, Thomas JL, Morrison WA, Thompson EW, Mitchell GM. An 
endogenously deposited fibrin scaffold determines construct size in the surgically 
created arteriovenous loop chamber model of tissue engineering. Journal of vascular 
surgery. 2008;48:974-85. 
[361] Findlay MW, Dolderer JH, Trost N, Craft RO, Cao Y, Cooper-White J, et al. 
Tissue-engineered breast reconstruction: bridging the gap toward large-volume tissue 
engineering in humans. Plastic and reconstructive surgery. 2011;128:1206-15. 
[362] Messina A, Bortolotto SK, Cassell OC, Kelly J, Abberton KM, Morrison WA. 
Generation of a vascularized organoid using skeletal muscle as the inductive source. 
The FASEB Journal. 2005;19:1570-2. 
 236 Chapter 5: Discussion, Conclusions and Future Directions 
[363] Eterno V, Zambelli A, Pavesi L, Villani L, Zanini V, Petrolo G, et al. Adipose-
derived Mesenchymal Stem Cells (ASCs) may favour breast cancer recurrence via 
HGF/c-Met signaling. Oncotarget. 2014;5:613. 
[364] Huang C, Holfeld J, Schaden W, Orgill D, Ogawa R. Mechanotherapy: 
revisiting physical therapy and recruiting mechanobiology for a new era in medicine. 
Trends in molecular medicine. 2013;19:555-64. 
[365] Yuan Y, Ogawa R. Tissue-Engineered Breast Reconstruction: Bridging the 
Gap toward Large-Volume Tissue Engineering in Humans. Plastic and reconstructive 
surgery. 2015;135:236e-7e. 
[366] Yang X, Cai X, Wang J, Tang H, Yuan Q, Gong P, et al. Mechanical stretch 
inhibits adipogenesis and stimulates osteogenesis of adipose stem cells. Cell 
proliferation. 2012;45:158-66. 
[367] Nava MM, Raimondi MT, Pietrabissa R. Controlling self-renewal and 
differentiation of stem cells via mechanical cues. BioMed Research International. 
2012;2012. 
[368] Vazquez B, Given KS, Houston GC. Breast augmentation: a review of 
subglandular and submuscular implantation. Aesthetic plastic surgery. 1987;11:101-
5. 
[369] Mukhopadhyay S, Farver CF, Vaszar LT, Dempsey OJ, Popper HH, Mani H, 
et al. Causes of pulmonary granulomas: a retrospective study of 500 cases from 
seven countries. Journal of clinical pathology. 2012;65:51-7. 
[370] Baer C, Squadrito ML, Iruela-Arispe ML, De Palma M. Reciprocal interactions 
between endothelial cells and macrophages in angiogenic vascular niches. 
Experimental cell research. 2013;319:1626-34. 
[371] Eirin A, Zhu X-Y, Li Z, Ebrahimi B, Zhang X, Tang H, et al. Endothelial 
outgrowth cells shift macrophage phenotype and improve kidney viability in swine 
renal artery stenosis. Arteriosclerosis, thrombosis, and vascular biology. 
2013;33:1006-13. 
[372] He H, Xu J, Warren CM, Duan D, Li X, Wu L, et al. Endothelial cells provide 
an instructive niche for the differentiation and functional polarization of M2-like 
macrophages. Blood. 2012;120:3152-62. 
[373] Spiller KL, Anfang RR, Spiller KJ, Ng J, Nakazawa KR, Daulton JW, et al. 
The role of macrophage phenotype in vascularization of tissue engineering scaffolds. 
Biomaterials. 2014;35:4477-88. 
[374] Ludin A, Itkin T, Gur-Cohen S, Mildner A, Shezen E, Golan K, et al. 
Monocytes-macrophages that express α-smooth muscle actin preserve primitive 
hematopoietic cells in the bone marrow. Nature immunology. 2012;13:1072-82. 
[375] Feil S, Fehrenbacher B, Lukowski R, Essmann F, Schulze-Osthoff K, Schaller 
M, et al. Transdifferentiation of vascular smooth muscle cells to macrophage-like 
cells during atherogenesis. Circulation research. 2014;115:662-7. 
[376] Duan H-Y, Ye L, Wu X, Guan Q, Yang X-F, Han F, et al. The in vivo 
characterization of electrospun heparin-bonded polycaprolactone in small-diameter 
vascular reconstruction. Vascular. 2014:1708538114550737. 
[377] Byun J-H, Lee HA, Kim TH, Lee JH, Oh SH. Effect of porous 
polycaprolactone beads on bone regeneration: preliminary in vitro and in vivo 
studies. Biomaterials Research. 2014;18:18. 
[378] Berner A. Quantitative and qualitative assessment of the regenerative potential 
of osteoblasts versus bone marrow derived mesenchymal stem cells in the 
reconstruction of critical sized segmental tibial bone defects in a large animal model. 
2013. 
 237 
Chapter 4: Discussion, Conclusions and Future Directions 237 
[379] Uhrig BA, Boerckel JD, Willett NJ, Li M-TA, Huebsch N, Guldberg RE. 
Recovery from hind limb ischemia enhances rhBMP-2-mediated segmental bone 
defect repair in a rat composite injury model. Bone. 2013;55:410-7. 
[380] Myckatyn T. Breast Augmentation and Implant Position. 2011. 
[381] Brown TD, Dalton PD, Hutmacher DW. Direct writing by way of melt 
electrospinning. Advanced Materials. 2011;23:5651-7. 
[382] Kim HW, Knowles JC, Kim HE. Hydroxyapatite and gelatin composite foams 
processed via novel freeze‐drying and crosslinking for use as temporary hard tissue 
scaffolds. Journal of Biomedical Materials Research Part A. 2005;72:136-45. 
[383] Vallet-Regí M, Balas F, Colilla M, Manzano M. Bone-regenerative bioceramic 
implants with drug and protein controlled delivery capability. Progress in Solid State 
Chemistry. 2008;36:163-91. 
[384] Jin Q, Anusaksathien O, Webb S, Rutherford R, Giannobile W. Gene therapy 
of bone morphogenetic protein for periodontal tissue engineering. Journal of 
periodontology. 2003;74:202-13. 
[385] Mouriño V, Boccaccini AR. Bone tissue engineering therapeutics: controlled 
drug delivery in three-dimensional scaffolds. Journal of the Royal Society Interface. 
2010;7:209-27. 
 
 
  
 238 Chapter 6: Appendix 
Chapter 6: Appendix 
Void-System for generation of void spaces within prevascularised implant for 
efficient transfer of free fat grafts including lipofilling 
The prevascularisastion method described in Study 4 would be rendered impractical 
if the host connective tissue occupies a majority of the volume of the scaffold such 
that no further volume remains for the secondary injection of fat tissue. Therefore, 
we have developed a system of removable space-occupying structures within the 
scaffold which can be removed prior to injection of the fat. These space-occupying 
structures, when removed, would create voids within the scaffold which can then be 
used to inject the fat.  
a) The geometric orientation of the void spaces: 
- Non-convergent: parallel orientated voids along one axes of the scaffold 
(as seen in Fig1 red). This method needs multiple access tunnels for fat 
transfer. 
- Convergent: radiating from one origin to enable minimally invasive 
procedures by fat tranfer using one central tunnel for access to all voids. 
b) The technology used for space occupation: 
- Liquid/gel-like 
o hydrogel can be aspirated by a syringe, which would help in its 
removal in a minimally invasive way. 
- Solid 
o Collapsible:  
 biocompatible polymer material filled with saline.  When 
the saline is removed, the polymeric tube network would 
collapse which aids in its explantation in a minimally 
invasive way. 
o Rigid:  
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 implants (e.g. made out of metal) which are placed in 
previously drilled wholes within the scaffold structure and 
removed manually before fat transfer 
 
Figure 5.6.1: Rendering of a breast-shaped scaffold containing a collapsible network of interconnected 
tubes filled with a fluid (blue) or hydrogel (red) 
 
 
Figure 5.6.2. Prototype of a breast-shaped porous tissue engineering scafffold (white) containing 
templates for spacers (black). Photos with blue blackground show a convergent design of spacers, 
while photos with off-white backgrounds show a non-convergent design.  
 
Methods for removing spacers: 
Spacers fabricated with low porosity: 
We propose a scaffold design containing precisely defined regions of low porosity 
and low mechanical integrity which can be subsequently removed from the scaffold 
by means of a specialized surgical tool. The low porosity ensures that there is no 
tissue ingrowth within such regions and the low mechanical integrity (created by a 
system similar to that of a perforated paper) will aid in their easy removal. The voids 
created by the removal of these regions will be filled with fat by the surgeon. 
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Figure 5.6.3: Rendering of a breast shaped scaffold containing regions of low porosity and low 
mechanical integrity (regions are shown in red). 
 
Figure 5.6.4: A specialised surgical cutting tool will be designed to remove such regions. 
 
Figure 5.6.5: The void left behind by removal of the low porosity regions will be used for lipofilling 
(fat tissue shown in yellow) 
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Figure 5.6.6. Fabricated breast shaped scaffold (white) containing regions of low porosity and low 
mechanical integrity (black). 
 
 
Figure 5.6.7. A cutting tool used to punch out the regions of low porosity and mechanical integrity. 
 
Figure 5.6.8. The void left behind by removal of the low porosity regions (highlighted with red circle) 
can be used for lipofilling 
A pilot study was undertaken whereby n=6 scaffolds (volume = 125cm
3
) based on 
Design #1 were fabricated using Poly(D,L)-Lactide polymer and implanted in 
immunocomptent minipigs for a period of 24 weeks.  Upon explantation, the 
scaffolds were well integrated with the surrounding tissue and there was a 
widespread invasion of host vasculature into the constructs. Visual examination 
revealed that the overall shape of the scaffolds did not change drastically over the 
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implantation period. Histological evaluation showed large areas of fat and 
vascularisation around the injection sites on all scaffolds (Fig 5.6.9) 
  
Figure 5.6.9 (TOP) Gross morphological images of scaffold containing void structures with and without the 
fat injected into the voids. (BOTTOM) Hematoxylin and Eosin stained section of a scaffold explanted after 
6 months implantation into minipigs. Photograph on top left shows a cut out of the area surrounding a 
randomly selected void filled with adipose tissue (adipose tissue encircled in yellow). The corresponding 
area in the histological section, also encircled in yellow, shows healthy well vascularised adipose tissue at 
the injection site with no signs of necrosis. 
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1c Biodegradable implant generating prevascularized connective tissue to 
resemble organic stromal tissue to be in situ carrier of functional cell colonies 
The impact of our technology goes beyond the reach of adipose tissue transfer. Every 
tissue engineering approach needs a functional vascular system within it. There are 
several ideas described in literature: e.g.  vessel loop, printed tubular sytems or 
coprogs. Our system is based on a rapid prototyping made scaffold that serves as 
organic stromal tissue. By that means our implant plays the role of the supporting 
connective tissue within any possible organ. Therefore our system can be used for 
different engineering purposes: e.g. salivary gland or pancreatic islet function. 
The technical idea hereby is based on the procedure using an implant that serves as 
connective tissue carrier in combination with our void-system: The invention of the 
void-system enables us to use our implant for every kind of tissue engineering 
approach, because after the removal of the occupying space holder, the void-system 
is filled with the organ specific functional cells, e.g. glandular epithelial cells or 
pancreatic islet cells. That leads to an universal applicability of our system in every 
kind of tissue engineering approach. 
Design #2 
Design #2 improves Design #1 by the introduction of a minimal invasive surgical 
access technology consisting of scaffold design, minimal-invasive removable void-
system and surgical assistance tool. 
The following illustrations demonstrate the conceptual approach of the regenerative 
implant with a void-system. 
Step 1. The scaffold is fabricated along with space-occupying structures. These 
space-occupying structures are then filled with a saline solution or a hydrogel (A, B) 
and then implanted into the patient (C). 
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Step 2. After a period of 6-8 weeks, the fluid within the space occupying structures is 
removed by means of a minimally invasive procedure. This causes the structures to 
collapse and then they can be easily removed, leaving behind void spaces within the 
scaffold (D,E). 
 
Step 3. Fat is isolated from a donor site within the patient and is then injected into the 
void space left by removal of the structures (F, G). 
 
During the removal of the space-occupying structure, it would be highly beneficial to 
follow a minimally invasive surgical procedure. Removal of the space occupying 
B C A 
E D 
G 
F 
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structures during a minimally invasive procedure would be significantly simplified if 
the structures do not adhere strongly to the host tissue.  To achieve this, we will coat 
the structures with a solution of the drug Tacrolimus. Tacrolimus, an FDA approved 
drug, works by proliferation control and prevents a fast ingrowth of host tissue. By 
that means we plan to reduce the attachment of tissue to the  implant and thus to 
reduce the adherence of the space-occupying system within the scaffold. All in all 
this idea facilitates the removal of the space-occupying system and minimizes 
complication risk due to the removal procedure like bleeding from attached tissue. 
Design #3 
Design #3 improves current fused deposition modeling technologies by introducing a 
new lay-down pattern leading to highly improved control over scaffold mechanical 
properties especially elasticity and compressibility.  
For breast tissue engineering applications, it is important to have flexibility and 
compressibility in the implanted scaffold. Currently, the only way to engineer such 
flexibility within tissue engineering scaffolds is to use an elastomeric biomaterial. 
Our novel approach aims at designing flexible implants made from semi-stiff 
biomaterials such as Polycaprolactone.  
The conventional laydown pattern for FDM-manufactured tissue engineering 
scaffolds is to use continuous bars and struts. Such a laydown pattern restricts lateral 
compressibility. Our first design modification is to use a non-continuous strut to 
better distribute the forces along the lateral axis.  
 
Figure 5.6.10: Left: Conventional laydown pattern consisting of continuous struts. Centre, Right: Our 
novel laydown patterns consisting of discontinuous struts 
 
The second design modification we propose, is to introduce an offset between 
vertically stacked struts. 
X
 
a
x
i
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Figure 5.6.11: On the left, conventional laydown pattern. On the right: Modified laydown pattern 
consisting of offset struts. Note that the struts in Y axis are not laid directly on top of each other. We 
not only can lay down the struts differently in every second layer but also create a repetition after 
every nth layer. 
 
Figure 5.6.12: Left: Conventional laydown pattern. Right: Modified laydown pattern 
   
Figure 5.6.13: Other examples of novel laydown patterns. 
Z 
a
xi
s 
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Figure 5.6.14. Left: Control polycaprolactone scaffold containing straight struts. Centre: Scaffold with 
zigzag laydown pattern. Right: Scaffold with zigzag laydown pattern AND offset between layers. 
These modifications allow us to control the flexibility of the scaffold to adjust the 
PCL scaffold to specific tissue needs: from stiff bones, to elastic cartilage to 
compressible connective tissue. Preliminary compression testing performed on 
scaffolds containing such modified laydown patterns indicates that such scaffolds are 
more flexible, can take the same stress as the control scaffolds and display a higher 
range of elastic deformation as compared to control scaffolds fabricated with the 
same parameters.  
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Figure 5.6.15. Stress vs Strain curves of scaffolds with either straight struts or a zigzag pattern of 
struts. 
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Figure 5.6.16. Timeline showing the evolution of the overall scaffold shape throughout the PhD project. Due to software limitations, scaffolds produced in 2012 were of 
geometrical shapes (dome-shaped). In 2013, Study 2 saw the development of computer software and algorithms which allowed fabrication of patient-specific scaffolds from 
medical imaging scans. However, the concave shape of the scaffolds does not permit easy and stable implantation into subglandular/submuscular pockets and, following a 
consultation with leading plastic surgeons, the scaffold shape was modified to match that of currently available anatomically-shaped silicone implants. The next generation 
implants imbibe all design principles described in the Appendix and have drastically reduced stiffness.  
 
